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ABSTRACT 
 
Exposure to ionizing radiation (IR), from both natural and man-made sources, is an 
inevitable part of modern life. It is well established that there are considerable inter-individual 
variations in sensitivity to IR among healthy individuals and cancer patients. However, the 
mechanisms involved in the heterogeneity of biological responses to IR are not well 
understood, and a reliable biodosimetric and clinical approach to measure and rank 
radiosensitivity remains to be established. In this thesis, we study the extent and impact of 
individual radiosensitivity in healthy individuals in the contexts of emergency dosimetry and 
radiotherapy, and we explore the roles of telomeres in the prediction of individual 
radiosensitivity and long-term human health risks following IR exposure (specifically, 
cardiovascular diseases and/or cancer). First, in the context of dosimetry in the event of an 
emergency situation (when rapid dose estimates of each individual in an irradiated 
population are needed), we demonstrate that the impact of individual radiosensitivity can be 
negligible using global cellular measurements of γH2AX fluorescence via flow cytometry in 
human fibroblasts and lymphocytes at 4 hours post-irradiation; this method could be an 
effective and rapid biodosimetry tool that can aid in the medical triage of irradiated 
individuals in an emergency setting based on individual levels of exposure. Second, we 
study the extent and influence of individual radiosensitivity on the induction of chromosomal 
aberrations following a routinely administered dose of 2 Gy during conventional fractionated 
photon radiotherapy (γ-rays) in lymphocytes of healthy individuals. For these analyses, we 
define individual radiosensitivity based on the frequency of IR-induced DNA double strand 
breaks (DSBs), which were calculated from the scoring of chromosomal aberrations 
visualized with telomere/centromere-fluorescence in situ hybridization (TC-FISH). This TC-
FISH staining of metaphasic chromosomes enhances the “gold standard technique” of 
biodosimetry (the dicentric chromosome assay) with the visualization of telomeres and 
centromeres and thereby provides improved simplicity and sensitivity to the classical 
cytogenetic assay. We also compare individual radiosensitivity following γ-irradiation to that 
following carbon irradiation, an up-and-coming ion species currently being used in charged 
particle radiotherapy. We provide dose response curves for both γ- and carbon irradiations 
based on the calculated frequency of IR-induced DNA DSBs at a range of doses, and 
estimate the relative biological effectiveness (RBE) of carbon irradiation relative to γ-
irradiation. We then estimate the RBE of a third type of IR also frequently used in charged 
particle radiotherapy (proton beams) in comparison to γ-irradiation, and compare individual 
radiosensitivity to each of these three types of IR with different IR energies. Third, we 
evaluate the roles of telomeres and telomere maintenance in the prediction of individual 
radiosensitivity; we find that inherent mean telomere length in combination with the IR-
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induced change in mean telomere length may be a strong predictor of individual 
radiosensitivity. Finally, we show how telomeres could be linked to long-term health risks 
following IR exposure: we demonstrate that telomere shortening could be a new prognostic 
factor for cardiovascular disease following radiotherapy, and discuss how telomeres could 
be key players in the process of radiation-induced carcinogenesis. In conclusion, we 
deliberate the relationships between telomere maintenance, radiation effects, and individual 
radiosensitivity, and propose a model of how telomeres could play crucial roles in the 
development of cardiovascular diseases and the process of IR-induced carcinogenesis. 
 
Key words: Ionizing radiation, individual radiosensitivity, telomere maintenance, relative 
biological effectiveness, biodosimetry, cytogenetics 
 
 
  
  
 
 
6 
RÉSUMÉ (FR) 
 
L'exposition aux rayonnements ionisants est une composante inévitable de la vie 
moderne. Il est bien établi qu'il existe une grande variabilité inter-individuelle de la 
radiosensibilité chez les individus sains et chez des patients atteints de cancer. Cependant, 
les mécanismes impliqués dans l'hétérogénéité des réponses biologiques radio-induites ne 
sont pas encore bien compris, et une approche biologique permettant d’établir de façon 
fiable le niveau de radiosensibilité reste à développer. Dans cette thèse, nous avons étudié 
l'ampleur et l'impact de la radiosensibilité individuelle chez les individus sains dans les 
contextes de dosimétrie d'urgence et de radiothérapie. Nous avons également examiné les 
différents rôles des télomères dans la prédiction de la radiosensibilité individuelle et des 
risques pour la santé humaine à long terme (spécifiquement, en ce qui concerne les 
maladies cardiovasculaires et/ou les cancers) après irradiation. Tout d'abord, dans le 
contexte de la dosimétrie dans le cas d'une situation d'urgence (lorsqu’il est nécessaire 
d’estimer rapidement la dose d’irradiation reçu par un individu), nous avons démontré que 
l'impact de la radiosensibilité individuelle peut être négligeable en utilisant des mesures 
globales de fluorescence de γH2AX via cytométrie en flux dans des fibroblastes humains et 
des lymphocytes à 4 heures après exposition ; cette méthode peut être un outil de 
biodosimétrie efficace et rapide qui peut aider au tri des personnes irradiées dans une 
situation d'urgence basées sur les niveaux individuels d'exposition. Dans un second temps, 
nous avons étudié l'ampleur et l'influence de la radiosensibilité individuelle sur l'induction 
d'aberrations chromosomiques après une irradiation de 2 Gy de rayons γ, correspondant à 
une fraction de radiothérapie conventionnelle, dans les lymphocytes d'individus sains. Pour 
ces analyses, nous définissons la radiosensibilité individuelle par rapport à la fréquence des 
cassures double-brin (CDB) radio-induite, qui ont été calculées à partir de la quantification 
des aberrations chromosomiques visualisées par hybridation in situ des télomères et 
centromères (TC-FISH). Ce marquage améliore et simplifie la technique « gold standard » 
de dosimétrie biologique (la quantification des chromosomes dicentriques). Nous avons 
également estimé la radiosensibilité individuelle à l’irradiation carbone, particules chargées 
utilisées en radiothérapie, et l'efficacité biologique relative (EBR) des ions carbone par 
rapport à une irradiation γ. Nous avons fourni des courbes dose-réponse pour ces deux 
types d’irradiations en fonction de la fréquence des CDB radio-induite par exposition à une 
gamme de doses. De plus, nous avons estimé l'EBR d'un troisième type de rayonnement 
également utilisé en radiothérapie de particules chargées (protons) par rapport à une 
irradiation γ, et nous avons comparé la radiosensibilité individuelle de ces trois types 
d'irradiation avec énergies différentes. Ensuite, nous avons évalué les rôles des télomères 
et de leur maintien pour la prédiction de la radiosensibilité individuelle. Nous avons constaté 
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que la longueur moyenne des télomères, en combinaison avec leurs modifications radio-
induites, peuvent être un bon prédicteur de la radiosensibilité individuelle. Enfin, nous avons 
montré comment les télomères pourraient être liés à des risques sanitaires à long terme 
après une irradiation: nous avons démontré que le raccourcissement des télomères pouvait 
être un nouveau facteur de prédiction de maladies cardiovasculaires après radiothérapie, et 
nous avons discuté par la suite, les télomères comme des acteurs clés dans le processus 
de cancérogenèse radio-induite. En conclusion, nous proposons un modèle présentant la 
façon dont les télomères pourraient jouer un rôle crucial dans ces deux pathologies radio-
induite, et nous délibérons des relations entre le maintien des télomères, les effets 
biologiques radio-induites, et la radiosensibilité individuelle. 
 
Mots clefs: Rayonnements ionisants, radiosensibilité individuelle, maintenance des 
télomères, efficacité biologique relative, biodosimétrie, cytogénétique 
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FOREWORD 
 
Exposure to ionizing radiation (IR) is an inevitable part of modern life, especially in 
the advent of diagnostic radiology, radiation therapy, and military/civilian nuclear technology. 
It is well established that there are considerable inter-individual variations in sensitivity to IR 
in the general population. As radiosensitivity can have significant impact on short-term and 
long-term IR effects, understanding the mechanisms involved in the heterogeneity of 
biological responses to IR and the development of a reliable clinical and biodosimetric 
approach to measure and rank radiosensitivity is essential for the refinement of radiation 
protection protocols, cancer radiotherapy regimens, and overall long-term human health. In 
this thesis, we study the extent and impact of individual radiosensitivity in healthy individuals 
in the contexts of emergency dosimetry and radiotherapy, and we explore the roles of 
telomeres in the prediction of individual radiosensitivity and long-term human health risks 
following IR exposure. First, we ask whether individual radiosensitivity measured in terms of 
the induction of γH2AX, a promising candidate as a biomarker for biodosimetry, significantly 
impacts the development of an effective and rapid biodosimetry tool that can aid in medical 
triage of irradiated individuals in a large-scale emergency setting. Second, we seek to 
characterize the extent and influence of individual radiosensitivity on the induction of 
chromosomal aberrations following a routinely administered dose during conventional 
fractionated photon (γ-rays) and charged particle (carbon and proton) radiotherapy, and we 
define the relative biological effectiveness (RBE) of these charged particles, as this remains 
a major issue in the improvement of modern radiotherapy regimens. For these analyses, we 
utilize an enhanced version of the dicentric chromosome assay (the “gold standard 
technique” of biodosimetry) that utilizes telomere/centromere peptide nucleic acid 
fluorescence in situ hybridization (TC-FISH), which provides improved simplicity and 
sensitivity to the classical cytogenetic assay. Finally, we ask whether telomeres, telomere 
maintenance, and telomere dysfunction play a role in the prediction of individual 
radiosensitivity and in the manifestation of long-term health risks following IR exposure 
(specifically, cardiovascular diseases and/or cancer). Therefore, throughout this manuscript, 
we describe individual radiosensitivity in healthy individuals and explore how telomeres and 
their IR-induced modifications could influence this variability and overall long-term human 
health post-irradiation. 
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AVANT-PROPOS (FR) 
 
L'exposition aux rayonnements ionisants est une composante inévitable de la vie 
moderne, en particulier dans l'avènement de la radiologie diagnostique, la radiothérapie, et 
la technologie nucléaire militaire/civile. Il est bien établi qu'il existe une grande variabilité 
inter-individuelle de la radiosensibilité dans la population générale. Comme la 
radiosensibilité peut avoir un impact significatif sur les effets radio-induits à court terme et à 
long terme, la compréhension des mécanismes impliqués dans l'hétérogénéité des réponses 
biologiques aux rayonnements ionisants et le développement d'une approche biologique 
permettant d’établir de façon fiable le niveau de radiosensibilité, sont essentiels pour 
améliorer les protocoles de radioprotection, les régimes de radiothérapie, et la santé 
humaine à long terme après exposition. Dans cette thèse, nous étudions l'ampleur et 
l'impact de la radiosensibilité individuelle chez les individus sains dans les contextes de 
dosimétrie d'urgence et de radiothérapie. De plus, nous avons examiné le rôle des 
télomères dans la prédiction de la radiosensibilité individuelle et des risques pour la santé 
humaine à long terme (pour ce qui est des maladies cardiovasculaires et / ou cancer) après 
une exposition aux rayonnements ionisants. Tout d'abord, nous nous sommes demandés si 
la radiosensibilité individuelle, mesurée par l'induction de γH2AX (candidat prometteur en 
tant que biomarqueur pour la biodosimétrie), a un impact significatif sur le développement 
d'un outil de biodosimétrie efficace et rapide, ceci afin de faciliter le tri des personnes 
irradiées lors de situations d'urgence. Dans un second temps, nous cherchons à caractériser 
l'ampleur et l'influence de la radiosensibilité individuelle sur l'induction d'aberrations 
chromosomiques à une dose de rayons γ correspondant à une fraction de radiothérapie 
conventionnelle (rayons γ) et de particules chargées (carbone et protons). Nous définissons 
également l'efficacité biologique relative (EBR) de ces particules chargées, car cela reste un 
problème majeur pour l'amélioration de nouvelles techniques de radiothérapie. Pour ces 
analyses, nous utilisons une version améliorée de la technique « gold standard » de 
dosimétrie biologique (quantification des chromosomes dicentriques) par hybridation in situ 
des télomères et centromères (TC-FISH), ce qui permet de simplifier et d’améliorer la 
sensibilité de l’analyse cytogénétique classique. Enfin, nous nous sommes demandés si les 
télomères et leur maintien peuvent jouer un rôle dans la prédiction de la radiosensibilité 
individuelle ainsi qu’au niveau des risques pour la santé à long terme après expositions aux 
rayonnements ionisants (spécifiquement les maladies cardiovasculaires et/ou cancer). Ainsi, 
au cours de ce manuscrit, nous détaillons la radiosensibilité individuelle chez les individus 
sains et explorons comment les télomères et leurs modifications radio-induites pourraient 
influencer cette variabilité et les conséquences sur la santé humaine globale à long terme, 
post-irradiation. 
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1 - INTRODUCTION 
 
Exposure to ionizing radiation (IR) is an inevitable part of the environment, and 
increasingly of modern life. IR is omnipresent in the environment from natural sources (e.g. 
cosmic rays, terrestrial sources in soil and rock, radon decay products in the air, and various 
radionuclides found in food and water), and from man-made sources released into the 
environment (e.g. fallout from nuclear weapons testing, discharges of radioactive waste, and 
consumer products). Additionally, individuals may be exposed to IR during occupational 
activities related to nuclear technology, mining, high altitude airline travel, and deep space 
exploration, as well as during medical procedures (e.g. diagnostic radiology, nuclear 
medicine, and cancer radiotherapy). Of these, of greatest significance perhaps is the 
increasing growth in the use of diagnostic radiology, where increasing numbers of 
individuals are being repeatedly exposed to significant doses of IR. This has led to 
significant increases in levels of human exposure to IR. As it is well established that there 
are considerable inter-individual variations in sensitivity to IR in the general population 
(Advisory Group on Ionising Radiation, 2013), these increasing levels of IR exposure may be 
an important public health issue in the future, particularly for highly radiosensitive individuals 
(Hall, 1984;UNSCEAR, 2010). A reliable biodosimetric and clinical approach to measure and 
rank radiosensitivity to identify and better protect these highly radiosensitive individuals still 
remains to be developed. In this thesis, we characterize the extent of individual 
radiosensitivity in healthy individuals and the impact of this variability in the contexts of 
emergency dosimetry and radiotherapy, and we demonstrate that telomeres could be linked 
to individual radiosensitivity and long-term human health risks following IR exposure 
(specifically, cardiovascular diseases and/or cancer).  
To introduce these various topics in this chapter, we start with a presentation of 
current general knowledge of telomeres, telomere maintenance, and consequences of 
telomere dysfunction, followed by an overview of various biological effects of IR exposure 
(focusing especially on IR-induced telomeric and chromosomal damages and repair, as well 
as IR-induced chromosomal instability). We then describe a variety of biomarkers that are 
used to measure these IR-induced biological effects, and, as we focus on cytogenetic 
methodologies in this thesis, we provide the current status of state-of-the-art cytogenetic 
biomarker assays that are being used for biodosimetry. Finally, we link these topics in the 
context of individual radiosensitivity, and provide an overview of the current understanding of 
the mechanisms, consequences, and prediction of individual radiosensitivity. 
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1.1 Telomeres 
1.1.1 Telomeres and telomere maintenance mechanisms 
Telomeres play a critical role as the guardians of genomic stability and integrity. As 
discussed in detail in our original paper (Shim et al., 2014) presented in Section 5.2, 
telomeres are specialized nucleoprotein structures located at the ends of linear eukaryotic 
chromosomes (Blackburn et al., 2006). As shown in Figure 1, they consist of a single-
stranded DNA portion (3' overhang) composed of G-rich tandem repeats of 5'-TTAGGG-3' 
sequences that protrudes beyond the double-stranded portion of telomeric DNA, along with 
six associated proteins, named TRF1, TRF2, TIN2, POT1, TPP1, and RAP1. Together, they 
form a protective cap called the shelterin complex (de Lange, 2005) that protects 
chromosome ends from being recognized as DNA double strand breaks (DSBs) and 
prevents unwanted activation of DNA damage response (DDR) and repair pathways (de 
Lange, 2005;Doksani and de Lange, 2014).  
 
 
Figure 1. (A) Structure of mammalian telomeres, including the double-stranded telomeric DNA, 
the single-stranded 3' overhang, and the shelterin complex. (B) Interactions of the six shelterin 
proteins with DNA, and their repression of six DNA damage response (DDR) pathways that 
threaten telomere integrity: (1) ATM and (2) ATR signaling, (3) classical and (4) alternative non-
homologous end joining (c-NHEJ and alt-NHEJ, respectively), (5) homology-directed repair 
(HDR), and (6) 5' resection. Removal of TRF2 and POT1a elicit ATM and ATR signaling, 
respectively. TRF2 blocks c-NHEJ, and Rap1, POT1a/b, and Ku70/80 block HDR. Alt-NHEJ and 
5' resection is blocked by multiple shelterin components (or their interacting factors), as well 
as Ku70/80 and 53BP1, respectively (Adapted from Sfeir and de Lange, 2012;Doksani and de 
Lange, 2014). 
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Telomeres can be found in the shape of T-loop structures, formed when the single-
stranded telomeric DNA invades the double-stranded portion (Griffith et al., 1999;de Lange, 
2004;Palm and de Lange, 2008). The G-rich single-stranded telomeric DNA may also form 
G-quadruplexes, which are formed from a series of G-quartets each containing four guanine 
bases arranged in a helical fashion (Huppert, 2008;Lipps and Rhodes, 2009). These 
structures may serve as an architectural solution to protect telomeres from DDR machinery 
(Griffith et al., 1999). Additionally, the shelterin proteins were shown to repress the activation 
of six independent DDR mechanisms at telomeres, indicating that many mechanisms are 
used to protect chromosomal ends from DNA damage surveillance proteins, as shown in 
Figure 1B. Namely, shelterin proteins block (1) classical and (2) alternative non-homologous 
end joining (c-NHEJ and alt-NHEJ, respectively) to prevent chromosome fusions; control (3) 
homologous recombination (HR) to regulate telomere lengths; prevent activation of (4) ATM 
(ataxia telangiectasia mutated) and (5) ATR (ATM- and RAD3-related) kinase pathways, 
which could induce cell cycle arrest; and protect chromosome ends from (6) hyper-resection 
(Sfeir and de Lange, 2012;Doksani and de Lange, 2014). 
Telomere length (TL) varies between organisms; in humans, the length of the double-
stranded end can be 2 to 20 kilobases (kb), while the length of the single-stranded G-rich 
overhang can be 50 to 500 nucleotides. TL also varies on individual chromosome arms 
(Pommier and Sabatier, 2002), and this inherent heterogeneity of TL is conserved during life 
(Graakjaer et al., 2003). TL in somatic proliferative tissues naturally declines with each cell 
replication cycle at a rate of approximately 20–300 base pairs per population doubling 
(varying with cell type) (Harley et al., 1990) due to the incomplete replication of telomere 
ends by conventional DNA polymerases, a situation known as the ‘end replication problem’ 
(de Lange, 2009). After many rounds of cell division, telomeres eventually become critically 
short and dysfunctional. In normal cells with intact p53 functions and cell cycle checkpoints, 
these dysfunctional/uncapped telomeres are sensed as DNA damage and trigger DDR 
pathways, forming telomere dysfunction-induced foci, termed TIFs (Takai et al., 2003). At 
this point, these DDR signals prevent the cell from further division (d'Adda di Fagagna et al., 
2003), and cells enter a stage of permanent growth arrest called replicative senescence 
(Hayflick and Moorhead, 1961). A recent study showed that DDR signals persist long after 
the onset of senescence, indicating that these signals are important both for senescence 
establishment and maintenance (Fumagalli et al., 2014). Progressive telomere shortening 
therefore acts as a 'molecular clock' that limits the number of cell divisions, thereby 
regulating cellular lifespan and aging (Harley, 1991).  
The natural progressive shortening of telomeres during cell replication can be 
accelerated via exposure to DNA damaging agents throughout the cell lifespan, leading to 
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premature replicative senescence. Indeed, DNA is continuously exposed to endogenous and 
exogenous damaging agents. Some endogenous DNA damaging factors include point 
mutations or deletions in genes encoding proteins involved in telomere protection, as well as 
recombination and epigenetic regulation. Telomere shortening can also be accelerated by 
external environmental stress and lifestyle factors that cause DNA DSBs or mis-replication 
of telomeres such as IR and other oxidizing agents, oxidative stress, inflammation, 
hyperoxia, oncogenes, toxins, chronic viral infections, smoking, alcohol consumption, 
obesity, stress, and even psychiatric conditions (Jackson and Bartek, 2009;Lin et al., 
2012;Price et al., 2013). As will be discussed in Section 1.1.3, reduced TL has been 
associated with numerous chronic diseases that are generally considered to be diseases of 
aging, such as diabetes, cancer, and heart disease (Blasco, 2005;Armanios and Blackburn, 
2012;Holohan et al., 2014). Furthermore, abnormal and persistent loss of telomeres may 
contribute to the increased frequency of secondary complications seen in long-term cancer 
survivors (Shim et al., 2014).  
The persistent shortening of telomeres can be offset in different cell types (i.e. normal 
somatic cells, germ cells, cancer cells) via two mechanisms of telomere elongation: (1) by 
telomerase, a specialized reverse transcriptase that elongates telomeres by adding 
TTAGGG DNA sequence repeats to the 3' G-strand overhang at chromosome ends (Greider 
and Blackburn, 1985; 1987), and/or (2) by homologous recombination (HR) of telomeres via 
“alternative lengthening of telomeres” (ALT), a pathway independent of telomerase activity 
(Bryan et al., 1995). Telomerase is primarily expressed in stem cells, germ cells, 
regenerating tissues, and cancer cells; it is silent in most differentiated cells, such as normal 
somatic cells (Wright et al., 1996), thereby resulting in telomere shortening after each round 
of cell division. The enzyme is up-regulated in about 85% of human cancers, suggesting its 
important role in the process of cellular immortalization and tumorigenesis (Shay and 
Bacchetti, 1997), and its down-regulation or inhibition has been shown to promote apoptosis 
in malignant cells (Massard et al., 2006); these properties make telomerase an attractive 
target for anti-cancer therapies (Olaussen et al., 2006;Mocellin et al., 2013) as telomerase 
inhibitors would target and sensitize telomerase-positive malignant cancers to cancer 
treatments while normal somatic cells, which do not express telomerase, are minimally 
affected (Buseman et al., 2012). However, a significant subset of human tumors (10-15%) 
employs the telomerase-independent ALT pathway (Bryan et al., 1995;Shay and Bacchetti, 
1997).  
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1.1.2 Telomere dysfunction, telomere fusions, and chromosomal instability 
As mentioned above, critically short telomeres due to natural and/or accelerated 
progressive shortening of telomeres during cell replication become dysfunctional and are 
sensed as DNA DSBs, which activate DDR pathways without actual presence of DSBs at 
telomeres. Dysfunctional telomeres can arise due to a number of other factors, including 
improper functioning of telomere maintenance mechanisms, or the loss or improper 
functioning of the shelterin proteins, which leads to loss of their protective capping functions 
(i.e. repression of the six DDR mechanisms at telomeres described above). Telomere 
dysfunction can also be due to loss or dysfunction of DDR proteins themselves, as these 
proteins were also shown to be involved in the normal maintenance and protection of 
telomeres (Ayouaz et al., 2008). Generally, shelterin protein levels were shown to be directly 
proportional to TL and the level of telomerase inhibition, and inversely correlated with the 
induction of DDR factors (such as ATM and γH2AX) (Raynaud et al., 2008a;Raynaud et al., 
2009;Raynaud et al., 2010).  
Upon activation of the DDR pathways, a complex signaling cascade is triggered to 
activate DNA repair pathways, induce cell cycle arrest to allow time for repair of DNA 
damage, and in certain cases, initiate senescence or apoptosis. DDR pathways will be 
discussed in detail in Section 1.2.3. In short, ATM, ATR, and DNA-PK (members of the 
phosphatidyl inositol 3-kinase-like kinase [PIKK] family) phosphorylate histone H2AX to form 
γH2AX around the DSB or dysfunctional telomere, which leads to both structural alterations 
to the chromatin around the damaged site to allow repair proteins access to the damaged 
regions of the DNA, as well as the recruitment and retention of key DDR factors including 
MDC1, the MRN complex (MRE11–RAD50–NBS1), 53BP1, and BRCA1. These proteins 
continue to initiate the phosphorylation and dimerization of checkpoint kinases CHK2/CHK1, 
which targets effectors including p53, CDC25A, and CDC25C that goes on to activate cell 
cycle checkpoints or induce apoptosis (Raynaud et al., 2008b;Thompson, 2012). At 
dysfunctional telomeres, the recruitment of DDR factors such as 53BP1, γH2AX, ATM, and 
MRE11 induces the formation of TIFs (Takai et al., 2003). An important study suggested that 
normal human cells are able to tolerate small numbers of dysfunctional telomeres, and cells 
can continue to proliferate until a threshold of five TIFs per cell is reached (Kaul et al., 2012), 
at which point senescence is triggered in normal cells with intact p53 functions and cell cycle 
checkpoints (Hayflick and Moorhead, 1961;d'Adda di Fagagna et al., 2003). The lack of 
chromosomal fusions in pre-senescent cells may indicate that sufficient levels of shelterin 
proteins are present at the telomeres to retain their protective roles. However, in cells that 
are unable to senesce due to the loss of cell cycle checkpoint proteins such as p53 or p16, 
senescence is temporarily bypassed, and cells continue to proliferate with further 
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accumulation of TIFs (Kaul et al., 2012) and telomere shortening, until “telomeric crisis” is 
reached. In virus-immortalized cells undergoing crisis, more than 5 dysfunctional telomeres 
were found (Kaul et al., 2012) along with massive chromosome fusion and cell death 
(Counter et al., 1992;Counter et al., 1994;Ducray et al., 1999), perhaps due to extreme 
telomere shortening and loss of shelterin proteins (Kaul et al., 2012). 
Damaged or dysfunctional telomeres, sensed as DNA DSBs, may result in telomeric 
end-to-end fusions and chromosomal aberrations (CAs) via DNA DSB repair mechanisms. 
As will be discussed in detail in Section 1.2.3, mammals possess two principle mechanisms 
of DNA DSB repair – non-homologous end joining (NHEJ) and homologous recombination 
(HR) repair – with the majority of chromosome fusions in mammalian cells occurring via 
NHEJ, the major form of DSB repair. Chromosome fusions due to telomere dysfunction from 
the loss or dysfunction of shelterin or DDR proteins have thus far been shown to occur via 
two pathways: the classical-NHEJ (c-NHEJ) pathway, or the alternative-NHEJ (alt-NHEJ) 
pathway. A compilation of published data on this subject is presented in our original paper 
(Shim et al., 2014); however, it should be noted that many conflicting data exist, and the 
consequences of the dysfunction of these proteins also appear to differ among species. The 
choice of repair pathway appears to depend on how the telomeres were rendered 
dysfunctional, as shown in Figure 1B (Sfeir and de Lange, 2012;Doksani and de Lange, 
2014); for instance, naturally shortened telomeres and loss of TRF2 result in chromosomal 
fusions via c-NHEJ, while loss of TPP1–POT1a/b result in chromosomal fusions via alt-
NHEJ (Rai et al., 2010;Decottignies, 2013). A recent study indicates a previously 
undescribed role of BRCA1 and CtIP in fusions of a large fraction of TRF2-depleted cells via 
alt-NHEJ in conjunction with EXO1, and LIG3; this study further highlights the complexity of 
telomere protection mechanisms (Badie et al., 2015). 
Telomeric regions (and sub-telomeric regions, extending at least 100 kb from the 
telomere) are particularly sensitive to DSBs, and thus the presence of DNA DSBs near 
telomeres leads to a higher propensity of chromosome rearrangements. It has been 
postulated that this is because c-NHEJ repair is repressed by TRF2 along with the 
inappropriate processing of DSBs in this region as though they are telomeres via alt-NHEJ 
(Muraki et al., 2012;Muraki et al., 2013); however, a recent study illustrated the c-NHEJ is in 
fact not deficient at telomeres and that the higher propensity of chromosome 
rearrangements following DSBs in this region is due to their excessive processing by 
MRE11 (Muraki et al., 2015). The presence of DNA damage within telomeric repeat 
sequences hinders telomere replication, leading to telomere shortening or loss, and the 
deficiency of DSB repair near telomeres has been suggested to play a role in chromosomal 
instability associated with human cancers (Muraki et al., 2012;Muraki et al., 2013). 
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Additionally, telomeric sequences can also be found at internal sites of chromosomes and 
may colocalize with fragile chromosomal sites that are more prone to breakage; these 
interstitial telomeric sequences could be associated with genomic instability, human disease, 
and cancers (Desmaze et al., 1999). Meanwhile, DSBs at interstitial chromosomal sites 
occur primarily through c-NHEJ. Large deletions and gross chromosomal rearrangements 
(inversions, translocations, dicentric chromosomes) have been observed when DSBs occur 
near telomeres (Muraki et al., 2012;Muraki et al., 2013) or at interstitial telomeric sequences 
(Aksenova et al., 2013), whereas small deletions have been found to be the most common 
CAs when DSBs were induced at interstitial DNA sites (Muraki et al., 2012;Muraki et al., 
2013).  
To compensate for the increased sensitivity to DSBs near telomeres, chromosome 
healing, or the de novo addition of telomeric repeat sequences at DSB sites, may serve as 
an alternate mechanism of repair. Chromosomal healing in human cells may or may not 
involve telomerase, and does not occur at interstitial DSBs in somatic cells (Rebuzzini et al., 
2005;Muraki et al., 2012;Murnane, 2012). However, interestingly, strong evidence suggests 
that telomerase was involved in the insertion of interstitial telomeric sequences during the 
repair of DSBs in rodents and primates during evolution (Nergadze et al., 2007). 
Chromosome healing results in terminal deletions, which are less detrimental than gross 
chromosome rearrangements, and thereby prevents chromosomal instability resulting from 
DSBs near telomeres. Chromosome healing may be deficient in human cancer cells, and 
may be responsible for the chromosomal instability observed in these cells (Muraki et al., 
2012;Murnane, 2012).  
Chromosome fusions result in the formation of dicentric chromosomes, which is an 
unstable, non-transmissible type of CA and cause cell cycle arrest in normal cells with intact 
cell cycle checkpoints. However, cells lacking normal checkpoints continue to divide, and 
chromosomal instability is propagated via breakage-fusion-bridge (B/F/B) cycles. As shown 
in Figure 2, B/F/B cycles are initiated when a dicentric chromosome is formed when sister 
chromatids fuse following the replication of a chromosome that has lost a telomere. This 
dicentric chromosome forms a bridge during anaphase, which breaks at a location other 
than the site of fusion when the centromeres are pulled in opposite directions during cell 
division. This results in the transfer of DNA from one chromosome to another, with large 
inverted repeats at the end of the chromosome in one daughter cell and a terminal deletion 
at the end of the chromosome in the other daughter cell. Since the chromosomes are still 
missing a telomere, they will fuse again in the next cell cycle, and the B/F/B cycles continue 
until each chromosome is stabilized by the acquisition of a new telomere, usually by 
translocation of the end of another chromosome. The instability is thus transferred to the 
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chromosome donating the telomere; therefore, the loss of a single telomere can cause 
chromosomal instability in multiple chromosomes (Murnane, 2012). As continuing 
chromosomal instability and cell proliferation may be key elements of the initiation and 
progression of multi-stage carcinogenesis (Sabatier et al., 1995;Raynaud et al., 2008b;Shim 
et al., 2014), understanding the factors promoting telomere loss and its consequences is 
important for understanding chromosome instability associated with human cancer. 
 
 
Figure 2. Propagation of chromosome instability via breakage-fusion-bridge (B/F/B) cycles. 
Telomeres are illustrated as gray squares, centromeres as circles, and the orientation of the 
sub-telomeric sequences are illustrated as horizontal arrows (Adapted from Murnane, 2012). 
 
The role of telomeres and DDR activation in the multi-stage carcinogenesis process 
was demonstrated in a previous study in our laboratory in colorectal carcinoma* (Raynaud et 
al., 2008a). As illustrated in Figure 3, telomere shortening, decreasing levels of TRF1/TRF2, 
and increasing activation of DDR processes (ATM, CHK2, and γH2AX) occur during the 
early stages of the carcinogenesis process; this telomere attrition in these early stages may 
have a protective mechanism against cancer as critically short telomeres induce a cell cycle 
arrest (i.e. replicative senescence). When the full invasive potential of the tumor has been 
reached, telomere length and TRF1/TRF2 levels increase with only low levels of DDR 
                                                
 
* In this study, 4 types of colon tissue samples representing the major histological steps of colorectal 
carcinogenesis were obtained from each of 15 patients: normal mucosal epithelia, 2 stages of benign 
epithelial tumors (low-grade and high-grade adenomas), and invasive (malignant) carcinoma. 
Telomere length, telomeric protein levels (TRF1 and TRF2), and DDR marker expression (ATM, 
CHK2, and γH2AX) were evaluated in these consecutive tissue sections from each patient (Raynaud 
et al., 2008a). 
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activation, suggesting that cancer cells may avoid apoptosis by impairing DDR (Raynaud et 
al., 2008a). 
 
 
Figure 3. DNA damage response (DDR) activation, TRF1/TRF2 expression levels, and telomere 
length in the multi-step process of colorectal carcinogenesis. H score, shown on the vertical 
axis, is a relative measure of protein expression level, and the stages of cancer progression 
are shown on the horizontal axis. Telomere shortening and decreasing levels of TRF1 and 
TRF2 with corresponding activation of DDR processes (increasing ATM, CHK2, and γH2AX 
protein expression levels) occur during the early stages of the carcinogenesis process (from 
normal mucosal epithelia to low-grade dysplasia and high-grade dysplasia, with attrition and 
activation peaks, respectively, occurring at the high-grade dysplasia stage; this telomere 
attrition in these early stages may have a protective mechanism against cancer as critically 
short telomeres induce a cell cycle arrest (i.e. replicative senescence). When the full invasive 
potential of the tumor has been reached (invasive carcinoma stage), telomere length and 
TRF1/TRF2 levels increase with only low levels of DDR activation, suggesting that cancer cells 
may avoid apoptosis by impairing DDR (Adapted from Raynaud et al., 2008a). 
 
1.1.3 Telomere-related human pathologies 
Short telomeres due to defects in telomere maintenance machinery has been linked 
to a spectrum of age-related human diseases, referred to as “telomeropathies,” “telomere 
disorders,” “telomere syndromes,” or “impaired telomere maintenance spectrum disorder.” 
New syndromes are increasingly being identified. Common symptoms of a telomeropathy 
include idiopathic pulmonary fibrosis (IPF) and bone marrow failure. Increasing evidence 
indicates that although clinical manifestations of symptoms are diverse, telomeropathies 
comprise a single spectrum of diseases defined by short telomeres that leads to proliferative 
failure of a variety of tissues (most importantly lung tissue and hematopoietic stem cells) 
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(Carroll and Ly, 2009;Diaz de Leon et al., 2010;Armanios and Blackburn, 2012;Holohan et 
al., 2014). 
 
Table 1. Summary of all genes known to cause telomeropathies when defective, and the 
telomere/telomerase-relevant complexes these genes participate in. Putative candidate genes 
and complexes are also presented (not bold) based on their known interactions with genes 
known to cause telomeropathies (bold) (Adapted from Holohan et al., 2014). 
 
 
Dyskeratosis congenita (DKC) was the first disorder linked to impaired telomere 
maintenance. It was originally diagnosed from the “diagnostic triad” of symptoms, namely 
oral leukoplakia, skin hyperpigmentation, and nail dystrophy. DKC is also associated with 
other symptoms, most frequently including organ failure (usually in the bone marrow, with 
some patients encountering pulmonary fibrosis before bone marrow failure), aplastic anemia 
(a deficiency of all types of blood cells due to bone marrow failure), or specific 
lymphopenias. The pathology and genetic cause of DKC overlaps significantly with three 
more severe and extremely rare forms of DKC, each with additional symptoms: Hoyeraal-
Hreidersson syndrome (HHS), Coats Plus syndrome, and Revesz syndrome†. These severe 
syndromes present during childhood, with symptoms including bone marrow failure and 
mucocutaneous abnormalities. Symptoms presenting during adulthood, on the other hand, 
generally include IPF, liver cirrhosis, aplastic anemia, and acute myelogenous leukemia 
(AML). However, due to the incomplete penetrance of symptoms and the rarity of HHS, 
                                                
 
† Other, less frequent symptoms of DKC include failure of a variety of endothelial and epithelial 
compartments (e.g. enterocolitis, emphysema, liver cirrhosis, premature hair graying, short stature, 
dental caries, osteoporosis, and esophageal stricture). Patients with HHS syndrome exhibit symptoms 
of DKC with the addition of intrauterine growth retardation, cerebellar hypoplasia, and microcephaly. 
Patients with Revesz syndrome present with symptoms of HHS with the addition of exudative 
retinopathy, while patients with Coats Plus syndrome exhibit symptoms of HHS and Revesz 
syndrome with the addition of cerebral calcifications. Despite these distinctions, cerebral calcifications 
and exudative retinopathy have been observed in patients with all three severe forms of DKC 
(Holohan et al., 2014). 
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Coats Plus, and Revesz syndromes, these diseases are difficult to distinguish. As they have 
overlapping symptoms and causes (Table 1), these disorders may in fact represent a single 
disease entity (not three distinct disorders) with multiple genetic mechanisms for the same 
pathological conditions (Holohan et al., 2014). 
 
 
Figure 4. Telomere replication and the molecular biology of telomeropathies. Genes with 
known disease-causing mutations are denoted in red. Telomeres are configured in a “T-loop” 
characterized by invasion of the single-strand onto the double-stranded DNA. To initiate 
telomere replication, the T-loop is resolved by the RTEL1 helicase. The blunt-ended (from 
leading-strand synthesis) and RNA primer–ended (from lagging strand synthesis) telomere 
ends created from DNA replication must be processed by the CST complex (composed of 
CTC1, STN1, and TEN1) and Apollo before telomerase activity. The assembly of telomerase, a 
complex containing TERT, TERC, and the Dyskerin complex dimer (Dyskerin, NOP10, NHP2, 
GAR1), is promoted by TCAB1 in the Cajal body. After telomerase assembly, it is localized to 
the replicated and processed telomere by TCAB1 and TPP1, where it can add new telomere 
repeats to the G-overhang. After telomerase activity, the CST complex and DNA polymerase-α 
perform a fill-in reaction and nucleolytic processing that creates an extended telomere that is 
closed to further action by telomerase (Adapted from Holohan et al., 2014). 
 
Defective genes that have been linked to DKC, HHS, Coats Plus, and Revesz 
syndromes, IPF, and aplastic anemia are summarized in Table 1. These disorders are 
associated with gene defects in the shelterin protein TIN2, RTEL1 helicase, CTC1 (a 
component of the CST complex), Apollo, telomerase components (TERT, TERC, Dyskerin, 
NHP2, NOP10), and TCAB1 in the Cajal body. These components and their roles in 
telomere replication and telomerase structure/assembly are illustrated in Figure 4. As shown 
in Table 1, there are indeed overlaps in the genetic causes of these disorders. However, a 
substantial portion (~40%) of DKC has no proven monogenic cause, and thus further studies 
are needed to uncover the genetic mutations and details of telomere maintenance 
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mechanisms responsible for these disorders. To aid in the search for genes that cause these 
disorders, candidate genes have been proposed in Table 1 based on their known 
interactions with the known genetic links to telomeropathies. However, it is possible that 
telomeropathies are linked to undiscovered components of telomere maintenance, or that 
some telomeropathies are not due to monogenic defects. Conversely, new human 
syndromes are expected to be revealed in the future, which may help to reveal more insight 
into basic telomere biology as well as the full spectrum of these diseases (Holohan et al., 
2014). 
Telomeropathies are complex to classify, as the manifestation of symptoms and the 
age of onset of these disorders are highly variable, even with the inheritance of the same 
genetic mutation. Indeed, successive generations in families with telomere disorders have 
been shown to exhibit different symptoms, with decreasing age of onset and increasing 
severity of symptoms, a phenomenon called genetic anticipation. Earlier generations 
manifest adult-onset symptoms (IPF, liver cirrhosis, aplastic anemia, AML) while later 
generations show at younger ages DKC/HHS symptoms (bone marrow failure, 
mucocutaneous abnormalities) (Armanios and Blackburn, 2012;Holohan et al., 2014).  
Age of onset of telomeropathies can be explained by a combination of inheritance of 
telomere length, environmental factors (e.g. environmental air pollution, tobacco exposure, 
stress, asthma, chronic obstructive pulmonary disease), and differential proliferative capacity 
and degree of telomere shortening in tissues (e.g. lung tissue and hematopoietic stem cells). 
As the hematopoietic compartment is a highly proliferative tissue, it is not surprising that 
telomere-associated disease leads to prominent manifestation in the bone marrow during 
childhood. On the other hand, in tissues with slower cell turnover such as the lung, additional 
telomere damage via endogenous or exogenous factors may be needed to accelerate 
telomere shortening, thereby explaining why telomere-mediated lung disease manifests in 
adulthood. Additionally, in slowly proliferating tissue, short telomeres can cause gene 
expression changes that lead to metabolic and mitochondrial dysfunction, as well as 
endoplasmic reticulum stress that can alter exocytosis in secretory tissues (e.g. pancreas, 
nervous system) (Armanios and Blackburn, 2012;Holohan et al., 2014).  
Though these factors can explain the age of onset of disease, they cannot readily 
explain genetic anticipation. Indeed, the mechanisms by which genetic anticipation occurs 
remain uncertain. To explain these generational differences in symptoms of telomere 
disorders, several models based on various interpretations of data about telomere dynamics 
in the two most important tissues (lung tissue and hematopoietic stem cells) have been 
presented: (1) differential rates of telomere shortening in the two tissues, (2) synchronous 
age-related telomere shortening in the two tissues but with alternative pathological 
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thresholds for IPF and bone marrow failure, and (3) a blend both possibilities by assuming 
synchronous age-related telomere shortening punctuated by rapid telomere loss via 
environmental telomere damage in specific tissues. Determining the mechanisms behind 
genetic anticipation will require further detailed knowledge of rates of telomere shortening 
and the sensitivity to shortened telomeres in various tissues (Holohan et al., 2014). 
Patients with telomere disorders have been shown to be predisposed to cancer 
despite conventional interpretation of telomere length as a limit on cellular proliferative 
capacity. This may be explained by more than one mechanism. Defects in telomere 
maintenance can lead to persistent DNA damage signals, telomere fusions, and 
chromosomal instability, all of which can initiate carcinogenesis. Additionally, telomere 
length can limit the proliferative capacity of the adaptive immune system, leading to 
immunodeficiency that can in turn lead to a failure in cancer surveillance. However, it is 
possible that the increased cancer incidence may be a consequence of the organ failure 
state itself, and not necessary the telomere defect. All in all, accumulating evidence of 
telomeropathies will not only clarifies their disease mechanisms, but will also contribute to 
overall knowledge of telomere biology and its influences on human health (Armanios and 
Blackburn, 2012;Holohan et al., 2014). 
 
1.2 Biological responses to ionizing radiation 
1.2.1 Overview of levels of human exposure to ionizing radiation in the modern 
era 
On the global scale, according to the United Nations Scientific Committee on the 
Effects of Atomic Radiation (UNSCEAR) 2008 Report, the average dose of IR exposure from 
natural sources is estimated to be 2.4 mSv (milli-Sieverts‡) per year, ~50% of which is from 
natural radionuclides (mainly radon) found in soil and rocks, and ~15% of which is from 
cosmic radiation (at sea level); the average dose of cosmic radiation at cruising altitudes on 
commercial flights can range from 0.003 to 0.008 mSv per hour. Meanwhile, the average 
dose of IR exposure from man-made sources (worldwide) is estimated to be 0.6 mSv per 
year, with medical diagnostic radiology as the predominant source of exposure (UNSCEAR, 
2010). Additional annual dose limits (i.e. excluding natural and medical IR exposure) for the 
general public and occupational workers are 1 and 50 mSv per year, respectively, as 
                                                
 
‡ Sieverts (Sv) is the unit of effective dose. It is an estimation of the overall harm to a patient caused 
by the IR exposure. The effective dose provides only an approximate estimate of the true risk 
(Brenner and Hall, 2007). 
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advised by several regulatory agencies (ICRP, 2007). Globally, the total number of 
diagnostic radiological examinations (both medical and dental) is estimated to have risen by 
~50% from 2.4 billion per year (in 1991–1996) to 3.6 billion per year (in 1997–2007), and the 
average dose is estimated to have increased from 0.4 to 0.6 mSv per year. The total number 
of diagnostic nuclear exams has increased by under 1% since the 1991–1996 survey, and 
the average annual dose due to nuclear exams is estimated to have increased by ~35%. 
The frequency of administration of radiotherapy treatments is also estimated to have 
increased from 4.3 to 5.1 million per year between 1997 and 2007 (UNSCEAR, 2010). 
According to the World Health Organization (WHO), these numbers have increased further 
since then worldwide to 37 million nuclear medicine procedures per year and 7.5 million 
radiotherapy treatments per year (WHO, 2015).  
Despite these global estimates, diagnostic radiology (X-ray) examinations in 
developed countries with high levels of health care (which account for 24% of the global 
population) are estimated to be over 65 times more frequent than in countries with the 
lowest levels of health care (which account for 27% of the global population). Thus, in these 
countries where diagnostic radiology is more readily available and more heavily prescribed, 
annual doses due to diagnostic radiology alone based on the UNSCEAR 2008 Report can 
be as high as 2.0 mSv per year (without including radiotherapy); this level of exposure from 
medical uses is, on average, ~80% of that from natural sources. These numbers continue to 
rise as the use of radiation in medicine increases due to the major improvements it provides 
in the diagnosis and treatment of human diseases, as well as due to the increasingly 
widespread use of new high-dose X-ray technology, particularly CT scanning (UNSCEAR, 
2010). Indeed, the use of CT scans has increased in the United States (US) by more than 3-
fold since 1993 to ~70 million scans per year (Berrington de Gonzalez et al., 2009), and ~7.6 
million CT scans were performed in France in 2007 (Journy et al., 2015a;Journy et al., 
2015b). Though CT scans are perhaps the single most important advancement in diagnostic 
radiology, as they provide three-dimensional views of the organ/region of interest that 
facilitates disease screening and diagnosis (Brenner and Hall, 2007), they deliver 5–20 
times the effective dose of conventional radiology, corresponding to organ doses of up to 
tens of milli-Grays§ (mGy) per scan (Journy et al., 2015b). In countries where CT scans are 
heavily prescribed, their increasing use of the scans, along with the higher doses of IR 
administered per scan, result in a marked increase in annual doses of IR exposure in the 
population to those that exceed, for the first time in history, doses from the previously largest 
                                                
 
§ Gray (Gy) is the unit of absorbed dose, or the energy absorbed per unit of mass. One gray is equal 
to 1 joule of radiation energy absorbed per kilogram. The organ dose will largely determine the risk 
level to that organ from IR exposure (Brenner and Hall, 2007). 
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source (natural background IR) (UNSCEAR, 2010). With these increasing levels of medical 
exposure in addition to exposure from natural sources, individuals may be receiving total 
annual doses of almost double that from natural sources alone.  
Exposure to increasing levels of IR can be associated with increased risks of IR-
related cancers. As will be discussed further in Section 1.2.5, the health risks of low levels of 
IR exposure (< 0.2 Gy) remain ambiguous and controversial, as epidemiological studies to 
evaluate the long-term health effects of exposure to low doses of IR are difficult to conduct 
and interpret. Thus, estimates of health risks to low doses are extrapolated based on 
extensive experimental studies of high doses of IR (> 1 Gy), long-term follow-up of survivors 
of atomic bombings and radiation accidents, and other large-scale epidemiologic studies 
(Brenner et al., 2003;National Research Council, 2006). It is estimated that the ~70 million 
CT procedures administered per year in the US may cause as many as 29,000 new cancer 
cases (Berrington de Gonzalez et al., 2009); as of 2006, ~1.5−2.0% of all cancers in the US 
may be attributable to the IR from CT studies, a drastic increase from the estimated 0.4% 
between 1991 and 1996. (Brenner and Hall, 2007). Despite this concern about long-term IR-
related health risks, the use of CT scans will undoubtedly continue to increase because of its 
superior diagnostic value (Amis et al., 2007). While the risk of cancer is not large for any one 
person, the increasing exposure to IR in the population (especially in children, who are more 
sensitive to IR than adults (Bakhmutsky et al., 2014)) may be a public health issue in the 
future. Reducing the population dose from CT scans (and other radiological procedures) and 
reducing this IR-related cancer risk may be achieved by simply reducing the inappropriate 
prescription of radiological procedures, which can lead to unnecessary IR doses; indeed, 
about one third of all CT scans are not justified by medical need, and perhaps 20 million 
adults and more than 1 million children per year in the US are being irradiated unnecessarily 
(Brenner and Hall, 2007). 
 
1.2.2 Targeted and non-targeted effects of exposure to ionizing radiation 
The biological effects of IR depend on the amount of energy absorbed by living 
matter (i.e. absorbed dose, measured in Gy§) and by the spatial distribution of the absorbed 
energy, which is related to the linear energy transfer (LET) of the IR. LET, expressed in keV 
µm-1, is defined as the amount of energy lost per unit length along the path travelled by the 
radiation; it is an average quantity, as the actual energy deposition has a particular 
distribution that varies as a function of depth in the target material (Hall, 2006).  
As illustrated in Figure 5A, low-LET IR (e.g. X- and γ-rays) deposits exponentially 
decreasing amounts of energy as a function of penetration depth in the target material. 
Doses of low-LET IR produce a uniform pattern of distribution throughout the target material. 
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On the other hand, high-LET IR (e.g. heavy charged particles, protons, neutrons, α-particles) 
have a well-defined range in matter: a relatively low entrance dose in the target material, 
followed by a pronounced sharp maximum dose near the end of their range called the Bragg 
peak, and energy close to zero beyond the Bragg peak. This ability to localize a great 
amount of energy at the Bragg peak is advantageous for use in cancer radiotherapy, as the 
tumor site can be precisely targeted by placing it at the Bragg peak while the surrounding 
normal tissues would be minimally exposed to IR (Hall, 2006).  
 
 
Figure 5. (A) Typical energy loss profiles as a function of the distance traveled in tissue for 
photons (i.e. X- and γ-rays) and heavy ions (i.e. carbon ions). The exponential tail in the 
photons curve indicates that they deposit their energy through the entire target with 
decreasing amounts of energy as a function of penetration depth in the target material. In 
contrast, heavy ions are characterized by a relatively low entrance dose in the target material, 
followed by a pronounced sharp maximum dose near the end of their range called the Bragg 
peak, and energy close to zero beyond the Bragg peak (Adapted from Pijls-Johannesma et al., 
2010). (B) Interactions of low-LET IR, high-LET IR, and high-LET heavy charged particles with 
DNA. Low-LET IR produces ionization events that are sparsely distributed along its traversal 
path, whereas high-LET IR and heavy charged particles produce ionization events that are 
more densely concentrated along the particle track. The extent of DNA damage depends on 
the specific physical characteristics of the IR such as energy and mass (Adapted from Park 
and Kang, 2011). 
 
When IR is absorbed by living cells, it deposits discrete packets of photon energy 
that cause the ejection of electrons from molecules along its traversal path. These ionization 
events cause cellular damage either directly (via direct impact on cellular structures, e.g. 
DNA, mitochondria) or indirectly (via excess reactive oxygen species [ROS] production from 
radiolysis of cellular water or mitochondrial dysfunction). The density of these ionization 
events, and the extent of the resulting biological damage, increases with dose and the LET 
(A)$$ (B)$
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of the IR. As shown in Figure 5B, low-LET IR produces ionization events that are sparsely 
distributed along its traversal path. However, when high-LET IR traverses a target material, it 
produces ionization events that are more densely concentrated along the track compared to 
low-LET IR (Hall, 2006); the local dose at the center of a particle track may be thousands of 
Gy, but a few microns away (e.g. a neighboring cell), the dose may be close to zero 
(Cucinotta et al., 2000). Because of these characteristics, direct traversal of high-LET IR 
through cellular DNA induces clustered damage along the radiation track that result in DNA 
DSBs, gene mutations, and other complex chromosomal aberrations (CCAs), with the extent 
of damage depending on the specific physical characteristics of the IR such as energy and 
mass (Goodhead, 1994). Direct traversal of low-LET IR through cellular DNA induces lower 
frequencies of DNA DSBs than high-LET IR; instead, direct traversal of low-LET IR 
predominantly causes DNA base damage and DNA single strand breaks (SSBs). Because 
high-LET IR deposits greater amounts of energy per unit length of traversed matter, there is 
a high possibility that multiple lesions are in close proximity within a short period of time 
(Cucinotta et al., 2003).  
 
 
Figure 6. Summary of the direct and indirect cellular effects of IR. Absorption of IR by living 
cells can induce direct DNA damage through direct interaction with atoms and molecules in 
DNA. DNA damage can also be induced indirectly through its interaction with atoms, 
particularly through radiolysis of cellular water and generation of reactive oxygen species 
(ROS). IR may also disrupt mitochondrial functions, which produces excess ROS and reactive 
nitrogen species (RNS) by stimulation of oxidases (e.g. SOD) and nitric oxide (NO) synthases. 
These reactions significantly contribute to persistent alterations in lipids, proteins, nuclear 
DNA (nDNA) and mitochondrial DNA (mtDNA) (Adapted from Azzam et al., 2012). 
 
  
 
 
42 
As mentioned above, IR-induced cellular damage can also occur indirectly through 
production of excess ROS from radiolysis of cellular water or IR-induced mitochondrial 
dysfunction. As shown in Figure 6, radiolysis of water (which makes up ~80% of the cell) 
generates free radicals (e.g. hydroxyl, superoxide radicals) and other ROS that go on to 
damage critical targets in the vicinity (e.g. DNA). Sparsely ionizing low-LET IR predominantly 
induces biological effects through these indirect mechanisms, while densely ionizing high-
LET IR induces direct, clustered cellular damage along the radiation track. Moreover, 
interaction of high-LET IR with water produces significantly higher levels of ROS compared 
to traversal of low-LET IR: it is estimated that ~2000 ROS per nanogram of tissue are 
generated within less than a microsecond from a single traversal of a high-LET 3.2 MeV α-
particle, whereas ~60 ROS are generated from a hit of low-LET 137Cs γ-rays. Consequently, 
for the same total absorbed dose, high-LET IR is more damaging than low-LET IR. Such 
ROS concentrations in the nucleus can obviously cause extensive oxidative injury and 
significantly modify normal biochemical reactions. ROS can cause other cellular damages, 
including lipid peroxidation, protein oxidation, oxidative alterations to nuclear and 
mitochondrial DNA, and inactivation of enzymes (Figure 6) (Hall, 2006;Dianov and Parsons, 
2007;Azzam et al., 2012). Though the immediate burst of excess ROS initially produced at 
the time of irradiation is believed to persist for only microseconds or less, IR-induced 
oxidative stress in the cell may be prolonged due to persistent long-term effects on oxidative 
metabolism caused by this initial IR-induced ROS insult (Spitz et al., 2004). Over the last two 
decades, increasing evidence has been gathered that shows that the long-term effects of IR 
exposure are due to persisting oxidative stress that causes continuous accumulation of DNA 
damage. Oxidative stress has been implicated in aging, degenerative diseases (including 
mitochondrial diseases), as well as cancer (Azzam et al., 2012). 
Similar to IR-induced chromosomal damage, IR-induced damage of telomeres can 
also occur directly (via ionization events via direct traversal of IR within telomere sequences) 
or indirectly (via post-irradiation telomere uncapping and alterations in telomere 
maintenance mechanisms) (Ayouaz et al., 2008). Since telomeres make up only a tiny 
portion (0.02%) of the total human genome (Fumagalli et al., 2012), the probability that a 
radiation particle will directly traverse a telomeric sequence is infinitesimally small. 
Therefore, IR-induced damage of telomeres more likely occurs through perturbations of 
telomere maintenance post-irradiation. The guanine-triplet repeats in telomeric sequences 
(5′-GGG-3′) were shown to be preferential targets for oxidative damage by ROS (Henle et 
al., 1999), which are well established to be formed in excess following IR exposure from 
water radiolysis and IR-induced mitochondrial dysfunction (Azzam et al., 2012), and these 
damages persist due to deficiencies in DNA repair at telomeres as discussed in Section 
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1.1.2 (Muraki et al., 2012). The presence of oxidized guanine bases in telomeric nucleotides 
has been shown to disrupt telomerase activity (Szalai et al., 2002) as well as inhibit the 
binding of telomeric shelterin proteins, i.e. TRF1 and TRF2 (Opresko et al., 2005). Excess 
ROS has also been shown to generate other oxidative DNA lesions including oxidized bases 
and DNA SSBs containing modified 3′-ends (Dianov and Parsons, 2007). Altogether, these 
damages interfere with DNA replication and results in telomere shortening and loss in cells 
undergoing oxidative stress (Tchirkov and Lansdorp, 2003). 
It was long believed that the biological effects of IR exposure were solely the 
consequence of DNA damage that occurs in cells during or shortly after direct traversal of an 
IR particle through a cell nucleus. However, this classical “target theory,” which used to be 
the central paradigm of radiation biology, has since been challenged by accumulating 
evidence over the last three decades that demonstrate that non-irradiated, “bystander” cells 
in the vicinity of irradiated cells as well as the progeny of irradiated and bystander cells 
present molecular, biochemical, and genetic abnormalities. These effects, coined “non-
targeted effects,” include IR-induced bystander effects, genomic instability, and adaptive 
response.  
The IR-induced bystander effect is the phenomenon where IR-induced stresses are 
transmitted from irradiated cells to their neighboring non-irradiated bystander cells (Little, 
2003). Indeed, bystander effects are well known to induce a spectrum of detrimental cellular 
responses in non-irradiated bystander cells that are similar to those observed in directly 
irradiated cells, such as DNA damage, chromosomal rearrangements, micronuclei, gene 
amplifications, gene mutations and neoplastic transformation, reduced cell survival (lethal 
mutations or delayed reproductive cell death), apoptosis, and mitochondrial alterations with 
increased ROS production (Morgan, 2003b;a;Shao et al., 2004;Belyakov et al., 2005;Azzam 
et al., 2012). In vivo occurrence of IR-induced bystander effects are demonstrated in 
situations where humans are partially exposed to low doses/low dose-rates of IR, such as 
during deep space exploration, mining, or residential radon exposure, where a small fraction 
of cells is exposed to IR at any one time. Particularly, in the case of radiotherapy, IR-induced 
damage, especially in tissues irradiated with high doses, may induce systemic effects that 
affect the whole body during, or a short time after, exposure. Indeed, significant biological 
changes have been observed in tissues that are widely separated from the irradiated area, 
and treatment directed at a tumor at one site may profoundly affect tumors and/or normal 
tissues located elsewhere in the body; these systemic effects may be either detrimental or 
beneficial (if they lead to shrinkage of distant tumors), and have been termed “abscopal 
effects” (Morgan, 2003b;Prise and O'Sullivan, 2009;Newhauser and Durante, 2011). 
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Memory of the initial stressful IR injury has been shown to be maintained in the 
progeny of both directly irradiated and bystander cells in the form of genetic instability 
(Terzaghi and Little, 1976;Seymour and Mothersill, 1997;Watson et al., 2000;Morgan et al., 
2002;Little, 2003), which induces increased rates of mutations and CAs in these progeny 
cells (Ilnytskyy and Kovalchuk, 2011). Propagation of IR-induced CAs through cell 
generations will be discussed in detail in Section 1.2.4, and the role of telomeres in the 
propagation of chromosomal instability has been discussed in Section 1.1.2. These long-
term effects of IR exposure may be due to prolonged oxidative stress that lead to continuous 
accumulation of DNA damage in the progeny of both irradiated and bystander cells; strong 
evidence indicates that these effects are dependent on factors such as radiation quality, 
dose, dose-rate, genetic susceptibility, and age (Azzam et al., 2012). Delayed health effects 
can be observed many years after IR exposure, illustrated by a higher incidence of 
secondary malignancies and a variety of degenerative conditions in long-term cancer 
survivors (Newhauser and Durante, 2011). Delayed effects are also observed following 
occupational IR exposure in miners, nuclear workers, and astronauts. As exposure to IR is 
an inevitable part of modern life, an understanding of the mediating biochemical events may 
have profound implications for long-term human health risks, and may lead to refinement of 
radiation protection guidelines (Mosse, 2012;Morgan and Bair, 2013) and therapeutic 
protocols (Mothersill et al., 2004;Hei et al., 2011;Mancuso et al., 2012;Schmid and Multhoff, 
2012). Conversely, knowledge of the mediating mechanisms of IR exposure may help in 
devising approaches to alleviate its detrimental effects.  
Apart from these detrimental damages, non-targeted effects can also induce 
protective mechanisms, called adaptive responses, where exposure to a small priming dose 
of IR protects cells from stress induced by a subsequent challenge from IR or other 
environmental agents; adaptive responses, mainly observed following in vitro or in vivo 
exposures to low doses of low-LET IR (X- or γ-rays) delivered at low dose-rates, can include 
secretion of inhibitory factors (Komarova et al., 1998), enhanced cell differentiation 
(Belyakov et al., 2002), and radio-adaptation (Iyer and Lehnert, 2002). Ultimately, these 
targeted and non-targeted biological effects of IR that could manifest in seconds to even 
decades after irradiation could have important short-term and long-term consequences on 
the health of the organism/being. 
 
1.2.3 DNA damage response pathways and DNA damage repair mechanisms 
As mentioned in Section 1.1.1, DNA is continuously exposed to damaging agents 
throughout the cell lifespan via endogeneous DNA damaging factors, external environmental 
stress, and lifestyle factors. This constant assault on DNA yields tens of thousands of DNA 
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lesions per day in every human cell. These DNA lesions must be repaired to prevent loss or 
incorrect transmission of genetic material, which can lead to tumorigenesis and other 
pathologies (Jackson and Bartek, 2009;Lin et al., 2012;Price et al., 2013).  
 
 
Figure 7. IR-induced DNA lesions. IR induces a wide range of damage in DNA including single 
strand breaks (SSB), base damage, abasic sites, DNA-protein cross-links, and double strand 
breaks (DSB) (Adapted from IAEA, 2011).  
 
As illustrated in Figure 7, targeted and non-targeted effects of IR exposure and IR-
induced ROS induce a wide range of DNA damage of varying levels of complexity, such as 
base damage, SSBs, abasic sites, DNA-protein cross-links, and DSBs (IAEA, 2011). As 
summarized in Figure 8, the choice of the repair system depends on the type of DNA lesion. 
SSBs or single-base damage (i.e. DNA lesions on a single strand that do not significantly 
disrupt the helical structure) are generally repaired by base excision repair (BER) (Chou et 
al., 2015), whereas DNA damage that significantly distorts the DNA helix (e.g. bulky lesions 
and crosslinks) is repaired by nucleotide excision repair (NER) (Petruseva et al., 2014). 
Small chemical changes affecting a single base are repaired via direct repair (DR) (Yi and 
He, 2013), and mismatches in base pairing caused by DNA replication errors are repaired by 
mismatch repair (MMR) (Larrea et al., 2010). Finally, as mentioned in Section 1.1.2 and will 
be discussed further in this section, DSBs are repaired via HR and/or NHEJ; the choice of 
repair system for DSB repair depends on the phase of the cell cycle, and the expression, 
availability, and activation of DNA repair proteins (Lieber, 2008;Shah and Mahmoudi, 2015). 
Upon induction of DSBs, DDR pathways are activated, which trigger a complex 
signaling cascade that includes activation of DNA repair pathways, cell cycle arrest to allow 
time for repair of DNA damage, and in certain cases, initiation of senescence or apoptosis. 
The central components of DDR activation are ATM, ATR, and DNA-PK, members of the 
phosphatidyl inositol 3-kinase-like kinase (PIKK) family. ATM and DNA-PK are 
predominantly activated by DNA DSBs, whereas other types of DNA damage (e.g. 
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replication-induced DSBs, base adducts, and cross-links) activate ATR (Branzei and Foiani, 
2008;Nam and Cortez, 2011;Shiloh and Ziv, 2013).  
  
 
Figure 8. Types of DNA lesions and their corresponding DDR pathways. SSBs or single-base 
damage (i.e. DNA lesions on a single strand that do not significantly disrupt the helical 
structure) are generally repaired by base excision repair (BER), whereas DNA damage that 
significantly distorts the DNA helix (e.g. bulky lesions and crosslinks) is repaired by 
nucleotide excision repair (NER). Small chemical changes affecting a single base are repaired 
via direct repair (DR), and mismatches in base pairing caused by DNA replication errors are 
repaired by mismatch repair (MMR). Finally, DSBs are repaired via homologous recombination 
(HR) and non-homologous end joining (NHEJ). AGT=O6-alkylguanine-DNA alkyltransferase; 
GG-NER=global genome NER; 06MeG=O6-methylguanine; TC-NER=transcription-coupled NER 
(Adapted from Postel-Vinay et al., 2012). 
 
As shown in Figure 8, DNA-PK and ATM are activated by the recruitment of 
KU70/KU80 and the MRN complex, respectively, to DSBs. KU70/KU80 and DNA-PK 
promote NHEJ repair of DSBs. As shown in detail in Figure 9, the DNA-PK catalytic subunit 
(DNA-PKcs) keeps the broken DNA ends in close proximity during NHEJ repair, and recruits 
end-processing factors (e.g. Artemis, PNKP, APE1, and TDP1), which prepare the DNA 
ends for re-ligation by the XRCC4–XLF– LIG4 complex (Postel-Vinay et al., 2012;Panier and 
Boulton, 2014). In recent years, alternative end-joining pathways have been described that 
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repair DSBs independently of one or more core components of this c-NHEJ machinery 
(Decottignies, 2013;Badie et al., 2015). 
 
 
Figure 9. DNA DSB repair pathways. The two main DNA DSB repair pathways in eukaryotic 
cells: non-homologous end joining (NHEJ; part a) and homologous recombination (part b). 
BLM=Bloom’s syndrome helicase; BRCA1/2=breast cancer 1/2; CtIP=CtBP-interacting protein; 
DNA2=DNA replication ATP-dependent helicase; DNA-PKcs=DNA-PK catalytic subunit; 
EXO1=exonuclease 1; LIG4=DNA ligase 4; MRN (MRE11–RAD50–NBS1) complex; 
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PNKP=polynucleotide kinase/phosphatase; RMI=RecQ-mediated genome instability protein 1; 
RPA= replication protein A; SDSA=synthesis-dependent strand annealing; ssDNA= single-
stranded DNA; TDP1=tyrosyl–DNA phosphodiesterase 1; TOP3α=topoisomerase 3α; 
XLF=XRCC4‑ like factor; XRCC4=X-ray repair cross complementing protein 4 (Adapted from 
Panier and Boulton, 2014). 
 
As a consequence of DSB induction, ATM is activated and phosphorylates the 
histone H2AX (to form γH2AX), which leads to both structural alterations to the chromatin 
around the damaged site to allow repair proteins access to the damaged regions of the 
DNA, as well as the recruitment and retention of key DDR factors; accumulating evidence 
indicates that γH2AX may also be involved in functions that are not directly related to its 
function as a DNA DSB marker** (reviewed in detail in Turinetto and Giachino, 2015). γH2AX 
foci are formed within minutes after IR exposure in a dose-dependent manner, peak at <1 
hour post-irradiation, and then rapidly decay to baseline levels within one to several days, 
depending on the dose received. H2AX phosphorylation leads to recruitment of many 
checkpoint and repair factors, such as MDC1, MRN, and the ubiquitin ligases RNF8 and 
UBC13 (Postel-Vinay et al., 2012;Panier and Boulton, 2014). These factors promote the 
recruitment of 53BP1, BRCA1, and more ATM to facilitate the spreading of the DDR signal 
through the nucleus. These proteins go on to initiate the phosphorylation and dimerization of 
checkpoint kinases CHK2/CHK1, which targets effectors including p53, CDC25A, and 
CDC25C that in turn activates cell cycle checkpoints or induce apoptosis (Raynaud et al., 
2008b;Thompson, 2012). 
While NHEJ is active in all phases of the cell cycle, HR is restricted to the S and G2 
phases when sister chromatids are available in close proximity as repair templates (Branzei 
and Foiani, 2008;Symington and Gautier, 2011). As shown in Figure 9, HR is initiated by the 
generation of long stretches of 3ʹ  single-stranded DNA (ssDNA), which activates ATR (Nam 
and Cortez, 2011). The 3ʹ  ssDNA are created via DNA end resection, a complex and highly 
regulated process that requires several nucleases including BLM, CtIP, the MRN complex, 
EXO1, and DNA2. The 3ʹ  ssDNA is then coated by RPA. Thereafter, RAD51, the key 
facilitator of HR, displaces RPA on the ssDNA with the help of mediator proteins such as 
BRCA1, BRCA2, and several RAD51 paralogues. The RAD51–ssDNA nucleofilament then 
forms a D-loop with a homologous sequence elsewhere in the genome, and DNA synthesis 
is initiated to replace the DNA around the former DSB site. Finally, depending on the type of 
                                                
 
** These ‘non-canonical’ H2AX roles include sex chromosome inactivation in male germ cells, X 
inactivation in female somatic cells, chromatin regulation in mitosis, embryonic and neural stem cell 
development, asymmetric sister chromosome segregation in stem cells, and cellular senescence 
maintenance (Turinetto and Giachino, 2015). 
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HR, the D‑loop is resolved either by dissociation of one of the invading strands via 
synthesis-dependent strand annealing (SDSA), or through migrating double Holliday junction 
intermediates that are either cleaved by resolvases or dissolved by the BLM–RMI–TOP3α 
complex (Panier and Boulton, 2014). 
As HR requires sequence homology of undamaged DNA for DSB repairs (thereby 
being active during S and G2 phases when homologous sister strands are available in close 
proximity), HR provides 'error free' repair. However, NHEJ could join any two DSB ends in a 
homology-independent manner (two ends may not necessarily be the original partners 
generated by a break), thus leading to 'error-prone' repair of DSBs DNA. Most chromosome 
aberrations in mammalian cells are formed via chromosomal fusions via NHEJ (Sasaki, 
2009). 
As will be discussed further in Section 1.4.1, defects in genes/proteins involved in the 
NHEJ and HR pathways confer dramatically increased radiosensitivity and/or 
immunodeficiency. Radiosensitivity disorders can also be caused from defects in proteins 
involved in DDR signaling and/or activation of cell cycle checkpoints (e.g. ATM, 53BP1, the 
MRN complex, RFN168) and/or in carrying out histone modifications around the DSB (e.g. 
H2AX to form γH2AX), or due to mutations in cohesins (proteins involved in holding 
chromosomes together during DNA replication/repair). Currently, there are 15 known genetic 
disorders that are associated with increased cellular radiosensitivity, which in some cases 
could also be related to increased susceptibility to IR-induced cancer (Advisory Group on 
Ionising Radiation, 2013). 
 
1.2.4 Radiation-induced chromosomal aberrations and chromosomal instability 
As described in Section 1.2.2, IR exposure can produce DNA DSBs, with high-LET 
IR inducing more clustered damage at a given dose compared to low-LET IR, and could 
result in the formation of CAs if improperly repaired (Goodhead, 1994). IR-induced telomeric 
damage, post-irradiation telomere uncapping, and/or IR-induced alterations in telomere 
maintenance mechanisms could result in chromosome fusion (Murnane, 2012). CAs are of 
particular interest in the monitoring of IR-induced DNA damage as they can have significant 
cellular consequences, including cell death at short-term, or the initiation and propagation of 
human pathologies such as cancer at long-term if CAs are of the transmissible type that 
causes chromosomal instability (Sabatier et al., 1995;Raynaud et al., 2008b). CAs are also 
of special interest in the field of biodosimetry as their IR-induced frequency can provide 
sensitive dose estimates (IAEA, 2011).  
IR-induced CAs can be of the chromatid- or chromosome-type. Chromatid-type 
aberrations may be induced by irradiation during the G2 or S phases of the cell cycle; 
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ultraviolet light and chemicals can induce chromatid-type aberrations at any phase of the cell 
cycle, so these aberrations may also be of interest in the context of background frequency of 
chromosomal damage and delayed chromosomal instability. Chromosome-type aberrations 
may be induced by irradiation during the G0 or G1 phases of the cell cycle. As PBL that 
have been irradiated in G0 phase are generally used for various biodosimetry assays, 
chromosome-type aberrations are of particular interest in this context. Chromosome-type 
aberrations can be unstable (i.e. non-transmissible to progeny cells) or stable (i.e. 
transmissible to progeny cells). Various types of chromosome-type aberrations are outlined 
below (IAEA, 2011): 
 
Unstable IR-induced chromosome-type aberrations (non-transmissible): 
• Dicentric chromosomes, the main aberration used for biodosimetry (discussed in Section 
1.3.1), are formed from an exchange between the centromeric pieces of two broken 
chromosomes; in its complete form, it is accompanied by an acentric fragment, formed 
from the fusion of the two acentric pieces of these broken chromosomes.  
• Centric rings are formed from an exchange between two breaks on separate arms of the 
same chromosome; they are much rarer than dicentrics, and they are also accompanied 
by an acentric fragment. 
• Acentric fragments, or excess acentrics, can be formed independently of dicentrics and 
rings; they can be formed from either interstitial or terminal deletions. 
• Complex chromosomal aberrations (CCAs) involve three or more DSBs. 
Stable IR-induced chromosome-type aberrations (transmissible): 
• Reciprocal translocations (also called two-way translocations) are formed from the 
exchange of terminal portions of two chromosomes. 
• Non-reciprocal translocations (also called terminal, incomplete, or one-way 
translocations) are formed from an exchange of the terminal portion of just one 
chromosome; this type is less frequent and more unstable than reciprocal translocations. 
• Interstitial translocations (also called insertions) are formed when an acentric piece of 
one chromosome is inserted within an arm of another chromosome. 
 
Immediately following IR exposure of normal human cells, a selective process 
commences that selects against highly damaged cells; highly damaged cells harboring 
multiple CCAs either die or do not give rise to viable progeny cells. Interestingly, 
hypothermia during in vitro irradiation has been shown to have a sparing effect, inducing 
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decreased levels of chromosomal damage, which could be related to temperature-related 
effects on the indirect effects of IR (Lisowska et al., 2013). Irradiated cells that are viable 
undergo a delay in the cell cycle to allow for repair of IR-induced DNA damage (Azzam et 
al., 2000). The length of the cell cycle delay is dependent on the extent and complexity of IR-
induced damage, and most DNA repair is completed within the first few hours after 
irradiation (Houtgraaf et al., 2006). These surviving cells undergoing their first cell division 
post-irradiation were shown to harbor both stable/balanced transmissible (translocations, 
inversions) and unstable/unbalanced non-transmissible rearrangements (dicentrics, rings, 
CCAs) (Martins et al., 1993), with high-LET IR causing more clustered DNA DSBs and 
higher frequencies of CCAs that may be less likely to be repaired correctly compared to 
equivalent doses of low-LET IR (Sabatier et al., 1987;Testard et al., 1997;Anderson et al., 
2000;Testard and Sabatier, 2000).  
Transmissible mutations that can be propagated to progeny cells are believed to be 
fixed during DNA synthesis and cell proliferation, and unstable aberrations and those 
chromosomal lesions not compatible with cell survival are eliminated at subsequent cell 
divisions post-irradiation; dicentrics and CCAs decrease by 50% and 30%, respectively, at 
each cell generation (Al-Achkar et al., 1988). Consequently, a few passages after irradiation, 
most karyotypes are apparently normal, with few remaining balanced/transmissible 
anomalies, and these cells may harbor IR-induced recessive gene mutations that 
accumulate with each successive generation. At later passages, unstable chromosomal 
rearrangements reappear, mostly non- or poorly transmissible dicentrics that recurrently 
involve specific chromosomes in telomeric end-to-end associations. The occurrence of IR-
induced instability was shown to be further delayed in late passages after irradiation with 
higher LET IR (Sabatier et al., 1992;Martins et al., 1993); therefore, it can be concluded that 
high-LET IR has a higher capacity to induce delayed genomic instability compared to low-
LET IR (Kadhim et al., 2006). Eventually, these IR-induced or pre-existing recessive 
mutations may be unmasked and amplified, and upon loss of tumor suppressor function, 
those cells that harbor genetic alterations that give them a proliferative advantage invade the 
cell population. Continuing chromosomal instability and cell proliferation may be key 
elements of the initiation and progression of multi-stage carcinogenesis (Sabatier et al., 
1995;Raynaud et al., 2008b).  
Interestingly, several new types of CCAs have very recently been described. These 
CCAs, proposed to be named ‘chromoanagenesis’ (meaning ‘chromosome rebirth’), are 
formed as a result of multiple DNA DSB breaks that gets stitched back together in random 
order (most likely via NHEJ), leading to the generation of a highly rearranged 
chromosome(s) (Holland and Cleveland, 2012). Though the direct link between these new 
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types of CCAs and IR exposure has not yet been evaluated, chromoanagenesis has been 
identified in cancer cells and is linked to congenital diseases. However, its overall frequency 
in germline cells, healthy tissue, and cancer types, and its causative link with human 
diseases are unknown (Hatch and Hetzer, 2015). Three types of chromoanagenesis that 
have been described are as follows: 
• Chromothripsis (literally meaning ‘chromosome shattering’) involves the shattering of one 
(or a few) chromosome(s) typically into tens to hundreds of pieces from a single 
catastrophic event (during a single cell cycle) followed by repair by which the pieces are 
stitched back together in random order. Chromothripsis has been identified in at least 
2%–3% of all cancers across many subtypes (and in ~25% of bone cancers) (Meyerson 
and Pellman, 2011;Stephens et al., 2011) and germline cells (Kloosterman et al., 2011), 
and may be important in the early stages of carcinogenesis (Kloosterman et al., 2014) 
and the development of congenital diseases (de Pagter et al., 2015), respectively. A 
mechanism of chromothripsis has recently been demonstrated to explain how these 
massive chromosomal rearrangements are restricted to one chromosome, namely 
micronucleation, which involves chromosomal fragmentation and rejoining within a single 
micronucleus (Zhang et al., 2015). Other mechanisms of chromothripsis have been 
proposed, including telomere dysfunction and B/F/B cycles limited to one chromosome 
(Sorzano et al., 2013), abortive apoptosis (Tubio and Estivill, 2011), mitotic errors (Jones 
and Jallepalli, 2012), and p53 inactivation (Rausch et al., 2012). 
• Chromoanasynthesis affects a single chromosome or chromosome arm much like 
chromothripsis, but is characterized by the amplification of numerous chromosomal 
segments and has signatures of replication-mediated repair. This type of aberration has 
been linked to developmental delay and cognitive anomalies (Liu et al., 2011;Plaisancie 
et al., 2014). 
• Chromoplexy involves the rejoining of multiple DNA breaks (tens of breakpoints) on 
multiple chromosomes, resulting in the joining of many distant loci and chromosomes 
together. This event has been shown to be a common occurrence in prostate cancer 
(Baca et al., 2013;Shen, 2013). 
 
1.2.5 Low dose biological and health effects 
As mentioned briefly in Section 1.2.1, the biological effects and health risks of high 
doses of IR (> 1 Gy) have been well characterized through extensive experimental studies 
and epidemiological surveys of survivors of atomic bombings and radiation accidents 
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(Brenner et al., 2003;National Research Council, 2006). It is well known that the extent and 
complexity of biological damage induced by direct IR exposure to high doses is directly 
proportional to the radiation dose and LET, and cancer risk at these doses is established to 
increase linearly with dose. However, the health risks of low levels of IR exposure (< 0.2 Gy) 
remain ambiguous and controversial. Epidemiological studies to evaluate the long-term 
health effects of exposure to low doses of IR are difficult to conduct and interpret, as 
humans are constantly exposed to many confounding factors that can also contribute to 
adverse health effects (e.g. diet, smoking, exposure to diagnostic radiology, stress, etc.). 
Therefore, mechanistic in vitro and in vivo studies are necessary to expand knowledge of 
cellular and molecular processes underlying low dose IR-induced biological effects (de 
Toledo et al., 2011;Il'yasova et al., 2014). Coupled with epidemiology, these mechanistic 
studies should further refine estimates of radiation risks at low doses and help formulate 
adequate radiation protection guidelines. 
Due to the absence of reliable epidemiological estimates of health risks at low doses, 
the International Commission on Radiation Protection (ICRP) recommends a linear 
relationship between IR dose and cancer risk, termed the linear no-threshold (LNT) model, 
extrapolated from data obtained at high doses. This model states that exposure to any dose 
of IR, however small or large, causes a linear increase in risk of detrimental health effects 
that is directly proportional to the dose; furthermore, this model states that the effects of 
sequential doses are additive (curve a in Figure 10) (Preston, 2003;National Research 
Council, 2006). However, the validity of this LNT model is controversial and has been the 
subject of intense debate.  
 
 
Figure 10. Proposed models for predicting the cancer risks from exposure to low doses of IR. 
The current linear no-threshold (LNT) model (curve a) extrapolates from data obtained at high 
doses, and assumes a linear relationship between IR dose and cancer risk, at all dose levels. 
Other proposed models of the relationships between radiation dose and cancer risk: the LNT 
model underestimates risk (curve b); the LNT model over-estimates risk (curve c); a threshold 
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exists below which harmful effects are unlikely to arise (curve d); a J-shaped curve (curve e) 
where exposure to very low dose radiation may be beneficial (hormesis) (Adapted from 
Brenner et al., 2003). 
 
Different models have been proposed to represent cancer risk at low doses (Figure 
10). Some postulate that the LNT model underestimates risk (curve b in Figure 10), while 
others postulate that the LNT model over-estimates risk (curve c in Figure 10). Some 
propose that there is a threshold below which harmful effects are unlikely to arise (curve d in 
Figure 10) (Tubiana and Aurengo, 2005), and others suggest a J-shaped curve (curve e in 
Figure 10) where exposure to very low dose radiation may be beneficial (hormesis). These 
extrapolations that challenge the LNT model are based on the observations of several 
complex biological phenomena that are not readily predictable by dose: growing evidence 
has emerged that the non-targeted IR effects discussed above in Section 1.2.2 (namely the 
adaptive response, bystander effects, and genomic instability) may be particularly important 
in modulating the biological responses to low doses of IR. These phenomena may or may 
not be harmful to the cell/being. Furthermore, the influence of LET in the induction of these 
low dose effects is also controversial. 
In our original paper, (de Toledo et al., 2011) found in Appendix A.3.1 of this thesis, 
we discuss in detail evidence from mechanistic studies of the influence of radiation LET on 
the induction of the adaptive response and non-targeted effects following exposure to low 
doses of IR. In summary, normal human or rodent cells exposed to low chronic doses of low-
LET IR were able to adapt to be better able to correctly repair DNA lesions resulting from 
endogenous metabolism or a subsequent challenge exposure to IR, and were less likely to 
be transformed to the neoplastic phenotype. In contrast, cells exposed to low-doses of high-
LET IR (e.g. alpha and heavy ions) did not induce adaptive responses, but instead showed 
persistent stressful effects such as oxidative stress, mitochondrial dysfunction, and genomic 
DNA damage in the directly targeted cell, as well as their neighboring bystander cells and 
their progeny. This data strongly support a role for IR dose and quality (i.e. LET) in 
determining the nature of the induced IR effects at low doses. 
 
1.2.6 Biomarkers of IR exposure 
The wide range of biological effects following direct or indirect IR exposure, some of 
which are described in the preceding sections, can be quantified by measurements of a 
variety of biomarkers of IR exposure. Biomarkers are reviewed in detail in (Pernot et al., 
2012;Manning and Rothkamm, 2013), and are illustrated in Figure 11. 
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Figure 11. A non-exhaustive list of biomarkers of IR exposure. Vertical double lines represent 
pairs of chromosomes and horizontal double lines represent double strands of DNA. A=acetyl 
group; CCR=complex chromosomal rearrangement; CNV=copy number variant; CRP=C-
reactive protein; GYPA=glycophorin A; HPRT=hypoxanthine-guanine phosphoribosyl 
transferase; M=methyl group; miRNA=microRNA; P=phosphate group; SNP=single nucleotide 
polymorphism; U=ubiquitin; 6-TG=6-Thioguanine; 8-oxo-DG=8-Oxo-deoxyguanosine (Adapted 
from Pernot et al., 2012). 
 
As illustrated in Figure 11, biomarkers of IR exposure can be classified into seven 
categories (Pernot et al., 2012): 
• Cytogenetic biomarkers: e.g. dicentrics, translocations, CCAs, prematurely condensed 
chromosomes (PCC), micronuclei, telomere length 
• Biomarkers related to nucleotide pool damage and DNA damage: e.g. DNA SSBs and 
DSBs, γH2AX, extracellular 8-oxo-dG 
  
 
 
56 
• Biomarkers related to germline inherited mutations and variants: e.g. single nucleotide 
polymorphisms (SNP) and inherited gene mutations, copy number variants (CNV) and 
alterations (CNA) 
• Biomarkers related to induced mutations: e.g. glycophorin A (GYPA) in MN blood group 
heterozygotes, hypoxanthine-guanine phosphoribosyl transferase (HPRT) gene 
• Biomarkers related to transcriptional and translational changes: e.g. changes in RNA 
levels identified by transcriptomics, proteins identified by proteomics, ATM/CHK2/p53 
pathway, serum amylase, Flt3-ligand, C-reactive protein (CRP), cytokines 
• Biomarkers related to epigenomic modifications: e.g. histone modifications, DNA 
methylation, micro-RNA (miRNA), phosphoproteome 
• Other biomarkers: e.g. ROS, metabolites and metabolomics, biomarkers associated with 
cell cycle delay, apoptosis and cell survival, biophysical markers of exposure (e.g. 
electron paramagnetic resonance, EPR) 
 
As these biomarkers can detect IR-induced biological effects at various time points 
post-irradiation (ranging from seconds to years to decades), these biomarkers can be further 
classified based on their persistence post-irradiation into four categories (Pernot et al., 
2012): 
• Biomarkers of exposure, which can be used to assess IR-induced biological responses 
either shortly after exposure (seconds to hours to weeks) or long after exposure (months 
to years to decades) 
• Biomarkers of susceptibility, which can be used to predict an increased risk of IR-
induced health effects based on gene or protein profiles that remain constant throughout 
the lifetime of an individual 
• Biomarkers of late effects, which can be used to assess health effects that are present a 
long time after IR exposure 
• Biomarkers of persistent effects, which can be used to assess radiation effects present a 
long period of time after IR exposure 
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Table 2. Summary of the classifications of different types of biomarkers (Adapted from Pernot 
et al., 2012). 
 
 
These categories consider not only the immediate and short-term effects of IR 
exposure, but also the delayed effects of IR exposure, which can have profound implications 
for long-term human health risks (e.g. emergence of secondary cancers and other 
pathobiological conditions after radiotherapy and following occupational IR exposure in 
miners, nuclear workers, and astronauts) (Newhauser and Durante, 2011;Mosse, 
2012;Morgan and Bair, 2013). As summarized in Table 2, there may be overlap between the 
types of biomarkers, and biomarkers can belong to multiple categories. Currently, the most 
well-established and validated biomarkers are the ones measured shortly after irradiation at 
moderate to high doses. Potential biomarkers of exposure, susceptibility, and late/persistent 
effects at low doses remain to be validated (Pernot et al., 2012).  
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Figure 12. Examples of cytogenetic assays used for biodosimetry (Giemsa stained). (A) The 
DC assay, considered as the “gold standard” of biodosimetry. (B) The PCC assay. (C-J) 
Examples of the CBMN cytome assay: (C) mono-nucleate cell; (D) binucleate cell; (E) multi-
nucleate cell; (F) binucleate cell containing one (left) or two (right) micronuclei; (G) binucleate 
cell containing nucleoplasmic bridges (and micronucleus); (H) binucleate cell containing 
nuclear buds (NBUD); (I) early necrotic cell; (J) late apoptotic cell (Adapted from Fenech, 
2007;IAEA, 2011). 
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1.3 Biological dosimetry 
In the event of accidental exposure to IR (e.g. radiation/nuclear accidents or mass 
casualty events), timely dose estimation and medical triage of exposed individuals (e.g. 
exposed workers or the general population) based on individual levels of exposure is 
essential. Some victims, for whom physical signs of IR exposure are not immediately 
observable but were exposed to significant amounts of IR (> 1 Gy), may be at risk of 
developing acute radiation syndrome (ARS)††, which can be fatal (depending on the dose) 
even with proper medical attention (Lopez and Martin, 2011;Macia et al., 2011). Individuals 
exposed to smaller doses of IR may be at risk of eventually developing long-term IR-induced 
health effects (e.g. cataracts, cardiovascular diseases, cancer), and thus, may require 
medical follow-up. Biological dosimetry, which utilizes the measurement of IR-induced 
biological responses or consequences in an individual to estimate dose, can be used to 
properly triage and prioritize victims based on level of urgent medical care and/or need for 
medical follow-up following a large-scale accident.  
Biodosimetry relies on the measurement of biomarkers, discussed above in Section 
1.2.6 (Pernot et al., 2012). Listed below are the established and emerging dosimetry 
methods that are currently employed following accidental IR exposure (Sullivan et al., 2013):  
• Cytogenetic techniques: dicentric chromosome (DC) assay, chromosomal translocations 
analysis, PCC assay, cytokinesis block micronuclei (CBMN) assay (Figure 12), and 
fluorescent in situ hybridization (FISH) which can be applied to each of these cytogenetic 
techniques (Figure 13) (Terzoudi and Pantelias, 2006;Pinto et al., 2010;IAEA, 
2011;Wong et al., 2013) 
• Genetic techniques: somatic mutation assays of GYPA or HPRT, and gene expression 
assays (Brzoska and Kruszewski, 2015) 
                                                
 
†† Acute radiation syndrome (ARS), also known as radiation toxicity or radiation sickness, is an acute 
illness following acute, high dose (> 1 Gy delivered within minutes) whole-body (or significant partial-
body) irradiation with penetrating IR (i.e. able to reach internal organs, e.g. high energy X-rays, γ-rays, 
neutrons) that classically involves the cutaneous, hematopoietic, gastrointestinal (GI), and 
neurovascular systems, either individually or in combination. The onset, manifestation, and severity of 
ARS symptoms depend on the received dose: generally, doses of < 0.5 Gy are not expected to cause 
ARS, doses of 4.5 Gy are lethal for 50% of exposed persons, and doses of > 10–12 Gy are 100% 
fatal. ARS can occur within hours or up to several months after exposure, depending on the received 
dose ARS progresses in three phases, namely the prodromal phase (early symptoms of ARS, e.g. 
anorexia, apathy, nausea, vomiting, diarrhea), the latent phase (when the patient looks and feels 
generally healthy, but stem cells in bone marrow and/or cells lining GI tract are dying), and the 
manifest illness phase. Hematopoietic, GI, and neurovascular syndrome onsets occur at doses of > 
2–3 Gy, 5–12 Gy, and 10–20 Gy, respectively (Lopez and Martin, 2011). 
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• Haematological techniques: differential blood cell count, and lymphocyte depletion rate 
(LDR) (Hu et al., 2015) 
• Protein expression techniques: γH2AX, CRP, and serum amylase (Ainsbury et al., 
2011;Sproull et al., 2015) 
• Physical techniques: EPR with tooth enamel and bones (Wieser and Darroudi, 
2014;Khvostunov et al., 2015), thermoluminescence or optically stimulated luminescence 
(OSL) in building materials or consumer products, and nuclear activation of biological 
tissues or metallic consumer products (Swartz et al., 2014b) 
• Computational techniques: analytical dose reconstruction (‘time and motion’ calculations) 
using the state-of-the-art realistic analytical dose reconstruction with uncertainty 
estimation (RADRUE), and dose reconstruction by numerical approaches based on 
Monte Carlo radiation transport codes (Ainsbury et al., 2011) 
 
The method of biodosimetry deployed would need to be adjusted depending on the 
scale of the emergency/accident and the urgency with which dosimetric results are needed 
(Swartz et al., 2014a;Swartz et al., 2014b); balancing accuracy, speed, and the ability to 
perform high-throughput analyses is important particularly in the case of a large-scale 
radiation incident. Several of these manual and automated systems (especially the DC, 
CBMN, and γH2AX assays) have been harmonized and validated as triage tools in the case 
of a large-scale radiological emergency within several national/regional/international 
networks, including:  
• The European Multibiodose project (www.multibiodose.eu), a network of 11 European 
laboratories that recently adapted and harmonized seven biodosimetric tools, including 
the DC assay (Romm et al., 2013a;Romm et al., 2014a;Romm et al., 2014b), the CBMN 
assay (Thierens et al., 2014), the γH2AX assay (Ainsbury et al., 2014a), the skin speckle 
assay, serum protein assay, and EPR and OSL in portable electronic devices (Jaworska 
et al., 2013;Jaworska et al., 2015), to mass-casualty scenarios using common software 
to integrate and report dose estimates (Ainsbury et al., 2014b) 
• The RENEB project (Realising the European Network of Biodosimetry, www.reneb.eu), a 
network of 23 laboratories from 16 European Union countries (Kulka et al., 2012;Kulka et 
al., 2015) that recently harmonized the γH2AX assay (Barnard et al., 2015) 
• Other European platforms include some biodosimetry topics, e.g. EURADOS (European 
Radiation Dosimetry Group, www.eurados.org) (Ruhm et al., 2015) and NERIS 
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(European platform on preparedness for nuclear and radiological emergency response 
and recovery, www.eu-neris.net) 
• Other national/regional networks in the USA (Blumenthal et al., 2014), Canada (Wilkins 
et al., 2015), Japan (Yoshida et al., 2007), and Latin America (Garcia et al., 1995;Di 
Giorgio et al., 2011;Garcia et al., 2013) 
• International networks that include many of the members of national/regional networks, 
e.g. WHO BioDoseNet network (Blakely et al., 2009;Christie et al., 2010;Livingston et al., 
2011;Maznyk et al., 2012), WHO REMPAN network (Radiation Emergency Medical 
Preparedness and Assistance Network, www.who.int/ionizing_radiation/a_e/rempan/en), 
and the International Atomic Energy Agency (IAEA) EPR-RANET network (Emergency 
Preparedness and Response-Response and Assistance Network, available at www-
pub.iaea.org/MTCD/Publications/PDF/EPR-RANET_2013_web.pdf)  
• The North Atlantic Treaty Organization (NATO) inter-comparison exercise organized by 
the NATO Research Task Group RTG-033 “Radiation Bioeffects and Countermeasures” 
of different biodosimetry assays (Rothkamm et al., 2013b), including the manual and 
automated DC assay (Beinke et al., 2013), CBMN assay (Romm et al., 2013b;De 
Sanctis et al., 2014), γH2AX assay (Rothkamm et al., 2013c), and the gene expression 
assay (Badie et al., 2013)  
 
Historically, biodosimetric approaches have been focused on cytogenetic 
biodosimetry assays (illustrated in Figure 12), which estimate the absorbed dose in the 
exposed individual based on analysis of IR-induced chromosomal alterations. The DC assay 
(Figure 12A) remains the international “gold standard” of biodosimetry (Pinto et al., 
2010;IAEA, 2011;Wong et al., 2013). In the following sections, we elaborate on the current 
status of each of the four cytogenetic assays (DC, translocations, PCC, CBMN; Figure 12), 
and the applications of FISH (Figure 13) as well as the widely used γH2AX assay 
(summarized in Table 3). As will be discussed in the following sections, each of these 
assays has potential advantages and challenges as biodosimeters, and many of these 
assays have been automated to allow for high-throughput analyses and faster acquisition of 
results. 
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Table 3. Summary of current status of cytogenetic assays used for biodosimetry (automated 
and manual). 
 DC assay PCC assay CBMN assay FISH assay γH2AX assay 
Types of 
aberrations 
scored for 
biodosimetry 
applications 
• Dic 
• Rings 
• Ac 
• Dic 
• Rings 
• Transloc 
• MN 
• NPB 
• NBUD 
• Dic 
• Rings 
• Ac 
• Transloc 
• γH2AX foci 
• γH2AX 
fluorescence 
intensity 
Typical IR 
scenario 
applications 
• Acute / 
Chronic 
• Recent 
exposure 
• Acute 
• Recent 
exposure 
• Acute / 
Chronic 
• Recent 
exposure 
• Acute / 
Chronic 
• Recent / Old 
exposure 
• Acute 
• Recent 
exposure 
Acute dose range 
limits 0.1 to 5 Gy 0.2 to 20 Gy 0.3 to 4 Gy 0.25 to 4 Gy 
Depends on 
time point post-
irradiation 
Minimum time 
required to 
obtain results* 
2.4-6 days < 1 day 4-8 days 
2-5 days, 
depending on 
assay 
< 1 day – 2 
days 
Status of assay 
standardization 
(ISO, 2008; 
2014a) NA (ISO, 2014b) NA NA 
Stability of 
aberration post-
IR exposure 
• Dic: weeks • PCC 
fragments: 
immediately 
• PCC rings: 
weeks 
• MN: weeks 
 
• Transloc: 
years 
 
• γH2AX:  
hours to 1 
day 
 
* Based on (IAEA, 2011;Beinke et al., 2013;Romm et al., 2013b;Rothkamm et al., 2013b;Rothkamm 
et al., 2013c). Ac=acentrics; Dic=dicentrics; Gy=Gray; MN=micronuclei; NA=not applicable; 
NBUD=nuclear buds; NPB=nucleoplasmic bridges; Transloc=translocations. 
 
 
1.3.1 The dicentric chromosome (DC) assay 
As mentioned above, the DC assay, considered the international “gold standard” 
method of biodosimetry, is the technique with which newer biodosimetric approaches are 
compared for validation. The dicentric chromosome is the biomarker of choice for 
biodosimetry (for recent IR exposure, as the frequency of this CA decreases with 
lymphocyte turnover) due to its relative specificity to IR exposure, low background levels, 
and high sensitivity. The technique and performance criteria in peripheral blood lymphocytes 
(PBL) are highly standardized by the IAEA and the International Organization for 
Standardization (ISO) to ensure reproducibility and accuracy for routine or triage use (ISO, 
2008;IAEA, 2011;ISO, 2014a). The DC assay is considered the most precise and sensitive 
method of dose estimation; it is capable of detecting doses as low as 0.1 Gy, and can 
differentiate between partial and whole body exposures as well as chronic and acute 
exposures (IAEA, 2011).  
However, the usefulness of this technique in a large-scale emergency setting is 
limited by the time-consuming and laborious nature of the assay, as this technique requires 
at least 4 to 5 days until results are available. This delay is due to several unavoidable 
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variables. To apply the DC assay, collected PBL need to be stimulated and cultured for a 
fixed, incompressible time of ~2 days until they reach first mitosis; a recent study 
investigating alternative methods of lymphocyte stimulation to determine whether this most 
time-consuming portion of the DC assay can be effectively reduced found that the 
conventional protocol using the lectin PHA-M (Phytohemagglutinin M) is superior to 
higher/lower concentrations of PHA-M and in comparison with seven other mitogens‡‡ 
(Beinke et al., 2015). Additionally, low mitotic index of irradiated cells, especially at high 
doses (> 4 to 5 Gy of low-LET IR), as well as dose-dependent mitotic delay and/or cell 
death, may hinder acquisition of sufficient numbers of analyzable cells and may lead to 
underestimation of dose; a recent study demonstrated that treatment of lymphocyte cultures 
with caffeine can overcome the upper dose limit of 4 to 5 Gy and allows for DC analysis of 
doses of up to 25 Gy (Pujol et al., 2014). Furthermore, the classic DC assay utilizes uniform 
staining (i.e. Giemsa) of metaphases (Figure 12A), which requires a high level of trained 
expertise (as CAs are scored based solely on chromosomal morphology), and sufficient time 
is needed to individually analyze large numbers of cells to minimize large inter-cellular 
differences especially following low doses of IR exposure (IAEA, 2011).  
Strategies to shorten analysis time and increase the throughput of the DC assay 
have been developed. Such strategies include modified methods of manual DC scoring 
following uniform metaphase staining, including scoring cells in a less restrictive manner 
(QuickScan Mode) (Flegal et al., 2010;Flegal et al., 2012;De Amicis et al., 2014), and 
scoring lower numbers of metaphases (Triage Mode) (Lloyd et al., 2000;Romm et al., 
2011;De Amicis et al., 2014). The sharing of high resolution images via the internet and 
web-based manual scoring (tele-scoring) by trained scorers anywhere in the world (thereby 
eliminating the need to mail blood samples or slides) may be an immediate solution to 
increasing throughput of this labor-intensive analysis; this strategy has recently been 
recommended by the US Department of Homeland Security as an immediate solution to 
addressing the shortage of laboratory capacity in the US in the event of a nuclear detonation 
in an urban environment (along with providing biodosimetry and DC scoring training to the 
~150 cytogenetics laboratories in the US to further improve capacity) (Blumenthal et al., 
2014); scoring exercises and inter-comparisons have been performed within the networks of 
WHO BioDoseNet (Livingston et al., 2011;Maznyk et al., 2012), Latin America (Garcia et al., 
2013), and Japan (Yoshida et al., 2007), and promising results have been reported in the 
                                                
 
‡‡ The seven mitogens investigated in this study included five lectins named CNA (concanavalin A), 
PW (pokeweed), LMA (lectin from M. amurensis), LTV (lectin from T. vulgaris), PHA-L 
(Phytohemagglutinin L), administered either alone or combined with LPS (E. coli lipopolysaccharide) 
and SLO (streptolysine O) (Beinke et al., 2015). 
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Multibiodose project with both conventional DC scoring and scoring in QuickScan Mode 
(Romm et al., 2014a). 
Automation of at least some portions of the DC assay is recommended to further 
increase throughput analysis (Blumenthal et al., 2014). Several automated systems have 
been developed, including automated DC scoring via imaging flow cytometry (Beaton et al., 
2013), and semi-automated DC scoring following uniform staining using commercial image 
analysis software DCScore (MetaSystems) (Vaurijoux et al., 2009;Vaurijoux et al., 
2012;Gruel et al., 2013;Romm et al., 2013a;De Amicis et al., 2014). There have been joint 
efforts to harmonize these manual and automated scoring approaches in international 
networks (Wilkins et al., 2008;Di Giorgio et al., 2011;Wilkins et al., 2011;Beinke et al., 
2013;Jaworska et al., 2013;Romm et al., 2013a;Rothkamm et al., 2013b;Ainsbury et al., 
2014a;Romm et al., 2014b). However, existing software for automated DC scoring is able to 
detect only half of the dicentrics and rejects many of the metaphases. The difficulty in 
obtaining sufficient numbers of metaphases from irradiated samples due to the lack of 
sensitivity of the existing software, limits the capacity to perform sensitive and precise 
biological dosimetry at both low and high doses using existing automated DC scoring 
systems.  
 
1.3.2 Fluorescence in situ hybridization (FISH) and chromosomal translocations 
analysis  
The development of fluorescence in situ hybridization (FISH) techniques (Figure 13) 
have allowed for easy visualization and assessment of IR-induced structural CAs for routine 
biodosimetry applications that were not before possible with G banding and Giemsa staining 
(Edwards et al., 2005). As dicentric chromosomes and CCAs (a biomarker of high-LET IR 
exposure) are unstable, non-transmittable CAs, they decrease in frequency with PBL 
turnover and are thus reliable as biomarkers of recent IR exposure (weeks). Translocations, 
however, are stable, transmittable CAs and thus allow for biodosimetry for past IR exposure 
(years) (Anderson et al., 2000;Pernot et al., 2012;Cho et al., 2015). The FISH technique 
allows chromosomes to be “painted” by attaching specific DNA sequences (probes) to 
various fluorochromes. A large variety of probes are now available, so FISH can be 
employed to selectively visualize a wide spectrum of the genome: from a specific portion of 
chromosome (e.g. centromeres, telomeres; Figure 13A), to one or multiple specific 
chromosomes (chromosome painting), to painting of the entire genome (M-FISH and 
karyotype analyses; Figure 13B). Furthermore, by attaching fluorochromes in varying ratios 
to specific sites, different regions can be visualized simultaneous with a wide range of 
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colors. FISH can also be applied to other cytogenetic techniques like the PCC and CBMN 
(Figure 13C) assays to carry out various analyses (IAEA, 2011).  
 
 
Figure 13. Examples of FISH assays. (A) Visualization of IR-induced dicentric chromosomes 
and other CAs using TC-FISH. (B) Visualization of IR-induced translocations using M-FISH and 
analysis of translocations using karyotyping (Images of CEA LRO). (C) Examples of a 
micronucleus that is centromere-negative and centromere-positive in binucleate cells stained 
with a pan-centromeric probe, and nuclei and micronuclei counterstained with DAPI (Adapted 
from IAEA, 2011). 
 
As will be discussed in detail later in Section 3, the “gold standard” DC assay can be 
simplified and improved with the application of telomere/centromere-fluorescence in situ 
Normal'
chromosome'
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hybridization (TC-FISH), which simultaneously stains telomeres and centromeres using 
peptide nucleic acid (PNA) probes§§ (Shi et al., 2012;M'Kacher et al., 2014). The throughput 
of the TC-FISH technique can potentially be further enhanced by the use of a microwave 
oven to shorten the hybridization time of the PNA probes (Cartwright et al., 2013). In a 
recent study in our laboratory, TC-FISH staining was shown to be a cost-effective method 
that significantly simplifies the manual scoring of dicentric chromosomes (thereby eliminating 
the need for trained specialists to analyze samples). Furthermore, the automated scoring 
system (TCScore) developed in our laboratory is able to detect IR-induced CAs with the 
same efficacy as manual scoring in a fraction of the time. The TCScore software provides 
automated analysis of three-channel (RGB) images (red, green, and blue channels 
containing telomere, centromere, and DAPI DNA staining information, respectively) split into 
their individual channels by any image processing software (e.g. Image J) and generates an 
intuitive and interactive report of CA classes that can be reviewed and corrected in batches 
by an investigator (M'Kacher et al., 2014). Recent expansion of the robotically based ultra-
high throughput biodosimetry workstation (RABiT, Rapid Automated Biodosimetry 
Technology), which was originally designed to implement the CBMN and γH2AX assays 
from a single drop of blood from a fingerstick, allows automated sample processing, image 
capture, and DC scoring using PNA or FISH probes (Garty et al., 2015). These improved, 
automated approaches will open up new horizons for the use of this assay for rapid 
biodosimetry. 
The M-FISH technique is a powerful tool for detailed analyses of translocations and 
CCAs in the whole genome at very low to high doses of IR exposure, as it allows all 
chromosomal homolog pairs to be differentiated (Speicher et al., 1996;Loucas and 
Cornforth, 2001). It was shown to be sensitive enough to detect translocations and other 
CAs at doses as low as 0.1 Gy of low-LET IR (Nieri et al., 2013). Though the long-term 
stability of translocations and the usefulness of this technique was recently validated (Cho et 
al., 2015), M-FISH analysis is laborious, time-consuming (~ 5 days to obtain results), and 
expensive; standardization and automation will be key to improving the significance of FISH-
based translocation assays. Furthermore, the frequencies of translocations at baseline and 
their persistence post-irradiation at various doses, as well as potential inter-individual 
                                                
 
§§ Peptide nucleic acid (PNA) probes have synthetic (unnatural) pseudo-peptide polymer backbones 
to which nucleobases are linked. Due to their unnatural backbones, PNA probes can hybridize faster 
and with higher affinity and specificity to complementary sequences of DNA and RNA compared to 
DNA or RNA probes (1 hour vs. ~12 hour hybridization times for PNA vs. DNA/RNA probes, 
respectively). PNA probes are also advantageous over DNA or RNA probes as they are resistant to 
nuclease and proteinase degradation and to polymerase amplification (Paulasova and Pellestor, 
2004;Shi et al., 2012). 
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variability in their levels, need to be further characterized, especially in the low dose range 
(Tucker, 2008). Such data would be valuable for studying the long-term health risk of IR 
exposure, and may generally contribute to understanding the link between CAs and human 
diseases and cancer (Beinke and Meineke, 2012). 
Recently, a new FISH approach called directional genomic hybridization (DGH) has 
been developed that combines DNA sequence information and the strand-specific 
Chromosome Orientation-FISH (CO-FISH) technique to hybridize genomic targets that share 
the same 5'à3' orientation. Based on this concept, painting of a single chromatid of human 
chromosome 3 was developed to analyze chromosomal inversions, a stable, transmissible 
CA like translocations. A recent study illustrated that DGH-detectable IR-induced inversions 
can be useful as a biodosimetric tool, as the frequency of IR-induced inversions increased 
with dose in human lymphocytes and fibroblasts following γ-irradiation (0 to 4 Gy) and high-
LET iron and oxygen irradiations (0 to 0.4 Gy). Though more work needs to be done to 
establish chromosomal inversions as a reliable biomarker of past IR exposure, this 
technique provides a promising biodosimetry approach of measuring another stable, 
transmissible IR-induced CA with the added benefit of less labor-intensive analysis (Ray et 
al., 2013;Ray et al., 2014). 
 
1.3.3 The premature chromosome condensation (PCC) assay 
Premature chromosome condensation (PCC) enables the visualization of CAs in 
non-stimulated interphasic PBL (Figure 12B), thereby removing the delay due to the 
incompressible time needed to stimulate and culture the PBL until they reach first mitosis for 
the DC assay; IR-induced CA can be observed within 3 hours after blood sampling using 
PCC (compared to 49 hours using the DC assay). PCC can be induced by either mitotic cell 
fusion or by chemical means. Cell fusion-mediated PCC can be induced by fusing 
interphasic human PBL to mitotic Chinese hamster ovary (CHO) using polyethylene glycol 
(PEG) as the fusing agent; this fusion process takes only 4 minutes, and is followed by 1 
hour of additional cell culture incubation with Colcemid. This technique enables the scoring 
of IR-induced human chromosomal fragments using Giemsa staining, and dicentric 
chromosomes using C banding or chromosome painting with or without a pan-centromere 
probe in other phases of the cell cycle than the conventional M (mitosis) phase, thus 
allowing these CAs to be tracked as cells cycle through each cell cycle phase (IAEA, 2011). 
PCC can also be induced by chemical means using inhibitors of DNA phosphorylation such 
as okadaic acid or calyculin A, adenosine triphosphate, and p34cdc2/cyclin B kinase following 
cell culture of just 3 hours, i.e. the rapid interphase chromosome assay (RICA); IR-induced 
chromosomal exchanges between different chromosome domains can be visualized using 
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chromosome painting or FISH (Prasanna et al., 2000). Chemically-induced PCC can also be 
used to score ring chromosomes following Giemsa staining in other phases of the cell cycle 
(PCC-Rch), a useful technique to reduce scoring time particularly following very high doses 
(up to 20 Gy of low-LET IR vs. up to ~4 to 5 Gy for the conventional DC assay). However, 
this technique does not significantly reduce cell culture time compared to the DC assay (48 
hours vs. 49 hours to obtain metaphases for the DC assay) (Kanda et al., 1999;IAEA, 2011), 
though the use of an automated metaphase finding system (MetaSystems) significantly 
increases the speed of scoring these chemically-induced PCC spreads (Balakrishnan et al., 
2010); a recent study demonstrated that the culture time for this technique could be reduced 
to 40-42 hours (PCC-R assay) with adequate precision in dose estimation for doses 
between 5 and 10 Gy of low-LET IR (Romero et al., 2015). 
The PCC assay (with the exception of the chemically-induced PCC-ring assays) is 
advantageous over the conventional DC assay because of the reduced cell culture time from 
blood sampling to analysis. The scoring of dicentric chromosomes using the PCC method is 
particularly interesting for biodosimetry, as it allows these CAs to be observed in cells that 
would otherwise not be observed with the conventional DC assay (irradiated cells may 
undergo cell death or never enter mitosis, especially at high doses when mitotic index 
decreases). Additionally, the PCC assay can accurately discriminate between whole and 
partial body exposures since the number of normal cells more accurately reflects the 
proportion of non-irradiated PBL (IAEA, 2011). However, despite the advantages of the PCC 
assay, it is not yet routinely used. 
The major drawback of this approach, which utilizes Giemsa staining, is the difficulty 
of scoring the IR-induced CAs in the PCC spreads. Chromosomal fragments, rings, and 
acentric chromosomes can be scored with Giemsa staining, but dicentric chromosomes 
cannot be visualized because of the morphology of the interphase-condensed chromosomes 
and the inability to detect centromeric regions with Giemsa staining. Conventional 
techniques such as C banding or centromeric/whole-chromosome FISH can be applied to 
PCC spreads to simplify the scoring of CAs. However, FISH probes are costly, and FISH 
techniques can take from 2 days (for centromeric or simple chromosome painting) to 5 days 
(for M-FISH).  
A few strategies to shorten analysis time and increase the throughput of the PCC 
assay have been developed, including dose estimation based on the length ratio of the 
longest and the shortest chromosome pieces (Gotoh and Tanno, 2005;Wang et al., 
2007;Gonzalez et al., 2014), or based on the scoring of ring chromosomes in cell fusion-
mediated PCC (PCC-Rf assay) instead of the more time-consuming chemically-induced 
PCC (Lamadrid Boada et al., 2013). Dose estimations for doses of up to 10 Gy may also be 
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made based on the proportion of condensed chromosomes in each cell cycle phase*** (a 
novel biodosimetric parameter, the cell-cycle progression index) using the calyculin A-
induced PCC assay (Miura et al., 2014); previously, G2-PCC chromosomes have been 
shown to be a simple and rapid method of biodosimetry following low-LET IR exposure 
(Gotoh et al., 2005) and after high-LET exposure with carbon ions (Wang et al., 2007). 
The scoring of IR-induced CAs using the PCC assay has been improved with the 
application of TC-FISH, which shortens hybridization times, increases specificity and signal 
intensity, and lowers cost. Suto et al recently employed an improved rapid protocol that 
enabled dose estimation results to be obtained in as short as 6 hours after blood sampling; 
however, the detection of the much shorter, weakly staining telomere sequences (and 
analysis of IR-induced CAs) in human cells was impeded by the long, brightly staining, 
interstitial telomere sequences of CHO cells (Suto et al., 2013;Suto et al., 2015). By the 
same time, this TC-FISH technique on PCC spreads was further enhanced in our laboratory 
by optimizing hybridization conditions and image capture parameters, to increase the 
sensitivity and effectiveness of CA scoring. Furthermore, we have automated CA scoring 
using PCC-TCScore software, developed in our laboratory. This new approach will open up 
new horizons for biodosimetry, particularly following low and high doses, as well as partial-
body irradiation, as it allows for the scoring of unstable CAs when conventional techniques 
are inadequate and when speed of obtaining results matters (M'Kacher et al., 2015a).  
 
1.3.4 The cytokinesis block micronuclei (CBMN) assay  
The cytokinesis block micronuclei (CBMN) assay in PBL (Figure 12F) is a well-
established and standardized technique that is considered as a main biodosimetry tool for IR 
exposure along with the “gold standard” DC assay. This method has been proposed as an 
alternative to the DC assay, as it requires less time and cytogenetic expertise (IAEA, 
2011;Vral et al., 2011;ISO, 2014b). Micronuclei are formed from acentric fragments or whole 
chromosomes that are unable to interact with the mitotic spindle during anaphase and are 
thus not included in the nuclei of daughter cells; they are small distinct spherical objects 
within the cytoplasm of the cell that have the same morphology and staining properties as 
the main nuclei. For the CBMN assay, cytokinesis is blocked in dividing lymphocytes by 
adding cytochalasin B to the medium; since division of the nuclei is not inhibited, cytokinesis 
block produces binucleate cells since the two daughter cells are not permitted to separate. 
                                                
 
*** Calyculin A induces chromosome condensation in various phases of the cell cycle and since IR 
exposure predominantly induces G2/M checkpoint in the cell cycle (Miura et al., 2014). 
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This protocol allows for distinction between proliferating and non-proliferating cells, and MN 
can be scored specifically in proliferating cells, i.e. binucleate cells (IAEA, 2011).  
Micronuclei are not IR-specific (they can arise from exposure to various genotoxic 
agents), and inter-individual variability in baseline frequency of micronuclei exists based on 
age, gender, and life-style factors††† (Fenech and Bonassi, 2011); thus, the lower dose limit 
for the CBMN assay is ~0.2 to 0.3 Gy of low-LET IR (Vral et al., 2011;Tucker et al., 2013). 
Indeed, women are known to have higher baseline micronucleus frequencies than men 
(Bonassi et al., 2001;Fenech et al., 2011a), and the frequency of micronuclei has been 
shown to increase with age (Bolognesi et al., 1997;Bonassi et al., 2001). Micronuclei 
formation due to chromosome loss has been shown to increase with age, and the X-
chromosome appears to be almost always involved in this chromosome loss, which may 
explain the gender difference observed in spontaneous micronuclei frequencies (Vral et al., 
2011). 
The number of IR-induced micronuclei is strongly correlated with IR dose. Generally, 
a linear-quadratic dose-response relationship (y  =   c  +  αD  +   βD2)‡‡‡ has been reported for 
low-LET IR, while a linear dependence (y  =  c  +  αD)‡‡‡ has been observed for high-LET IR, 
with high-LET IR being more effective in generating micronuclei compared to equivalent 
doses of low-LET IR. These curve fittings follow the same shape as described for the 
standard DC assay (Vral et al., 2011). A recent study showed a linear-quadratic dose-
response relationship following irradiation (1 to 5 Gy) with high-LET protons (30 MeV) 
(Litvinchuk et al., 2015). However, due to inter-laboratory differences caused by the use of 
different protocols, scoring criteria, etc, it is necessary that each laboratory intending to use 
this assay for biodosimetry establishes its own dose-response calibration curves (Romm et 
al., 2013b). Micronuclei induction has been shown to level off at doses higher than 5 Gy, a 
phenomenon that is well observed for other cytogenetic end points (i.e. dicentrics) that is 
attributed to the selection against heavily damaged cells that cannot enter mitosis (Vral et 
al., 2011). At higher doses (> 3 Gy), a wide range of inter-individual variability may also be 
observed (Kacprzak et al., 2013;Antunes et al., 2014). Interestingly, a recent study 
employing M-FISH on IR-induced micronuclei revealed that at high doses (> 2 Gy of low-
                                                
 
††† To assess environmental effects on chromosomal damage in the human population based on 
micronuclei frequency, an international collaborative project called HUMN (HUman MicroNucleus, 
www.humn.org) was launched in 1997. With over 40 laboratories participating worldwide, they aim to 
provide a powerful tool for the evaluation of micronuclei frequencies for public health and 
epidemiological studies by combining available micronuclei data from a variety of human populations. 
‡‡‡ In the equations, y represents the yield of micronuclei per binucleate cells, c is the background 
frequency of micronuclei, D is the absorbed dose (Gy), and the α and β coefficients refer to 
micronuclei per binucleate cell per Gy and per Gy2, respectively. 
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LET IR), micronuclei formation might be complex involving multiple chromosome fragments 
(Balajee et al., 2014). 
The development of new scoring approaches to increase the speed and decrease 
inter-scorer variability is required in order for this assay to be applied as a biodosimetry tool 
in a large-scale emergency. Several methods have been proposed, including manual 
scoring of lower numbers of cells (Triage Mode) (McNamee et al., 2009;De Amicis et al., 
2014). Several automated micronuclei scoring systems, which enable faster delivery of 
results and reduced inter-scorer variability, have been developed, including imaging flow 
cytometry (ImageStreamX) (Rodrigues et al., 2014b;a) and laser scanning cytometry 
(Francois et al., 2014). Additionally, sophisticated image analysis software (e.g. Metasystem 
Metafer MNScore, IMSTAR PathFinder Screentox Auto-MN, Compucyte iCyte) have been 
tested and validated as biodosimetry tools for IR exposure; the automated and semi-
automated MetaSystems platforms were recently harmonized within the framework of the 
European Multibiodose project, with the semi-automated approach showing more added 
value compared to the automated approach (Ainsbury et al., 2014a;Thierens et al., 2014). 
These automated techniques can be further refined with the use of centromere and telomere 
probes, which allow the origin of the micronuclei to be determined (from acentric fragments 
vs. whole chromosomes) (Decordier et al., 2011;Rossnerova et al., 2011;Fenech et al., 
2013). Recent improvements of the ultra-high throughput RABiT workstation allows 
automated sample processing, image capture, and CBMN scoring from a single drop of 
blood from a fingerstick (Garty et al., 2010;Garty et al., 2015). 
The CBMN assay has recently been expanded to a more comprehensive version 
known as the cytokinesis block micronucleus cytome (CBMN Cyt) assay (Figure 12C-J) 
(Fenech, 2007), which can be used for measurements for DNA damage, cytostasis 
(measure of cell proliferation), and cytotoxicity (measure of cell death). DNA damage events 
can be scored in binucleate cells as micronuclei (a biomarker of acentric fragments and/or 
whole chromosome loss), nucleoplasmic bridges (a biomarker of dicentric chromosomes), or 
nuclear buds (a biomarker of gene amplification) (Fenech et al., 2011b). Cytostatic effects 
can be measured by calculating the proportion of mono-, bi-, and multinucleated cells. 
Finally, cytotoxicity can be measured by determining the ratios of necrotic and/or apoptotic 
cells. These measures can provide additional details of the biological effects of IR exposure 
that are informative for biodosimetry and environmental/chemical genotoxicity studies 
(Fenech, 2010;IAEA, 2011). 
  Micronucleus induction following IR exposure has been reported in cell types and 
tissues other than lymphocytes (e.g. erythrocytes, hair root cells, buccal cells), but these 
methods have not yet been adequately validated for biodosimetry (Fenech, 2010). Indeed, a 
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recent study intra- and inter-laboratory comparison study demonstrated that the buccal 
micronucleus cytome (BMCyt) assay is at an early stage of development and requires 
further standardization to produce reproducible results (Bolognesi and Fenech, 
2013;Bolognesi et al., 2013;Bolognesi et al., 2015). 
 
1.3.5 Quantification of γH2AX 
γH2AX, the phosphorylated form of the H2AX histone, is a promising candidate as a 
biomarker that can be used for rapid emergency biodosimetry shortly after acute irradiation 
(Rothkamm et al., 2013b). γH2AX foci form at the site of DNA DSBs (Scully and Xie, 
2013;Valdiglesias et al., 2013), and can be readily visualized by immunofluorescence 
microscopy or flow cytometry. Foci are formed within minutes after IR exposure in a dose-
dependent manner, peak at <1 hour post-irradiation, and then rapidly decay to baseline 
levels within one to several days, depending on the dose received.  
Manual γH2AX foci scoring via immunofluorescence microscopy is currently the most 
sensitive method of γH2AX analysis. The number of manually scored γH2AX foci is well 
established to be correlated one-to-one with the number of DSBs, which in turn, can easily 
be correlated to the received IR dose (Rothkamm and Lobrich, 2003;Joubert et al., 2008). 
However, manually scoring foci is time-consuming, fastidious, requires trained investigators, 
and produces inter-investigator and inter-laboratory variations in results; indeed, recent inter-
comparison exercises of several laboratories that analyzed the same samples of irradiated 
whole blood (Rothkamm et al., 2013c) and lymphocytes (Rothkamm et al., 2013a;Barnard et 
al., 2015) revealed dramatic variations of manually scored foci yields. Additionally, for the 
γH2AX assay to be used as a biodosimetric triage tool, inter- or intra-individual variability in 
the basal levels of γH2AX as well as the time course of γH2AX induction and decay following 
irradiation (which depend on individual DSB repair capacity, which in turn may reflect 
individual radiosensitivity) is a crucial issue that must be addressed (Rothkamm and Horn, 
2009;Roch-Lefèvre et al., 2012). 
To reduce γH2AX quantification time and minimize scoring artifacts, several 
automated foci scoring systems have been developed (Bocker and Iliakis, 2006;Hou et al., 
2009;Roch-Lefevre et al., 2010;Runge et al., 2012). Another less automated approach 
based on individual foci scoring following a rapid "lyse/fix" method on a 96 well plate, which 
allows a significant reduction of sample processing time, was well correlated with the 
classical γH2AX quantification in isolated lymphocytes (Moquet et al., 2014). γH2AX can also 
be quantified as global fluorescence intensity in the whole nucleus, instead of scoring 
individual foci. This approach may be a more rapid method to obtaining biodosimetric results 
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than by foci scoring. Flow cytometry and immunofluorescence microscopy have previously 
been used for global γH2AX fluorescence quantification (MacPhail et al., 2003;Hamasaki et 
al., 2007;Ismail et al., 2007;Garty et al., 2010;Horn et al., 2011;Roch-Lefèvre et al., 2012); in 
our recent paper, presented in Section 2, we have validated global fluorescence intensity 
measurements via flow cytometry and immunofluorescence microscopy as a reliable 
dosimetry tool in comparison to the now well-established γH2AX foci scoring method (Viau 
et al., 2015). The ultra-high throughput RABiT workstation (previously discussed for 
automated DC and CBMN analyses) allows automated sample processing, image capture, 
and γH2AX analysis based on foci scoring or global fluorescence from a single drop of blood 
from a fingerstick (Garty et al., 2010;Garty et al., 2015;Sharma et al., 2015). The 
optimization of miniaturization and the increase in the number of analyzed samples have 
recently been improved (Repin et al., 2014). However, inter-comparison exercises of several 
laboratories to compare automated and manual foci scoring showed vast inter-laboratory 
differences in results (Rothkamm et al., 2013a;Ainsbury et al., 2014a;Barnard et al., 2015). 
Though these studies confirm that γH2AX foci assays can be useful as a biodosimetric triage 
tool, they brought to light the complexity in the standardization of an automated γH2AX 
biodosimetry protocol between multiple laboratories. Additionally, these studies showed the 
importance of balancing the higher speed and convenience of automated foci scoring 
systems with their compromised accuracy and sensitivity of dose estimation (Rothkamm et 
al., 2013a;Barnard et al., 2015).  
In light of these limitations of the γH2AX immunofluorescence techniques as a high 
throughput assay, a promising new assay using a high throughput electrochemiluminescent 
platform from Mesoscale Discovery Systems was developed to quantify γH2AX levels in a 
larger dose range (Avondoglio et al., 2009). A simplified enzyme-linked immunosorbent 
assay (ELISA) has also been recently developed that relies on direct antibody-based 
detection of cellular proteins from sample lysate immobilized on a solid substrate from a 
small volume of minimally prepared sample (Johnston et al., 2015). 
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1.4 Individual radiosensitivity  
With increasing levels of IR exposure throughout our lifetime, there is growing 
concern of the long-term health effects of such exposures. To “review work on the biological 
and medical effects of [IR] relevant to human health in the occupational, public health, 
medical and environmental fields and advise on research priorities,” the Advisory Group on 
Ionising Radiation (AGIR) was convened in 1995 by the Health Protection Agency in the 
United Kingdom. In their most recent report, published in March 2013, they extensively 
review evidence of inter-individual variability in radiosensitivity from epidemiological, clinical, 
and experimental studies, consider mechanisms of radiosensitivity and the impact of 
individual variability on long-term human health effects, and discuss ethical implications for 
radiation protection of current and potential future knowledge on radiosensitivity in the 
human population. Based on this evidence, they conclude that there is growing evidence of 
inter-individual differences in radiosensitivity that can influence risk of IR-induced cancers. 
However, knowledge of the mechanisms that determine radiosensitivity is accumulating, but 
remains incomplete (Advisory Group on Ionising Radiation, 2013)§§§. 
 
1.4.1 Mechanisms of radiosensitivity 
The term “radiosensitivity” can be referring to either the extent of IR-induced 
biological responses or the susceptibility to IR-induced carcinogenesis from the standpoint of 
the cell, tissue, or individual/organism. Cellular radiosensitivity can be quantified by 
measurements of a variety of biomarkers of IR exposure, which were discussed in detail in 
Section 1.2.6 (Pernot et al., 2012;Manning and Rothkamm, 2013). Notably, depending on 
the underlying cause of radiosensitivity, cellular radiosensitivity may not be detectable using 
one assay, but may be detectable using another. Based on these measurements, cellular 
variations in radiosensitivity are well observed between individuals, as well as between 
different cell types and between cells of the same type within a single individual; variations in 
radiosensitivity also exist between normal and cancer cells. It is well established that 
intrinsic, genetically determined differences in cellular responses to IR-induced damage, 
particularly the repair of DNA DSBs****, is associated with these intra- and inter-individual 
differences in cellular radiosensitivity. Genetic differences in the initiation and maintenance 
                                                
 
§§§ Articles in French: (Joubert and Foray, 2007;Granzotto et al., 2011;Joubert et al., 2011;Foray et 
al., 2013;Lacombe et al., 2013). 
**** DNA SSBs and base damages are redundantly and efficiently repaired, so deficiencies in repair 
pathways for these types of DNA lesions causes only minor radiosensitivity (Advisory Group on 
Ionising Radiation, 2013).  
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of cell cycle checkpoint arrest, as well as the cellular ability to activate apoptosis, could also 
be a source of individual radiosensitivity. Moreover, the accuracy of DSB repair is important 
to avoid genetic instability and ultimately IR-induced carcinogenesis (Advisory Group on 
Ionising Radiation, 2013). 
As discussed in Section 1.2.3, mammals possess two principal mechanisms of DNA 
DSB repair: NHEJ and HR repair. The NHEJ pathway is the major DNA DSB repair pathway 
in mammalian cells; defects in proteins involved in this pathway (e.g. DNA-PKcs, DNA LIG4, 
Artemis, Cernunnos) confer dramatically increased radiosensitivity and immunodeficiency 
(e.g. severe combined immunodeficiency, SCID, or T- and B-cell lymphocytopenia). HR 
repair is active in DSB repair in the G2 and S phases of the cell cycle; radiosensitivity 
disorders associated with defects in HR repair can be caused by mutations in genes that 
cause Fanconi anemia (e.g. FANCD1 or BRCA2, FANCD2, FANCI, FANCJ, FANCN), 
Rad51 paralogues (e.g. RAD51C, RAD51B, RAD51D, XRCC2, XRCC3), and possibly 
Bloom’s syndrome (BLM). Radiosensitivity can also be caused from defects in proteins 
involved in DDR signaling and/or activation of cell cycle checkpoints (e.g. ATM, 53BP1, 
Mre11/Rad50/Nbs1 or the MRN complex, RFN168) and/or in carrying out histone 
modifications around the DSB (e.g. H2AX to form γH2AX), though these signaling are not 
required for DSB repair by NHEJ. Finally, cellular radiosensitivity disorders may arise due to 
mutations in cohesins, which are proteins involved in holding chromosomes together during 
DNA replication/repair; such disorders include the Cornelia de Lange syndrome (mutations 
in NIPBL, or in cohesin subunits SMC1A or SMC3), Robert’s syndrome (mutations in 
ESCO2), and Warsaw breakage syndrome (mutations in DDX11) (Advisory Group on 
Ionising Radiation, 2013).  
Overall, there are currently 15 known genetic disorders involving mutations in genes 
mentioned above that are associated with increased cellular radiosensitivity; all are rare 
recessive disorders, with the exception of the Cornelia de Lange syndrome (which is a rare 
autosomal dominant disorder). Several of these disorders have shown unusual 
radiosensitivity at the clinical level, namely ataxia telangiectasia (ATM mutation), LIG4 
syndrome (LIG4 mutation), Nijmegen breakage syndrome (NBS mutation), and potentially 
Fanconi anemia (Advisory Group on Ionising Radiation, 2013). Homozygous carriers of LIG4 
and ATM mutations are severely radiosensitive (hyper-radiosensitive), with clonogenic 
survival fraction at 2 Gy (SF2) of only 1%–3%; radiotherapy may be fatal for patients with 
LIG4 and ATM mutations. However, the occurrence of these syndromes in the population is 
very rare: there is only one known case of LIG4 mutations in the world, and ATM mutations 
are found at a frequency of ~1 in 100,000. Heterozygotes of ATM and NBS mutations may 
exhibit radiosensitivity that is intermediate (SF2 of 40%–60%) between individuals with 
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homozygous mutations and normal genotypes. Other homozygous recessive syndromes 
that are more frequent than homozygous LIG4 and ATM mutations are less dramatically 
radiosensitive (intermediate or moderate radiosensitivity), with SF2 between 10% and 50%. 
Interestingly, ATM heterozygotes may be at two-fold greater risk of IR-induced breast 
cancer. Heterozygotes of BRCA1, BRCA2, and P53 (Li-Fraumeni syndrome) are also 
predisposed to IR-induced cancers. BRCA1/BRCA2 mutations are somewhat more common 
in the population, with an incidence of ~1 out of 1000; Li-Fraumeni syndrome occurs at an 
incidence of 1 out of 200,000 (Foray et al., 2012). Overall, hyper-radiosensitive individuals 
(homozygotes) comprise of ~1%–5% of the population, whereas moderately radiosensitive 
(heterozygotes) and radioresistant individual comprise of 5%–20% and 75%–85% of the 
population, respectively (Foray et al., 2013). All of the genetic mutations conferring 
increased radiosensitivity or susceptibility to IR-induced cancer may represent a significant 
proportion of the whole population (5%–15%) (Foray et al., 2012).  
Besides inherent genetic factors related to DSB repair, radiosensitivity can also be 
influenced by confounding variables (e.g. co-morbid conditions such as diabetes and 
collagen vascular disease) and non-genetic exogenous factors (e.g. age, smoking). A range 
of stress responses, including cytokine signaling and activation of inflammatory responses, 
can also influence radiosensitivity by impacting the microenvironment around the 
irradiated/damaged cell/tissue; these responses can enhance tissue damage, prevent 
wound healing, and may exacerbate IR-induced oxidative stress. Furthermore, these IR-
induced damages may be propagated to non-irradiated neighboring cells via bystander 
signaling (discussed in Section 1.2.2). Notably, there may be important distinctions between 
the mechanisms of radiosensitivity following exposure to high and low doses of IR due to 
differences in the triggering of mechanisms of DNA damage repair following these doses 
(which depend on the frequency of IR-induced cellular damages). Furthermore, as the type 
and extent of cellular damage (and mechanism of repair) differs between IR of high- and 
low-LET, individual radiosensitivity to different types of IR may not be equivalent (Advisory 
Group on Ionising Radiation, 2013).  
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Figure 14. (A) Classification of 40 human fibroblast cell lines representing at least 8 different 
genetic syndromes into 3 radiosensitivity groups based on the surviving fraction of cells at 2 
Gy (SF2) and the evaluation of unrepaired DSB using a variety of molecular markers (e.g. 
MRE11, MDC1, 53BP1, and phosphorylated forms of H2AX and DNA-PK). The radioresistant 
Group I (comprising of normal, healthy control cells) showed SF2 of 45–65%. The hyper-
radiosensitive Group III (SF2 of < 7%) is comprised of the classical homozygous ATM-mutated 
(Group IIIa) and LIG4-mutated (Group IIIb) cell lines. The moderately radiosensitive Group II 
(SF2 of 7–45%) is comprised of fibroblasts derived from individuals with other genetic 
disorders that confer radiosensitivity. (B) Based on these radiosensitivity categories, the 
radioresistant Group I (which is capable of properly repairing IR-induced DSBs during the 24 
hours between each fraction of radiotherapy with their intact DDR pathways) never 
accumulate the hypothetical level of unrepaired DNA damage (dotted line) to trigger toxic 
tissue overreactions. The moderately radiosensitive Group II, however, may reach this level of 
unrepaired DNA damage after several sessions, whereas the hyper-radiosensitive Group III 
may reach it following the first session (Adapted from Joubert et al., 2008;Granzotto et al., 
2011). 
 
In one of the largest studies of the spectrum of intrinsic radiosensitivity in human 
fibroblasts, Joubert et al (Joubert et al., 2008) characterized 40 human fibroblast cell lines 
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representing at least 8 different genetic syndromes. Based on SF2 and the evaluation of 
unrepaired DSB using a variety of molecular markers (e.g. MRE11, MDC1, 53BP1, and 
phosphorylated forms of H2AX and DNA-PK) at several time points post-irradiation, the 
authors categorized fibroblasts into three groups of radiosensitivity: Group I (radioresistant), 
Group II (moderately radiosensitive), and Group III (hyper-radiosensitive). As shown in 
Figure 14A, the radioresistant Group I (comprising of normal, healthy control cells) showed 
SF2 ranging from 45–65%, and is characterized by an intact NHEJ repair pathway. The 
hyper-radiosensitive Group III (SF2 of < 7%) is comprised of the classical homozygous ATM-
mutated and LIG4-mutated cell lines. This hyper-radiosensitive group can be subdivided into 
two groups based on activation of MRE11: Group IIIa (ATM-mutated cells) are characterized 
by absent or rare MRE11 activation, and Group IIIb (LIG4-mutated cells) are characterized 
by deficiency in the DNA-PK-dependent NHEJ pathway but over-activation of MRE11 (thus 
making this group markedly less radiosensitive than Group IIIa, as some DSB repair is 
activated unlike Group IIIa). The moderately radiosensitive Group II was comprised of 
fibroblasts derived from individuals with other genetic disorders that confer radiosensitivity 
such as heterozygous ATM mutations, Nijmegen Breakage syndrome (NBS mutations), 
Fanconi anemia (FANC mutations), Bloom’s syndrome (BLM mutations), Xeroderma 
Pigmentosum (XP mutations), Cockayne syndrome (CS mutations), and mutations of ligase 
I (LIG1). Group II showed SF2 of 7–45%, and is characterized by intact NHEJ repair 
pathway but abnormal MRE11 signaling, which may increase predisposition to cancer. 
Importantly, this study confirmed that no single assay is capable of discriminating all of the 
various causes of human radiosensitivity, and highlights that the choice of molecular assay 
depends on the characteristics of the underlying causes of radiosensitivity (Granzotto et al., 
2011;Joubert et al., 2011). 
 
1.4.2 Individual radiosensitivity and radiotherapy 
Radiotherapy elicits a wide range of biological effects in not only the targeted 
(cancer) tissue/cells, but also in normal tissue/cells within or near the targeted region. IR-
induced effects can also be observed in tumors and/or normal tissues that are widely 
separated from the irradiated area, a detrimental or beneficial (if they lead to shrinkage of 
distant tumors) phenomenon termed “abscopal effects” that is an illustration of the in vivo 
occurrence of IR-induced bystander responses (Mothersill et al., 2004;Hei et al., 
2011;Mancuso et al., 2012;Schmid and Multhoff, 2012). Acute radiotherapy toxicity induces 
systemic effects that affects the whole body during, or a short time after, exposure, whereas 
late radiotherapy toxicity can be observed many years after the end of treatment, as 
illustrated by a higher incidence of secondary malignancies and a variety of degenerative 
  
 
 
79 
conditions in long-term cancer survivors (Morgan, 2003b;Prise and O'Sullivan, 
2009;Newhauser and Durante, 2011).  
Individual radiosensitivity is well established to significantly influence clinical 
outcomes of radiotherapy, termed “clinical radiosensitivity,” including normal tissue toxicity 
(in non-targeted tissue) as well as differences in responses to radiotherapy in targeted 
(cancer) tissues. For example, highly radiosensitive patients may develop early and/or late 
side effects due to radiation toxicity, while radioresistant patients may receive an insufficient 
dose of radiation due to dose limitations in current general radiotherapy protocols. Factors 
that can potentially influence radiotherapy toxicity and the prediction of clinical radiotherapy 
was reviewed by the AGIR (Advisory Group on Ionising Radiation, 2013). In their report, they 
concluded that the influence of sex, ethnicity, body mass index, diet, or alcohol consumption 
on clinical radiosensitivity is inconclusive. However, increased clinical radiosensitivity is 
associated with increasing age in adults, smoking, diabetes, and collagen vascular disease 
in radiotherapy patients. Genetic syndromes (e.g. ATM, LIG4, NBS mutations) also influence 
radiosensitivity, as discussed in Section 1.4.1. Importantly, cellular radiosensitivity may not 
necessarily be linked to clinical radiosensitivity, and vice versa.  
Radiotherapy is often administered in fractionated doses, i.e. large total doses are 
delivered in small amounts over a period of time; conventional fractionated radiotherapy 
involves doses of 2 Gy administered every 24 hours over a period of several weeks. 
Administration of fractionated doses allows normal, healthy cells to recover between 
treatments, thereby decreasing side effects and the risk of induction of ARS (in the case of 
whole-body irradiation) compared to administering a single large dose. As the extent of IR-
induced cellular damages and the speed of DNA damage repair differ based on individual 
radiosensitivity, individuals of differing radiosensitivity could react differently to each fraction 
of radiotherapy. As illustrated in Figure 14B, adapted from (Granzotto et al., 2011;Joubert et 
al., 2011) based on their radiosensitivity classification groups of human fibroblasts, the 
radioresistant Group I (with their intact DDR pathways) is capable of properly repairing IR-
induced DSBs during the 24 hours between each fraction of radiotherapy, and therefore 
never accumulate the hypothetical level of unrepaired DNA damage (dotted line in Figure 
14B) to trigger toxic tissue overreactions. The moderately radiosensitive Group II, however, 
may reach this level of unrepaired DNA damage after several sessions, whereas the hyper-
radiosensitive Group III may reach it following the first session. A fast and reliable clinical 
method to measure radiosensitivity of cancer patients and/or predict radiotherapy toxicity 
(especially to identify hyper-radiosensitive individuals) would permit personalized 
radiotherapy treatment; however, such a method still remains to be established (Fernet and 
Hall, 2004;Andreassen et al., 2012).  
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1.4.3 Prediction of radiosensitivity 
The ability to rank and predict individual radiosensitivity has a wide range of real-
world applications as it directly impacts the formulation of cancer treatment strategies and 
the establishment of everyday/environmental/occupational radiation protection guidelines. 
Current radiotherapy and radiation protection protocols do not take into account the 
individual variations in radiosensitivity, but rather rely on population averages of radiation 
responses. Refining these protocols to consider individual radiosensitivity, especially the 
more radiosensitive and cancer-prone, may help to alleviate the detrimental delayed effects 
of IR. As mentioned above, knowledge of each patient’s individual radiosensitivity would 
allow for personalization of radiotherapy regimens, including not only the customization of 
radiation dose, but potentially the prediction and prevention of acute and late radiation 
toxicity and secondary cancers (Fernet and Hall, 2004;Andreassen et al., 2012;Mirjolet et al., 
2015). Additionally, knowing individual radiosensitivity can help to make an informed 
decision on the risk-benefit ratio in the use of diagnostic radiology or radiation treatment of 
those who are highly sensitive to IR. This logic can also be applied to other medical or non-
medical situations, including the identification of highly sensitive individuals following 
environmental or occupational IR exposure, radiologic accidents, or nuclear catastrophe, 
and for the selection of candidates for spacecraft missions or atomic submarine crews 
(Il'yasova et al., 2014).  
 
 
Figure 15. Confounding factors that influence the measurement of biomarkers, which in turn 
influence the study and measurement of individual radiosensitivity. Conversely, individual 
radiosensitivity for each of these confounding factors needs to be characterized. 
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The study and quantification of inter-individual variability in radiosensitivity directly 
depend on the measurement of biomarkers of IR exposure, which were discussed in detail in 
Section 1.2.6. Though these biomarkers allow for the detection and measurement of 
radiosensitivity, their measurements are difficult to translate into routine clinical or 
biodosimetric practice to rank and predict individual radiosensitivity. The ideal 
assay/technique for this purpose would be fast and easy, capable of high throughput 
applications, and would be able to distinguish between partial and whole body exposure; 
thus far, such an assay has not yet been established. The characterization and 
quantification of individual radiosensitivity has been challenging due to confounding factors 
that conversely also affect the induction of the biomarkers that are used to measure 
individual radiosensitivity (summarized in Figure 15). That is, the induction and kinetics of 
the biomarkers (i.e. dose-response curves) may vary depending on the dose of exposure 
(high vs. low doses), the LET of the IR (high-LET vs. low-LET), and dose rate (acute vs. 
chronic exposure). Dose response curves may also vary depending on the time point after 
exposure at which the biomarker is measured (seconds to years to decades), as well as the 
cell type chosen for these analyses. Additionally, the quantification of inter-individual 
variability in radiosensitivity depends on the ability of the assay/technique to detect the 
minute inter-individual differences of the biomarker, which is dependent on the sensitivity of 
the assay/technique. Notably, as discussed in previous sections, depending on the 
characteristics of the underlying cause of radiosensitivity, radiosensitivity may be detectable 
using one specific molecular assay but not with another; to date, no single assay is capable 
of discriminating all of the various causes of human radiosensitivity (Chua and Rothkamm, 
2013). Furthermore, cellular radiosensitivity may not necessarily translate to manifestation of 
clinical radiosensitivity. 
In addition to optimizing the ability to measure biomarkers to predict individual 
radiosensitivity, the effect of individual radiosensitivity on the individual induction of these 
biomarkers must also be contemplated. Evidently, in the context of biodosimetry, which 
estimates an unknown dose based on the measurement of IR-induced biological responses 
or consequences, the existence of individual variations in radiosensitivity confounds the 
development of protocols that can be applied to the general population. For use in the event 
of mass accidental exposure to IR, the ultimate goal is to develop a biodosimetric test that 
can accurately estimate dose with non-invasively obtained biological samples using a fast 
and easy technique that can handle high-throughput analysis. For medical triage purposes in 
this scenario, triage categories based on these results must be able to account for the 
existence of individual variations in radiosensitivity in the general population. This, again, 
relates back to the ability to measure and rank individuals based on their radiosensitivity. 
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The development of such an approach is yet to be accomplished. With accumulating 
knowledge, the AGIR advised that progress in the development of such an assay would 
require better standardization of assay protocols, development of guidelines and larger 
multi-center collaborative studies, and the identification of better predictive biomarkers 
(Advisory Group on Ionising Radiation, 2013). 
Recently, the field of radiogenomics has evolved to accomplish the dual purposes of 
(1) developing an assay that can predict individual radiotherapy and normal tissue toxicity to 
radiotherapy, and (2) learning more about the molecular pathways responsible for IR-
induced normal tissue toxicities. Radiogenomics is an upgrade from the traditional (thus far 
unsuccessful) approach of identifying single candidate genetic variants, mainly single-
nucleotide polymorphisms (SNP) based on their known link to radiosensitivity (e.g. genes 
related to DDR, oxidative stress, apoptosis, cell proliferation), and takes advantage of recent 
advancements in genotyping technology. Radiogenomics employs the genome-wide 
association study (GWAS), which provides a comprehensive and unbiased assessment of 
the association between SNPs (the independent variable) and a phenotype of interest (the 
dependent variable, which in the case of radiogenomics is adverse effects of radiotherapy); 
this technique has successfully identified ~2000 new human trait/disease susceptibility loci, 
including those for prostate cancer and Hodgkin lymphoma. GWASs survey nearly all 
common genetic variants (rather than rare mutations such as those found in radiosensitivity 
syndrome genes, like those discussed in Section 1.4.1) in a cost-effectiveness manner using 
genotyping arrays to identify associations with adverse effects to radiotherapy. “Common” in 
the context of GWASs refers to SNPs that are present in the population with a prevalence of 
at least 1%. In order for the GWAS approach to be successful in the development of a 
reliable clinical assay, it requires large cohorts and rigorous testing of associations found 
using this method, both of which can be accomplished by large-scale multisite and 
multinational collaborative research (Kerns et al., 2014b;Rosenstein et al., 2014;Guo et al., 
2015). Several national and international collaborative studies have been initiated, including 
Gene-PARE (Ho et al., 2006), RadGenomics (Iwakawa et al., 2002), RAPPER (Burnet et al., 
2013), and the REQUITE project (West et al., 2014). Furthermore, the International 
Radiogenomics Consortium (RGC) has been established in 2009 to foster large-scale 
collaborative projects (West et al., 2010). To improve reproducibility of results and to 
improve the quality of research in this rapidly changing and advancing field, the RGC has 
recently provided the STROGAR guidelines to increase the transparency and completeness 
of reporting radiogenomics studies (Kerns et al., 2014a). The field of radiogenomics provides 
a promising approach to the personalization of radiotherapy protocols based on individual 
radiosensitivity (Kerns et al., 2014b;Rosenstein et al., 2014;Guo et al., 2015). 
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1.5 Aims and Hypothesis  
In this thesis, we aim to paint a picture of the range of inter-individual variability in 
radiosensitivity in normal tissue of healthy individuals in the contexts of emergency 
dosimetry (Section 2) and radiotherapy (Section 3), and we explore the roles of telomeres in 
the prediction of these variations in radiosensitivity (Section 4) and long-term human health 
risks following IR exposure (specifically, cardiovascular diseases and/or cancer; Section 5). 
We study two biomarker assays for the measurement of individual radiosensitivity: global 
quantification of γH2AX via flow cytometry (Section 2) and chromosomal aberrations via TC-
FISH (Section 3). We hypothesize that, in the context of emergency biodosimetry (when 
rapid dose estimates of each individual in an irradiated population are needed, and when the 
existence of individual radiosensitivity confounds the creation of effective triage categories), 
the measurement of global quantification of γH2AX can aid in the medical triage of irradiated 
individuals, independent of individual radiosensitivity, if a time point of few hours post-
irradiation is used (Section 2). In the context of radiotherapy, we hypothesize that significant 
inter-individual differences in radiosensitivity exist in normal human tissue, measured in 
terms of IR-induced chromosomal aberrations, and we aim to determine whether individuals 
have different sensitivities to different types of IR (Section 3). Then, we investigate the 
potential link between telomeres and individual radiosensitivity, and we hypothesize that 
individual radiosensitivity can be predicted using a combination of telomere-related 
biomarkers, such as telomere length and IR-induced telomere dysfunctions (Section 4). 
Finally, as radiosensitivity can also have significant impact on long-term health following IR 
exposure, we postulate a role of telomeres and IR-induced telomere dysfunction in the 
development of cardiovascular diseases and/or cancer long after IR exposure (Section 5). 
Ultimately, these results can provide insight for the assessment of individual radiosensitivity 
and overall long-term human health that can have important implications in biodosimetry, 
radiation protection, and cancer radiotherapy.  
 
1.5.1 Description of thesis contents 
In the following chapters presenting the results of this thesis (Sections 2 to 5), 
previously published articles are included if available, along with a short introduction and a 
summary of the key results. 
This thesis is structured as follows: 
• In Section 2, we characterize the impact of individual radiosensitivity in the context of 
emergency biodosimetry. Results and discussion are presented in our published article: 
Viau M€, Testard I€, Shim G€, et al. Mutat Res Genet Toxicol Environ Mutagen. 2015; 
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793: 123-131. € co-first authors. The article is provided in this chapter, along with a short 
introduction and a summary of the key results. 
• In Section 3, we study the extent and influence of individual radiosensitivity on the 
induction of chromosomal aberrations in lymphocytes of healthy individuals following 
irradiation with γ-rays, carbon ions (75 MeV/u), or proton beams (73 MeV and 200 MeV) 
using telomere/centromere-fluorescence in situ hybridization (TC-FISH). We also 
determine the relative biological effectiveness (RBE) of carbon ions and proton beams 
(ion species currently being used in charged particle radiotherapy) in comparison to γ-
irradiation.  
Ø An article presenting these results is currently under preparation for submission:  
Shim G, et al. Int J Radiat Oncol Biol Phys. manuscript in preparation.  
• In Section 4, we evaluate the roles of telomeres and IR-induced telomere dysfunction in 
the prediction of individual radiosensitivity. We find that inherent mean telomere length in 
combination with the IR-induced change in mean telomere length may be a strong 
predictor of individual radiosensitivity.  
Ø These results are not yet published, and so they are presented in full (in Section 4) 
with discussion and conclusions (in Section 6.2). 
• In Section 5, we explore the roles of telomeres in long-term human health risks following 
IR exposure, specifically focusing on the development of cardiovascular diseases and/or 
the process of carcinogenesis. In Section 5.1, we show that telomere shortening could 
be a new prognostic factor for cardiovascular disease following radiotherapy. Results 
and discussion are presented in our published article (M'Kacher et al., 2015b); the article 
is provided, along with a short introduction and a summary of the key results. In Section 
5.2, we provide our review article (Shim et al., 2014) that discusses the relationships 
between telomere maintenance and radiation effects, and propose a model of how 
telomeres could be key players in the process of IR-induced carcinogenesis. 
• Finally, in Section 6, we integrate our findings on individual radiosensitivity and the novel 
link between telomere shortening and cardiovascular disease into our previously 
proposed model for IR-induced carcinogenesis (Shim et al., 2014); we postulate how 
telomeres could play important roles in the development of cardiovascular disease and 
the process of IR-induced carcinogenesis, we propose how these processes can be 
accelerated particularly in highly radiosensitive individuals (Section 6.1). We also argue 
how telomeres could predict individual radiosensitivity (Section 6.2).  
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2 - INDIVIDUAL RADIOSENSITIVITY AND ROUGH DOSE ESTIMATION 
FOR EMERGENCY BIODOSIMETRY 
 
In the case of large-scale accidental exposure to radiation, a method of biodosimetry 
that is rapid, accurate, and can accommodate high throughput analysis is needed to 
efficiently triage victims of a mass accident based on individual levels of exposure. γH2AX, 
the phosphorylated form of the H2AX histone, is a promising candidate as a biomarker that 
can be used for this purpose shortly after acute irradiation. Manual and automated methods 
to quantify γH2AX are discussed in detail in Section 1.3.5 of this thesis. However, for the 
γH2AX assay to be used as a biodosimetric triage tool, inter- or intra-individual variability in 
the basal levels of γH2AX as well as the time course of γH2AX induction and decay following 
irradiation (which depend on individual DSB repair capacity, which in turn may reflect 
individual radiosensitivity) is a crucial issue that must be addressed. These inter-individual 
variations in the basal levels and kinetics of γH2AX induction and decay after irradiation are 
not yet well characterized at a range of time points post-irradiation (Rothkamm and Horn, 
2009;Roch-Lefèvre et al., 2012).  
Indeed, vast inter-individual differences in the basal levels of γH2AX and the kinetics 
of γH2AX induction and decay post-irradiation have been observed using γH2AX foci scoring 
methods (manual and automated) (Roch-Lefevre et al., 2010) as well as global quantification 
methods (Hamasaki et al., 2007;Ismail et al., 2007;Andrievski and Wilkins, 2009;Roch-
Lefèvre et al., 2012). Basal levels of γH2AX may vary depending on a variety of physical, 
chemical, and biological factors (Takahashi and Ohnishi, 2005) as well as lifestyle factors 
(Roch-Lefevre et al., 2010). Basal levels of γH2AX measured by manual foci scoring have 
been shown to yield inter-individual differences of as much as 15 fold (Roch-Lefevre et al., 
2010); we have also observed this large variability in basal levels both via manual scoring 
(shown in Figure A-1 in the Appendix) and global fluorescence quantification (shown in 
Figure 4 in our recent paper (Viau et al., 2015)). The induction and decay of γH2AX after 
irradiation may depend on inherent genetic factors (i.e. DNA repair capacity), which may in 
turn be linked to individual radiosensitivity; indeed, acute IR responses and reduced DSB 
repair kinetics are seen in individuals with well-known genetic disorders that directly impact 
the cellular DNA repair machinery, such as mutations in ATM, NBS1, MRE11, FANC, BLM 
or LIG1 (Nussenzweig and Nussenzweig, 2007;Joubert et al., 2008). A high individual 
variability leads to a decreased sensitivity of the γH2AX assay. Therefore, characterizing 
these inter-individual differences at various time points post-irradiation remains a crucial 
issue that needs to be addressed to establish dose response curves for biodosimetric 
purposes that can be applied to the general population. 
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In this study, presented in our recent paper (Viau et al., 2015), we assess the 
usefulness of global γH2AX quantification as a method for rapid biodosimetry in an 
emergency situation. For this purpose, we seek to better establish the correlation between 
global γH2AX fluorescence intensity (using flow cytometry and low-magnification 
immunofluorescence microscopy) and the foci scoring method (using high-magnification 
immunofluorescence microscopy) following exposure to a range of doses (0.25 Gy to 6 Gy) 
of either γ-rays from a Cesium-137 source or X-rays (200 kV). In the case of a large-scale 
accidental exposure, we estimate that biological samples cannot be obtained within less 
than 4 hours of IR exposure; therefore, we study this time point for γH2AX analyses. To 
evaluate the impact of inter-individual differences in the kinetics of IR-induced γH2AX 
induction and decay on dose-response curves at this time point, we studied human 
fibroblasts from 19 donors and lymphocytes from 11 donors of varying radiosensitivity.  
 
2.1 Summary of key results  
• The two approaches that we used to quantify global γH2AX fluorescence intensity (flow 
cytometry and low-magnification immunofluorescence microscopy) were well correlated 
with the now well-established γH2AX foci scoring method (R2 = 0.81 to 0.89) in irradiated 
human fibroblasts (0.5 to 5 Gy of X- or γ-rays) at 4 hours after irradiation, indicating that 
global γH2AX fluorescence measurements are suitable for dose estimation at this time 
point post-irradiation.  
• Based on these findings, we propose the use of flow cytometry for rapid triage purposes 
in an emergency situation, as it is more highly correlated with foci scoring and because 
of the speed and ease of the technique.  
• Inter-individual variability in global γH2AX fluorescence using flow cytometry 
measurements is statistically insignificant at 4 hours post-irradiation in irradiated human 
fibroblasts (17 donors of varying radiosensitivity) and lymphocytes (11 healthy blood 
donors), based on their respectively plotted dose response curves (0.25 to 6 Gy of X- or 
γ-rays). 
• In lymphocytes, there was a high level of inter-individual variability in the induction of 
global γH2AX fluorescence post-irradiation. The degree of inter-individual variations 
increased with dose and decreased with time. This was also observed following manual 
scoring of γH2AX foci (results shown in Figure A-1 in the Appendix). Inter-individual 
variability in the induction of global γH2AX fluorescence immediately after irradiation (30 
min post-irradiation) may be moderately correlated (R2 = 0.595) with cellular 
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radiosensitivity†††† measured using cytogenetic approaches (correlation results are 
shown in Table A-1 and Figure A-2 in the Appendix). However, at later time points (> 3 
hours) post-irradiation, no correlations with radiosensitivity†††† were observed (results 
shown in Table A-1 in the Appendix), illustrating that at the time point studied in this 
paper (4 hours post-irradiation), inter-individual variability in global γH2AX fluorescence 
is independent from individual radiosensitivity. 
• Based on these data, we propose calibration curves that can be applied to populations 
exposed to moderate radiation doses to estimate individual received doses, independent 
of individual radiosensitivity, at this specific time point post-irradiation using human 
fibroblasts and lymphocytes.  
• We define three triage categories that could facilitate immediate and follow-up care in the 
case of a radiological accident. These triage categories were based on previously 
reported (IAEA, 2002;Rea et al., 2010) dose limits of 2 Gy and 3 Gy as the minimal 
values which result in moderate (variable care) and severe symptoms (urgent care), 
respectively. 
• The usefulness and real-world applicability of this rapid and high-throughput technique 
using flow cytometry measurements of global γH2AX fluorescence may be limited by the 
time-sensitive nature of this radiosensitivity-independent measurement of γH2AX, which 
is heavily reliant on the specific time point of 4 hours post-irradiation. However, this 
method could potentially be developed into a commercialized kit that could be kept on 
site of radiation or nuclear facilities, and could offer new possibilities in the field of 
emergency biodosimetry.  
                                                
 
†††† Results of cellular radiosensitivity measured using cytogenetic approaches are presented in 
Section 3.1.1 of this thesis. 
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3 - INDIVIDUAL RADIOSENSITIVITY AND NORMAL TISSUE 
REACTIONS IN HEALTHY INDIVIDUALS 
3.1 Individual radiosensitivity to γ-irradiation  
As discussed in Section 1.4.2, inter-individual differences in radiosensitivity can have 
significant impact on clinical outcomes of radiotherapy. Thus, to characterize the extent and 
influence of individual radiosensitivity on normal tissue reactions to 2 Gy of γ-rays, a 
routinely administered dose during fractionated radiotherapy (Denekamp et al., 1997;Hartel 
et al., 2010), we evaluate the frequency of IR-induced DNA DSBs based on the scoring of 
IR-induced CAs visualized with TC-FISH (Figure 16) in PBL isolated from the whole blood of 
healthy individuals. We also examine radiosensitivity at other doses of γ-irradiation and 
formulate dose response curves. Additionally, we expand upon the findings of a recent 
paper of our laboratory (M'Kacher et al., 2014) to assess the sensitivity of TC-FISH analyses 
in cells cultured in different ways; for this analysis, we compare these results obtained in the 
isolated PBL to cells cultured in whole blood (without the isolation of PBL) of a separate 
cohort of healthy individuals that was analyzed in the article (M'Kacher et al., 2014). 
 
 
Figure 16. Method of estimating the number of IR-induced DSBs per cell that gave rise to each 
type of CA using TC-FISH. A dicentric or a centric ring with an acentric fragment (ac) 
containing 4 telomeres (telo) are considered as 2 DSBs. Excess acentric fragments with 2 
telomeres are considered as resulting from 1 DSB (terminal deletion). Excess acentric 
fragments with 0 telomeres are considered as resulting from 2 DSBs (interstitial deletion). 
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For these analyses of individual radiosensitivity, we utilize TC-FISH, which as we 
briefly mentioned in Section 1.3.2, simultaneously stains telomeres and centromeres using 
PNA probes (Shi et al., 2012;M'Kacher et al., 2014). As demonstrated in a recent paper of 
our laboratory (M'Kacher et al., 2014), TC-FISH significantly simplifies the previously taxing 
DC analyses of Giemsa stained metaphases (discussed in Section 1.3.1), which required a 
trained cytogeneticist. It allows for a simple, rapid, and more accurate scoring of not only 
dicentrics, but also of all other types of IR-induced CA, such as centric and acentric rings 
and acentric fragments (with 0, 2, or 4 telomeres), without significantly increasing the cost. 
From this information, a precise estimate of the number of IR-induced DSBs that gave rise to 
the CA can be calculated (as illustrated in Figure 16). Generally, a dicentric or a centric ring 
with an acentric fragment containing 4 telomeres are considered as 2 DSBs; excess acentric 
fragments with 2 telomeres are considered as resulting from 1 DSB (terminal deletion); and 
excess acentric fragments with 0 telomeres are considered as resulting from 2 DSBs 
(interstitial deletion). This modified scoring technique was shown to provide improved 
sensitivity compared to the classical DC analyses. Additionally, in this same paper, the 
automated system that was developed in our laboratory for automated TC-FISH analysis 
(TCScore) is presented. This novel system allows for detection not only of 95% of dicentrics 
and centric rings, but also of different acentric fragments with the same efficacy as manual 
scoring, but in a fraction of the time. This improved, automated approach will open up new 
horizons for the assessment of genotoxic risk and for biological dosimetry, particularly for 
low doses (M'Kacher et al., 2014;M'Kacher et al., 2015a).  
A summary of the key results of (M'Kacher et al., 2014) is as follows: 
• Both the scoring of dicentrics and the frequency of DSBs per cell that was calculated 
using the TC-FISH technique at the low dose of 0.1 Gy allowed for statistically significant 
distinction from that of controls (0 Gy), a distinction that is less statistically significant with 
the traditional Giemsa staining.  
• The calculated frequency of DSBs per cell was shown to be the more sensitive approach 
for detecting CAs at low doses compared to scoring of dicentrics alone.  
• The scoring of CAs using the TC-FISH technique does not require a high level of trained 
expertise, as variability between results obtained from trained and untrained operators 
yielded no statistically significant differences.  
• The improved sensitivity, ease, and replicability of analysis using TC-FISH demonstrate 
the robustness of this approach and the transferability of this technique to multiple 
cytogenetic laboratories.  
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Results 
3.1.1 Individual radiosensitivity following exposure to 2 Gy of γ-rays 
Here, we present the extent of individual radiosensitivity in PBL isolated from the 
whole blood of 18 healthy individuals, following in vitro exposure of PBL to 2 Gy of low-LET 
γ-rays, a routinely administered dose during fractionated radiotherapy (Denekamp et al., 
1997;Hartel et al., 2010). Radiosensitivity was measured based on the mean number of IR-
induced DSBs per cell, calculated based on the scoring of CAs following TC-FISH staining 
as described in Figure 16, in cells undergoing first mitosis at 60 hours post-irradiation.  
 
 
Figure 17. (A) Inter-individual differences in radiosensitivity following in vitro exposure to 2 Gy 
of γ-rays. Radiosensitivity was measured based on the mean number of DSBs per cell, 
calculated based on TC-FISH data as described in Figure 16, in PBL isolated from whole blood 
of 18 healthy individuals, in cells undergoing first mitosis at 60 hours post-irradiation. (B) 
Distribution of the number of DSBs per cell for each donor. 
 
Radiosensitivity to 2 Gy of γ-irradiation is plotted in Figure 17A in the order of 
increasing sensitivity to radiation. Individuals were designated as Donors A through R in this 
order of ‘radioresistant’ to ‘radiosensitive’ donors. We use this ranking throughout the thesis 
as the definition of each of these donors’ radiosensitivity. In other words, the ranking of the 
radiosensitivity of this cohort of donors was based on the mean number of DSBs per cell, 
calculated using TC-FISH analysis, following in vitro exposure of PBL to 2 Gy of γ-rays.  
As shown in Figure 17A, following exposure to a dose of 2 Gy of γ-irradiation, there is 
a range of ~1.5 to 2.8 DSBs per cell. Comparison of data obtained from samples irradiated 
on different dates and analyzed by different individuals showed no significant differences in 
the measurement of the mean number of DSBs per donor (p>0.05). No correlations were 
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observed between this radiosensitivity and levels of spontaneous or IR-induced apoptosis (0 
to 6 Gy; results shown in Figure A-3, Table A-2, and Table A-3 in the Appendix). As the 
susceptibility to IR-induced apoptosis in the T4-EM subpopulation was found to be 
correlated with radiosensitivity following γ-irradiation (Schmitz et al., 2007), we looked at 
whether the slope of IR-induced apoptosis in T4-EM lymphocytes between the doses of 0 
and 6 Gy of γ-irradiation (blue data points in Figure A-3C) correlates to the individual 
radiosensitivity of these donors to 2 Gy of γ-irradiation (Figure 17A); as shown in Figure A-
3D, no correlations were found (R2 = 0.045). Radiosensitivity may be moderately correlated 
(R2 = 0.595) with inter-individual variability in the induction of global γH2AX fluorescence 
immediately after irradiation (30 min post-irradiation) (results shown in Table A-1 and Figure 
A-2 in the Appendix); at later time points (3 to 24 hours) post-irradiation, no correlations with 
radiosensitivity were observed (results shown in Table A-1 in the Appendix). As shown in 
Figure 17B, donors classified as more radiosensitive harbor more DSBs per cell, with a 
wider range of distribution of DSBs per cell, compared to the more radioresistant donors. For 
example, the mean of the range of DSBs per cell in radioresistant donors (Donors A through 
F) is found to be 9.0 compared to 12.5 in radiosensitive donors (Donors M through R). This 
indicates the presence of more IR-induced damage in radiosensitive donors compared to 
radioresistant donors following exposure to a dose of 2 Gy of γ-rays.  
 
 
Figure 18. Inter-individual differences in radiosensitivity in a separate cohort of 8 healthy 
donors from (M'Kacher et al., 2014). Whole blood (without the isolation of PBL) was irradiated 
in vitro with 2 Gy of γ-rays, and radiosensitivity was measured based on the mean number of 
DSBs per cell, calculated based on TC-FISH data as described in Figure 16, in cells 
undergoing first mitosis at 48 hours post-irradiation. 
 
These results were compared with the TC-FISH analysis of the whole blood (without 
the isolation of PBL) of a separate cohort of 8 healthy donors analyzed in (M'Kacher et al., 
2014); whole blood was irradiated with a range of doses (0 to 6 Gy) of γ-rays, and cells were 
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analyzed at 48 hours post-irradiation. As shown in Figure 18, TC-FISH analysis in the whole 
blood of 8 donors (labeled as Donors 1 through 8) showed a range of ~1.4 to 2.4 DSBs per 
cell (1.7-fold difference) and a mean of 1.87 DSBs per cell, compared to the range of ~1.5 to 
2.8 DSBs per cell (1.8-fold difference) and a mean of 2.17 DSBs per cell in the PBL samples 
(Figure 17A). Interestingly, the cohort in (M'Kacher et al., 2014), which comprised of a 
completely random group of healthy individuals that provided blood samples at the medical 
center at the CEA Fontenay-aux-Roses, France, yielded a range of IR-induced DSBs 
measured using TC-FISH that was similar to the cohort used for the analysis in Figure 17A, 
which comprises of individuals selected from a larger cohort of 63 individuals along the 
range of radiosensitivity measured previously based on the induction of IR-induced 
apoptosis (Schmitz et al., 2003); all TC-FISH analyses was, however, performed blindly. 
Though these analyses should be expanded to larger cohorts, the similarity in the range of 
these TC-FISH measurements between the randomly (M'Kacher et al., 2014) and non-
randomly selected (Figure 17A) cohorts suggest that these measurements could represent 
the range of radiosensitivity of a significant portion of the population.  
 
3.1.2 Individual radiosensitivity at other doses of γ-irradiation 
To evaluate inter-individual differences in radiosensitivity at other doses, PBL of the 
same cohort of donors as in Figure 17 were irradiated in vitro with a range of doses (0 to 5 
Gy) of γ-rays, and were analyzed using TC-FISH (Figure 16) at 60 hours post-irradiation. For 
the dose of 2 Gy, 18 donors (Donors A through R) were analyzed; to assess how dose-
response curves may vary in different radiosensitivity groups, these donors were separated 
into 3 categories as follows: Donors A through F (‘radioresistant’), Donors G through L 
(‘medium radiosensitivity’), and Donors M through R (‘radiosensitive’). For all other doses, 6 
of these donors were analyzed (Donors C, F, H, J, K, and O); these donors were separated 
into 3 radiosensitivity categories as follows: Donors C and F (‘radioresistant’), Donors H, J, 
and K (‘medium radiosensitivity’), and Donor O (‘radiosensitive’). Dose response curves for 
the doses of 0 to 5 Gy based on the mean number of dicentrics and DSBs per cell using TC-
FISH analyses are shown in Figure 19A and Figure 19B, respectively, and zoom-ups of 
each of these curves at low doses (0 to 1 Gy) are shown in Figure 19C and Figure 19D. The 
dose response curves of the mean of all analyzed donors are plotted in Figure 20. 
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Figure 19. Dose response curves (0 to 5 Gy) based on individual radiosensitivity in PBL of 
healthy individuals following γ-irradiation. (A) Dose response curves based on mean dicentrics 
per cell, or (B) based on mean DSBs per cell. (C) and (D) Zoom-ups of each of these curves at 
low doses (0 to 1 Gy). For the dose of 2 Gy, 18 donors (Donors A through R) were analyzed at 
the dose of 2 Gy; these donors were separated into 3 categories as follows: Donors A through 
F (‘radioresistant’), Donors G through L (‘medium radiosensitivity’), and Donors M through R 
(‘radiosensitive’). For all other doses, 6 of these donors were analyzed (Donors C, F, H, J, K, 
and O); these donors were separated into the 3 radiosensitivity categories as follows: Donors 
C and F (‘radioresistant’), Donors H, J, and K (‘medium radiosensitivity’), and Donor O 
(‘radiosensitive’). 
 
As shown in Figure 19B, dose response curves for the doses of 0 to 5 Gy based on 
the mean number of DSBs show parallel dose response trends between the three groups of 
radiosensitivity at all studied doses (0 to 5 Gy). However, as shown in Figure 19A, 
measurements based on dicentrics alone may not provide as accurate an assessment 
compared to DSB measurements, as illustrated by the overlap between the trend lines 
between the three groups of radiosensitivity at the studied doses. The zoom-up for low 
doses (0 to 1 Gy) of the curve showing the mean number of DSBs per cell (Figure 19D) 
R²#=#0.999#
R²#=#1.000#
R²#=#0.998#
0#
2#
4#
6#
8#
10#
12#
14#
16#
0# 1# 2# 3# 4# 5#
DS
B/
Ce
ll(
Dose((Gy)(
Radioresistant#
Medium#radiosensi;vity#
Radiosensi;ve#
R²#=#1.000#
R²#=#0.998#
R²#=#0.999#
0#
0.5#
1#
1.5#
2#
2.5#
3#
3.5#
4#
0# 1# 2# 3# 4# 5#
Di
c/
Ce
ll(
Dose((Gy)(
Radioresistant#
Medium#radiosensi;vity#
Radiosensi;ve#
(B)(((A)(
0#
0.2#
0.4#
0.6#
0.8#
1#
1.2#
1.4#
0# 0.2# 0.4# 0.6# 0.8# 1#
DS
B/
Ce
ll(
Dose((Gy)(
Radioresistant#
Medium#radiosensi;vity#
Radiosensi;ve#
0#
0.05#
0.1#
0.15#
0.2#
0.25#
0.3#
0.35#
0.4#
0.45#
0.5#
0# 0.2# 0.4# 0.6# 0.8# 1#
Di
c/
Ce
ll(
Dose((Gy)(
Radioresistant#
Medium#radiosensi;vity#
Radiosensi;ve#
(D)(((C)(
  
 
 
103 
suggests that the ‘radiosensitive’ group could exhibit a trend at low doses that does not 
conform as well to the overall trend over the wider dose range of 0 to 5 Gy; the trends at low 
doses for the moderately radiosensitive and radioresistant groups conform relatively well to 
the overall trend over the wider dose range. With dicentric measurements (Figure 19C), this 
deviation from the overall trend line (0 to 5 Gy) is also apparent in the moderately 
radiosensitive group; this may however be associated with the less sensitive measurement 
of scoring dicentrics compared to TC-FISH analyses, which considers all types of IR-induced 
CAs. These differences between radiosensitivity groups are especially apparent at the dose 
of ~0.5 Gy. Though these results must be verified in a larger cohort, they may demonstrate 
the drastically different response to low doses of IR exposure in individuals that are highly 
radiosensitive. These results may highlight the importance of identifying these highly 
radiosensitive individuals and adapting diagnostic radiology and radiation protection 
protocols based on individual radiosensitivity in order to better protect these individuals.  
 
3.1.3 Dose response curves following exposure to γ-irradiation 
Dose response curves based on the mean of all analyzed donors described above 
are shown in Figure 20. For the PBL samples, as described in Sections 3.1.1 and 3.1.2, 18 
donors (Donors A through R) were analyzed at the dose of 2 Gy of γ-irradiation, and all other 
doses (0 to 5 Gy) include the analyses of 6 of these donors (Donors C, F, H, J, K, and O). 
Results were compared with the TC-FISH and uniform staining (Giemsa) analyses of the 
whole blood (without the isolation of PBL) of a cohort of 16 donors from (M'Kacher et al., 
2014), irradiated with a range of doses (0 to 6 Gy) of γ-rays and analyzed at 48 hours post-
irradiation.  
Figure 20 shows the results of the comparisons of frequencies of dicentrics (Figure 
20A, and a zoom-up of 0 to 1 Gy in Figure 20C) and DSBs (Figure 20B, and a zoom-up of 0 
to 1 Gy in Figure 20D) per cell between these cohorts and techniques. The plots, which 
show the dose response curves based on the mean of all donors analyzed, indicate a 
second order polynomial trend between the doses of 0 Gy and 5 Gy (or 6 Gy for the cohort 
from M’Kacher et al). Notably, Giemsa-stained whole blood analysis of dicentrics per cell in 
the cohort from M’Kacher et al corresponds to the dose-response curves obtained after 
uniform staining by the CEA and published by the IAEA (IAEA, 2011), and obtained in a 
recent study of 14 healthy donors (Pajic et al., 2015). 
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Figure 20. Dose-response curves of TC-FISH analysis of PBL isolated from whole blood (using 
the standard Ficoll isolation technique) of the cohort of 18 healthy blood donors following 
irradiation with 0 to 5 Gy of γ-rays, and analyzed at 60 hours post-irradiation. Results were 
compared to those of TC-FISH and uniform staining (Giemsa) analyses of the whole blood of 
the cohort of 16 donors from (M'Kacher et al., 2014), irradiated with a range of doses (0 to 6 
Gy) of γ-rays and analyzed at 48 hours post-irradiation. (A) Dose-response curves (0 to 6 Gy) 
for dicentrics and (B) estimated DSBs per cell. (C) Zoom below 1 Gy of the dose-response 
curves for dicentrics and (D) estimated DSBs per cell. 
 
As shown in Figure 20, at all studied doses, TC-FISH using PBL was able to detect 
approximately double the number of DSBs and dicentrics per cell compared to analysis 
using uniform staining in whole blood. The analysis of dicentrics and DSBs using isolated 
PBL is more sensitive than the use of whole blood (cohort from M’Kacher et al), as more 
dicentrics and DSBs were scored at any given dose in isolated PBL compared to whole 
blood. A larger difference between TC-FISH analyses in PBL versus whole blood is 
observed using DSB measurements (Figure 20B and D) compared to dicentric 
measurements (Figure 20A and C) at all studied doses, illustrating the improved sensitivity 
of DSB scoring over the traditional dicentric scoring; this increased sensitivity is also 
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apparent at low doses (<1 Gy; Figure 20C and D). As described in Section 3.1.1, at the dose 
of 2 Gy, TC-FISH analysis in whole blood showed a range of ~1.4 to 2.4 DSBs per cell, with 
a mean of 1.87 DSBs per cell (Figure 18) compared to the mean of 2.17 DSBs per cell in the 
PBL samples (Figure 17A). TC-FISH analysis in PBL therefore detected 35-40% more DSBs 
and dicentrics per cell compared to TC-FISH analysis in whole blood. These data illustrate 
that using TC-FISH analyses in isolated PBL offers an even more precise estimation of dose 
than using the same analyses on whole blood. This improved approach may have important 
implications in the assessment of genotoxic risk and for biological dosimetry, especially at 
low doses. Whether the automated DCScore technique can confirm these results is yet to be 
determined. 
Notably, whole blood samples were harvested at 48 hours post-irradiation compared 
to the 60-hour incubation time for PBL. This shorter incubation time for whole blood samples 
allows less time for DNA damage repair to take place; therefore, more heavily damaged 
cells (especially after irradiation at higher doses) may not enter mitosis by this time and thus 
will not be included in analysis. The longer post-irradiation incubation time in PBLs allows 
additional time for heavily damaged cells to enter mitosis, and these cells are thereby 
included in analysis. This may explain the higher levels of DSBs found in PBLs in this 
analysis. Therefore, to verify the sensitivity of the TC-FISH analysis in whole blood samples 
versus PBL samples, it will be important to perform analysis in cells harvested at the same 
time point post-irradiation. However, as TC-FISH analysis in whole blood at 48 hours (Figure 
18) yielded DSBs per cell that were in the same general range as in PBL at 60 hours (Figure 
17A) at the dose of 2 Gy, it may be plausible to perform analysis in PBL at 48 hours to 
reduce the time to obtain results at this dose.  
 
3.2 Comparison of individual radiosensitivity to γ-rays and carbon ions 
Current radiotherapy regimens use photons (either X- or γ-rays) or protons for the 
treatment of a plethora of malignancies. However, radiotherapy for the treatment of cancer is 
now shifting to the use of heavier ion species (Schlaff et al., 2014), which may potentially 
offer radiobiological advantages over low-LET IR due to their inherent characteristics that 
are useful especially for the precisely targeted treatment of deep-seated tumors in the 
human body. Among various types of heavy ion species considered for radiotherapy, carbon 
ions are considered to have the most balanced and optimal properties in terms of physical 
dose distribution and RBE along its Bragg peak curve (Kamada et al., 2015). However, 
carbon ion radiotherapy is not yet widely used, with only a few centers worldwide (6 in Asia 
and 2 in Europe) that have treated ~13,000 patients (as of December 2013), compared to 
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~50 active proton therapy centers worldwide that have treated over 105,000 patients 
(Jermann, 2014). Though preliminary clinical data from the existing carbon ion therapy 
centers suggest favorable results for many of the malignancies that do poorly with 
conventional radiotherapy (Kamada et al., 2015), further clinical research and development 
of more carbon ion (and other charged particles heavier than protons) therapy centers in the 
US and worldwide are hindered by the lack of sufficient clinical evidence of the benefit of 
carbon ion therapy over conventional radiotherapy that would cost-effectively justify the 
establishment of such expensive facilities (Schlaff et al., 2014). Further investigation is 
necessary to characterize and understand how carbon ion therapy works in comparison to 
conventional radiotherapy.  
As mentioned above, one of the potential biological advantages of heavier ions like 
carbon ions is their significantly increased RBE, particularly in the Bragg peak region. 
Current experimental treatment planning with photon, proton, and carbon ion regimens 
assumes that the same biological effective dose is administered with a standardized 
fractionation dose. However, increased RBE with heavy ion therapy has to be taken into 
account in treatment planning, and additional knowledge is needed to better establish the 
RBE of heavy ions compared to conventional photon and proton therapies at the traditional 
fractionation dose of ~2 Gy per fraction to determine the appropriate prescribed dose for 
heavy ion treatments. Additionally, as RBE depends in a complex manner on physical and 
biological parameters, such as the particle species, ion beam energy, LET, dose, and the 
cell/tissue type under consideration, the effect of each of these parameters on RBE need to 
be determined. The accurate description and understanding of RBE at various doses is of 
particular interest for treatment planning since hypofractionated treatment schedules have 
become increasingly important in ion beam therapy (Friedrich et al., 2014). Furthermore, 
whether inter-individual differences in radiosensitivity exists following high-LET IR exposure 
and whether it plays a role in determining RBE of heavy ions remains to be established. 
In this study, we characterize inter-individual differences in radiosensitivity using the 
TC-FISH technique following a dose of 2 Gy of carbon-13 ions in PBL of healthy blood 
donors. We also examine radiosensitivity at other doses of carbon ions and formulate dose 
response curves. We compare these results with those obtained following γ-irradiation and 
provide RBE estimates for carbon ions at a range of doses in irradiated normal human 
lymphocytes. Furthermore, we compare a second cytogenetic technique, M-FISH, to the TC-
FISH technique to estimate RBE.  
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Results 
3.2.1 Individual radiosensitivity following exposure to 2 Gy of carbon ions 
As with γ-irradiation, inter-individual differences in radiosensitivity following in vitro 
exposure to 2 Gy of high-LET carbon-13 ions (75 MeV/u; LET ~36.5 keV/µm at the plateau 
region of the Bragg peak curve) was measured in PBL of 13 of the healthy blood donors 
analyzed for γ-irradiation above in cells undergoing first mitosis at 60 hours post-irradiation. 
Radiosensitivity was measured based on the mean number of IR-induced DSBs per cell, 
calculated based on TC-FISH data as described in Figure 16. Radiosensitivity to 2 Gy of 
carbon ions is plotted in Figure 21A in order of increasing sensitivity to radiation.  
 
 
Figure 21. (A) Inter-individual differences in radiosensitivity following in vitro exposure to 2 Gy 
of high-LET carbon-13 ions (75 MeV/u; LET ~36.5 keV/µm at the plateau region of the Bragg 
peak curve). Radiosensitivity was measured based on the mean number of DSBs per cell, 
calculated based on TC-FISH data as described in Figure 16, in PBL isolated from whole blood 
of 13 healthy individuals, in cells undergoing first mitosis at 60 hours post-irradiation. (B) 
Distribution of the number of DSBs per cell for each donor. 
 
As shown in Figure 21A, within the same cohort of blood donors studied for γ-
irradiation, inter-individual radiosensitivity was also observed following carbon irradiation; a 
range of ~5 to 8 DSB per cell was measured. Furthermore, within this cohort, the order of 
radiosensitivity to carbon irradiation was different from that for γ-irradiation (to be discussed 
further in Section 3.2.2). Based on this ranking of radiosensitivity, we find that the more 
radiosensitive donors to carbon irradiation harbored more DSBs per cell compared to the 
more radioresistant donors, as shown in Figure 21B; for example, the mean of the range of 
DSBs per cell in radioresistant donors (Donors C, H, E, J) was found to be 14.8 compared to 
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19.8 in radiosensitive donors (Donors F, A, Q, M, K). Upon analysis of the relationship 
between the susceptibility to IR-induced apoptosis in the T4-EM subpopulation and 
radiosensitivity (Schmitz et al., 2007), as we did for γ-irradiation in Section 3.1.1, no 
correlations were found (R2 = 0.004; Figure A-4D) between the slope of IR-induced 
apoptosis between the doses of 0 and 6 Gy of carbon irradiation (the blue data points in 
Figure A-4C) in the T4-EM subpopulation and radiosensitivity following 2 Gy carbon 
irradiation (Figure 21A). 
 
3.2.2 No correlations between radiosensitivity to 2 Gy of γ-rays and carbon ions 
To determine individual radiosensitivity in normal tissue of healthy individuals to IR of 
different LET, we compare radiosensitivity measurements using TC-FISH following exposure 
to 2 Gy of carbon ions (data from Section 3.2.1) and γ-rays (data from Section 3.1.1) in PBL 
of healthy blood donors.  
 
 
Figure 22. (A) No correlations between individual radiosensitivity following in vitro exposure to 
2 Gy of carbon ions and γ-rays. (B) Ranking of individual radiosensitivity to 2 Gy of carbon 
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ions and γ-rays. (C) Distribution of the number of DSBs per cell for each type of IR for all 
donors analyzed. 
 
As shown in Figure 22A, we find that there are no correlations between 
radiosensitivity to carbon ions and γ-rays at the dose of 2 Gy (R2 = 0.16). Indeed, the order 
of low to high radiosensitivity as classified according to 2 Gy of γ-irradiation did not hold for 
carbon irradiation following exposure to the same dose (Figure 22B, a compilation of plots 
Figure 17A and Figure 21A). This indicates that donors are not equally sensitive to different 
types of IR. Interestingly, though the ranking of radiosensitivity to carbon ions and γ-rays 
was different within this cohort, the trend lines for radiosensitivity to each type of IR (plotted 
in the order of increasing radiosensitivity to γ-rays) were parallel, both with a slope of 0.07. 
Notably, a high intra-cellular variability of IR-induced DSB among cells of the same donor 
was observed, illustrated by large error bars representing the 95% confidence interval for 
each data point. Intra-cellular variations following carbon irradiation were generally found to 
be larger than those following γ-irradiation. This may be expected due to the non-uniform 
spatial distribution of IR-induced DNA damage following heavy ion irradiation. Interestingly, a 
modest correlation was found between the dispersion of DSBs per donor (95% confidence 
interval) following γ- and carbon irradiation (R2 = 0.51). Finally, as expected, carbon 
irradiation cause more dispersion in the number of DSBs induced per cell compared to γ-
irradiation, with carbon ranging to up to 20 DSBs per cell and γ-rays ranging up to 12 DSBs 
(Figure 22C). This indicates that carbon irradiation cause a larger range of DSBs per cell 
and more IR damage that is less repaired compared to γ-rays.  
 
3.2.3 RBE factor of 3 after 2 Gy irradiation using both TC-FISH and M-FISH 
techniques 
We calculate RBE by dividing the mean DSBs per cell determined using TC-FISH 
following exposure to carbon ions by that following exposure to the same dose of γ-rays. At 
the dose of 2 Gy, the mean number of DSBs per cell was found to be 2.17 DSB per cell after 
γ-irradiation (18 donors), and 6.45 DSB after carbon irradiation (13 donors). Therefore, the 
RBE of carbon ions was determined to be approximately 3 times that of γ-rays at the dose of 
2 Gy using TC-FISH. These results were confirmed using M-FISH analysis of chromosomal 
rearrangements, visualized as illustrated in Figure 13B. The number of DSBs per cell using 
M-FISH analysis was calculated as illustrated in Figure 23; in general, dicentrics and 
translocations often involve 2 DSBs, whereas CCAs involve at least 3 DSBs of at least 2 
chromosomes (Loucas et al., 2013). 
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Figure 23. Method of estimating the number of IR-induced DSBs that gave rise to each type of 
chromosomal aberration using M-FISH. Dicentrics or translocations often involve 2 DSBs. 
CCAs (e.g. translocations with 3 chromosomes) involve at least 3 DSBs of at least 2 
chromosomes. 
 
M-FISH analyses in 4 donors (Donors A, C, L, R) indicated 3.26 DSBs per cell after 
γ-irradiation and 9.81 DSBs per cell following carbon irradiation. As M-FISH is a more 
detailed analysis of chromosomal damage compared to TC-FISH (since M-FISH allows 
analysis of translocations which are not visible with TC-FISH), it is expected that more DSBs 
per cell be calculated using M-FISH than using TC-FISH. However, as both techniques give 
an RBE factor of 3 at the dose of 2 Gy, the determination of RBE factor of carbon compared 
to γ-rays is independent of the method of scoring chromosomal damage. TC-FISH and M-
FISH can thus be considered to be two alternative approaches for scoring chromosomal 
damage. Based on these results, we propose that the TC-FISH technique is more practical 
for use in radiation dosimetry, as M-FISH is both expensive and time consuming in terms of 
hybridization technique and analysis compared to TC-FISH.  
 
3.2.4 RBE at various doses: high RBE factors at low doses 
To determine RBE at various doses, we compare mean DSBs per cell determined 
using TC-FISH following exposure to a range of doses (0.2 to 15 Gy) of high-LET carbon 
ions (75 MeV/u; LET ~36.5 keV/µm at the plateau region of the Bragg peak curve) and low-
LET γ-rays in PBL of healthy blood donors. For γ-irradiation at all doses except for 2 Gy 
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(which is the average of 18 donors; data in Figure 17A), the mean DSBs per cell represent 
the average of 6 donors (Donors C, F, H, J, K, and O; data in Figure 20B). For carbon 
irradiation at all doses except for 2 Gy (which is the average of 13 donors; data in Figure 
21A), the mean frequencies represent the average of 4 donors (Donors G, H, K, and M). 
 
 
Figure 24. RBE of carbon ions versus γ-rays at different doses.  The mean number of DSBs per 
cell was determined using TC-FISH and plotted versus doses of up to (A) 5 Gy and (B) 15 Gy. 
The mean DSBs per cell for all donors analyzed are indicated above each bar in (B). Error bars 
represent the standard deviation of the frequencies of DSBs per cell among the donors. (C) 
RBE factor of carbon ion versus γ-rays as a function of dose. 
 
Figure 24A shows a plot of the dose (0 to 5 Gy) of γ or carbon irradiation and the 
mean number of DSBs per cell averaged for all donors analyzed calculated using TC-FISH. 
This plot indicated second order polynomial trends between the doses of 0 and 5 Gy for both 
IR types. This plot was expanded to doses of up to 15 Gy in Figure 24B, which shows data 
for the frequency of DSBs per cell (averaged for all donors analyzed) at each dose with the 
exact mean indicated above each bar. Error bars in Figure 24A and Figure 24B represent 
the standard deviation of the frequencies of DSBs per cell among the averaged donors, 
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illustrating inter-individual variations in radiosensitivity at various doses. As for the RBE 
calculated at the dose of 2 Gy in Section 3.2.3, RBE factors shown in Figure 24C were 
calculated by dividing the mean DSBs per cell following a dose of carbon irradiation by the 
mean DSBs per cell following the same dose of γ-irradiation (values shown in Figure 24B). 
As shown previously (Friedrich et al., 2014), the RBE factor is dose dependent, with high 
RBE factors at low doses (0.2 and 0.5 Gy), and an RBE factor approaching 1 at high doses 
(10 and 15 Gy). It would be interesting to confirm these results using the automated 
DCScore technique that we discussed above, especially within the low dose range.  
 
3.3 Evaluation of the RBE of protons, and the effect of IR energy on 
radiosensitivity 
As mentioned above, current radiotherapy regimens use photons (either X- or γ-rays) 
or protons for the treatment of a plethora of malignancies. Proton therapy has been used at 
~50 active centers worldwide to treat over 105,000 patients (as of December 2013) 
(Jermann, 2014). Proton beams, like other charged particles, are characterized by a higher 
LET than photons, and provide a more localized energy deposition at their Bragg peak, 
which allows precise targeting of the tumor while limiting IR-induced damages in the 
surrounding normal tissue. During radiotherapy with proton beams, to treat the entire depth 
of the tumor, several individual proton beams of different energies (with Bragg peaks at 
different depths) are applied; the therapeutic radiation distribution of these proton beams 
optimized for radiotherapy, illustrated in Figure 25A below, is called the spread-out Bragg 
peak (SOBP).  
Despite the comparably large experience in the therapeutic use of protons compared 
to heavier ions, the differences in biological responses elicited in cells and tissues by 
protons compared to photons is not yet well established, and large uncertainties can be 
found in the literature concerning the definition of a RBE–LET relationship for protons. 
Currently, high-energy protons are considered as a photon-like low-LET IR, and a fixed RBE 
of 1.1 compared to therapeutic photons is being used in photon therapy for the whole 
radiation field. While some studies support the idea that this fixed RBE is a reasonable 
approximation, it remains to be discussed whether the use of a fixed RBE in proton is still 
appropriate, or whether current knowledge justifies a switch toward a variable RBE, taking 
into account the dependency on LET, tissue properties, dose, and dose fractionation. 
Recent studies suggest that the biological response is differentially modulated by protons 
compared to photons, and thus favors a new approach where high-energy protons should no 
longer be considered as a photon-like low-LET IR. Additionally, research in the field of 
medical physics highlights how variations in RBE that are currently neglected might actually 
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result in deposition of significant doses in healthy organs, particularly for normal tissues in 
the entrance region and for organs at risk close behind the tumor (Tommasino and Durante, 
2015). 
In this study, we evaluate the RBE of proton beams of two different energies (73 MeV 
and 200 MeV) at 3 different positions along the SOBP (Figure 25A) at the dose of 2 Gy. We 
then compare the effect of IR energy on radiosensitivity by comparing these results with 
those of γ-rays and carbon-13 ions (75 MeV/u; LET ~36.5 keV/µm at the plateau region of 
the Bragg peak curve) discussed above (Sections 3.1.1 and 3.2.1).  
 
 
Results 
3.3.1 RBE of 2 Gy of proton irradiation at different locations of the Bragg peak 
To evaluate RBE of protons optimized for radiotherapy (SOBP), samples were 
irradiated with 2 Gy of protons of two different energies (73 MeV and 200 MeV) at 3 different 
positions along the SOBP (illustrated in Figure 25A): at the entrance of the SOBP (Position 
A), in the middle of the SOBP (Position B), and at the end of the SOBP (Position C). The 
PBL of two healthy blood donors of moderate radiosensitivity to γ-rays (Donors H, K) were 
analyzed using TC-FISH.  
 
 
Figure 25. (A) Example of a spread-out Bragg peak (SOBP) used in proton radiotherapy. PBL 
samples were irradiated with 2 Gy of protons of two different energies (73 MeV and 200 MeV) 
at 3 different positions along the SOBP: at the entrance of the SOBP (Position A), in the middle 
of the SOBP (Position B), and at the end of the SOBP (Position C). (B) RBE at the dose of 2 Gy 
of protons at different locations along the SOBP relative to γ-rays in PBL of two healthy blood 
donors of moderate radiosensitivity to γ-rays (Donors H, K) analyzed using TC-FISH. 
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Mean DSBs per cell of these two donors following 2 Gy of proton (73 MeV) irradiation 
at each position were as follows: 1.39 at Position A, 2.12 at Position B, and 2.45 at Position 
C. Mean DSBs per cell of these two donors following 2 Gy of proton (200 MeV) irradiation at 
each position were as follows: 1.68 at Position A, 2.35 at Position B, and 1.95 at Position C. 
Figure 25B shows the RBE at each position compared to the mean DSBs per cell of these 
same two donors following 2 Gy of γ-irradiation (2.17 DSBs per cell). As shown in Figure 
25B, the RBE is lower at the entrance of the SOBP (Position A) compared to the mid- to end 
of the SOBP (Positions B and C, respectively) for both proton energy beams, and RBE 
ranges from 1.0 to 1.1 at the mid-region of the SOBP (Position B). Our data at the mid-
region of the SOBP (Position B) of RBE ranging from 1.0 to 1.1 for both proton energy 
beams are in general agreement of previous studies that find that high-energy protons can 
be considered as a photon-like low-LET IR in terms of biological effectiveness (Tommasino 
and Durante, 2015). 
 
3.3.2 Effect of IR energy on radiosensitivity at the dose of 2 Gy 
To study the effect of IR energy on radiosensitivity, we compare the effects of γ-rays 
(0.0013 MeV), carbon-13 ions (75 MeV/u), and protons of two different energies (73 MeV 
and 200 MeV) in PBL of healthy blood donors using TC-FISH.  
 
 
Figure 26. Effect of IR energy on radiosensitivity. The effects of 2 Gy irradiations of γ-rays 
(0.0013 MeV), carbon-13 ions (75 MeV/u), and protons of two different energies (73 MeV and 
200 MeV) were compared in PBL of healthy blood donors using TC-FISH. The three data points 
shown for each of the donors (Donor H in blue, and Donor K in red) for proton irradiations 
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represent the DSB per cell at the three positions along the SOBP (data shown in Figure 25B) to 
illustrate the possible range along the SOBP of proton beams. The relative radiosensitivity of 
Donors H and K are also highlighted, among the other donors (represented by each of the 
small gray data points), for γ- and carbon irradiations; each of these points are of the results 
shown in Figure 17A for γ-irradiation and Figure 21A for carbon irradiation. Error bars 
represent standard errors.   
 
Figure 26 shows the compiled results shown in previous sections of all analyzed 
donors for each type of irradiation at the dose of 2 Gy (Figure 17A for γ-irradiation, Figure 
21A for carbon irradiation, and Figure 25B for proton irradiations); error bars represent 
standard errors. Donors H and K are highlighted separately for comparative reference, and 
results of irradiations at the 3 points along the SOBP of proton beams (Positions A, B, and 
C; data shown in Figure 25B) are shown for each of the donors to illustrate the possible 
range along the SOBP. As shown in Figure 26, the two energies of protons (73 MeV and 
200 MeV) induce comparable ranges of DSBs per cell as γ-rays (0.0013 MeV) despite the 
drastic increase in IR energy from that of γ-rays (~1 to 3 DSBs per cell). Carbon ions (75 
MeV/u), however, induced an RBE of ~3.00 ± 0.15 compared to γ-rays and the two proton 
energy beams. These results, though it remains to be confirmed in a larger cohort, suggest 
that high-energy protons can be considered as a photon-like low-LET IR in terms of 
biological effectiveness, as previously described (Tommasino and Durante, 2015). 
 
 
 
  
  
 
 
116 
4 - TELOMERES AND THE PREDICTION OF INDIVIDUAL 
RADIOSENSITIVITY 
4.1 Inherent individual variations in telomere length and telomere 
instability 
As discussed in Section 1.1.1, telomere length (TL) varies between individuals and 
on individual chromosome arms (Pommier and Sabatier, 2002). This inherent heterogeneity 
of TL is conserved during life as TL in somatic proliferative tissues naturally declines with 
each cell replication cycle (Graakjaer et al., 2003), and telomere abnormalities and genomic 
instability may eventually arise. To better characterize the inherent levels of variability in TL 
and telomere dysfunction in healthy individuals before we study IR-induced effects on these 
variables, we measure TL and analyze basal levels of telomere dysfunction in metaphasic 
chromosomes of PBL of healthy individuals following TC-FISH staining.  
 
 
Results 
4.1.1 Inherent individual variations in telomere length 
We characterized the inherent differences in TL in PBL of 12 healthy individuals (5 
females and 7 males), ranging from age 32 to 57 (mean age of 47).  
 
 
Figure 27. Mean inherent telomere lengths of PBL of 12 healthy individuals in correlation to 
each individual’s age. Telomere lengths were measured as total fluorescence intensity 
(arbitrary units, A.U.) of telomeres per metaphase following TC-FISH staining, normalized to 
the number of chromosomes per metaphase. Error bars represent standard error of 
measurements per donor.  
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Following TC-FISH staining, metaphases were photographed under 63X objective 
using the AutoCapt software (MetaSystems), and TL was manually measured as total 
fluorescence intensity of the telomere probe in each metaphase using the ISIS analysis 
software (MetaSystems). As TL was measured in terms of fluorescence intensity, results 
here are given in terms of arbitrary (fluorescence) units (A.U.) instead of the conventional kb 
measurement. TL per metaphase was normalized to the number of chromosomes per 
metaphase.  
In this cohort of 12 healthy individuals, a wide range in TL was observed, ranging 
from 703 A.U. to 2343 A.U. and a mean TL of 1356 A.U. ± 502 (standard deviation). The 
correlation of inherent TL with age is shown in Figure 27. A general trend of decreasing TL 
with increasing age is observed (with a decrease by 16 A.U. per year), as would be 
expected since TL in somatic cells naturally declines with each cell replication cycle (Harley 
et al., 1990) due to the incomplete replication of telomere ends by conventional DNA 
polymerases, a situation known as the ‘end replication problem’ (de Lange, 2009). For the 5 
females analyzed (age range of 38 to 51, mean age of 45), the mean TL was 1612 A.U. ± 
717 (standard deviation), whereas mean TL was found to be 1173 A.U. ± 162 (standard 
deviation) for the 7 males analyzed (age range of 32 to 57, mean age of 49). Despite the 
higher mean age of the males, females showed longer TL than males, which is in agreement 
with recent findings of TL analyses of a large cohort of 110,266 individuals (Lapham et al., 
2015). Furthermore, the variability in TL within the male group was significantly less than in 
the female group, as illustrated by the standard deviation values (162 for males vs. 717 for 
females). Though the size of this cohort limits the power of this study on the effect of gender 
on TL, we speculate that the more homogenous TL in the male group can be attributed to 
the steady decrease in TL observed in males from young adulthood to approximately the 
age of 75, as found in (Lapham et al., 2015). Females, however, were shown to exhibit a 
change in TL patterns around the age of 50 (Lapham et al., 2015); though we measured TL 
in only 5 females in this study, as the mean age of these 5 females was 45, we can 
speculate that the large heterogeneity in TL observed can be attributed to the age-related 
changes in TL that are taking place around this age. 
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4.1.2 Basal individual variations in telomere instability 
To assess variations in basal levels of telomere abnormalities, we also quantified 
levels of telomere loss of 1 telomere or of 2 telomeres (from both sister chromatids) and 
doublets using TC-FISH (as shown in Figure 28A) in a separate cohort of 35 healthy 
individuals (age range of 23 to 58, mean age of 39.5); this study was an expansion of the 
data included in our original paper, (Pottier et al., 2013) found in Appendix A.3.4 of this 
thesis, which included this analysis for 20 healthy individuals. To evaluate inter-scorer 
variability in the scoring of each type of telomere abnormality via TC-FISH analysis, the 
same images were scored by 3 independent scorers in the laboratory. 
 
 
Figure 28. (A) Types of telomere abnormalities (telomere doublets, or loss of 1 or 2 telomeres) 
visualized with TC-FISH staining. Two examples of difficulties that may arise in interpreting 
fluorescence signals in the image as duplicated (doublet) are shown in (B) and (C). (B) The 
doublet signal is on the border of the end of the chromosome (marked by the yellow line), as 
seen with DAPI counterstaining of the DNA. (C) The doublet signal is slightly separated from 
the other telomere signal, and placed slightly away from the end of the chromosome (yellow 
line). Whether the scorer counts these as doublets or not is left to the scorer’s discretion; this 
is a source of inter-scorer variability in the frequency of these telomere abnormalities. 
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Figure 29. Basal levels of telomere abnormalities in PBL of 35 healthy individuals, analyzed by 
3 independent scorers using TC-FISH staining as shown in Figure 28A. Basal levels of (A) 
telomere loss, (B) telomere doublets, and (C) loss of 2 telomeres from both sister chromatids 
in increasing order of telomere loss, and their respective correlations with age. Error bars 
indicate inter-scorer variability in scoring each type of telomere abnormality. 
 
As shown in Figure 29, there is a large range of variation in basal levels of telomere 
abnormalities in human PBL. Within this cohort of 35 healthy individuals, a ~8 fold difference 
in basal levels of telomere loss (Figure 29A) and a ~5 fold difference in basal levels of 
telomere doublets (Figure 29B) is observed. Despite this large inter-individual variability, 
telomere doublets are, on average, the most frequently observed type of telomere 
abnormality, found in ~11% of chromosomes; telomere loss occurs at ~0.6% of 
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chromosomes, and loss of 2 telomeres from both sister chromatids occur at only ~0.03% of 
chromosomes. These basal levels of telomere abnormalities do not appear to be correlated 
with age, as illustrated by the lack of any trend in the respective plots in Figure 29. We 
hypothesize that though inherent telomere length is strongly influenced by age (Figure 27), 
basal levels of telomere instability are related to confounding factors such as lifestyle (Lin et 
al., 2012;Price et al., 2013). 
In our original paper, (Pottier et al., 2013) found in Appendix A.3.4 of this thesis, we 
found that in B3 cells (isolated from the human EJ30 bladder cell carcinoma cell line), 
telomere abnormalities following in vitro exposure to lead (Pb) in the form of lead nitrate 
(Pb(NO3)2) arose due to Pb-induced TIFs, which are formed when DNA repair machinery 
(e.g. γH2AX) recognize short or dysfunctional telomeres (uncapped or damaged telomeres) 
as DSBs, thus leading to γH2AX localization at these (intact) telomeres. The formation of 
TIFs at these intact telomeres likely leads to their loss due to perturbations of telomere 
replication (Pottier et al., 2013). Whether this same mechanism is true in normal 
lymphocytes remains to be determined. It would be interesting to investigate further the 
inter-individual variations in the basal levels of TIFs in lymphocytes of healthy individuals to 
determine whether correlations exist with levels of telomere abnormalities, as seen following 
Pb exposure in (Pottier et al., 2013).  
In addition to the above analysis, we also evaluated the reproducibility of scoring 
telomere abnormalities using TC-FISH. To assess inter-scorer variability, the gallery of TC-
FISH images (comprised of 50 metaphases for each of the 35 donors, for which results are 
shown in Figure 29) were scored by 3 independent scorers in the laboratory. As shown by 
the error bars in Figure 29, the scoring of telomere abnormalities using TC-FISH may 
produce inter-scorer variability. This is especially evident in the scoring of the loss of 2 
telomeres from both sister chromatids (Figure 29C) and, to a lesser extent, the scoring of 
telomere doublets (Figure 29B). As the manual scoring of telomere abnormalities of TC-
FISH stained metaphases requires visualization of every telomere on every chromosome in 
the metaphase, this inter-scorer variability can be attributed to either incomplete visualization 
of all the abnormalities in the metaphase, or the difficulties of interpreting fluorescence 
signals in the image as either missing (for the case of telomere loss) or duplicated (for the 
case of telomere doublets). Two examples of such are illustrated in Figure 28B and Figure 
28C; whether the scorer counts these as doublets or not is left to the scorer’s discretion, 
thus becoming a source of inter-scorer variability in the frequency of these telomere 
abnormalities. Consequently, it may be required for multiple scorers to verify the analysis of 
telomere abnormalities using TC-FISH. This complication may be resolved with the 
development of automated software for TC-FISH analysis of telomere abnormalities. 
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4.2 Telomere length as a predictor of short-term radiosensitivity to γ-
irradiation 
In this study, we evaluate whether individual radiosensitivity to the therapeutic dose 
of 2 Gy of low-LET γ-rays (described previously in Section 3.1.1 and presented in Figure 
17A of this thesis) can be predicted by a single or combination of variables, such as age, 
gender, inherent and IR-induced changes in telomere length (TL). For this discussion, we 
consider ‘radiosensitivity’ solely in terms of the mean number of IR-induced DSBs per cell, 
as described in Section 3.1.1. As plotted in Figure 17A, radiosensitivity to 2 Gy of in vitro γ-
irradiation of PBL isolated from whole blood samples of 18 healthy individuals was plotted in 
order of increasing DSBs per cell using TC-FISH analysis, as illustrated in Figure 16, and 
individuals were designated as Donors A through R in this order of ‘radioresistant’ to 
‘radiosensitive’ donors.  
In this section, using the Stata software, we estimate linear regression equations of 
various combinations of variables with the ordinary least squares (OLS) method to estimate 
whether radiosensitivity can be predicted by these variables. Linear regression equations 
are of the following general format: 
 
𝑦𝑦 = 𝛼𝛼 + 𝛽𝛽!𝑥𝑥! + 𝛽𝛽!𝑥𝑥!+. .. 
Equation 1. General linear regression equation. 
In this general equation (Equation 1), y is the dependent variable that is being predicted or 
explained, and the x variables are the independent variables that are being used to predict 
the y variable. α is the constant or y-intercept, or the expected effect if all independent 
variables equal zero, and each β coefficient is the slope (or the expected extent of effect on 
the y variable) for each corresponding x variable.  
For our study, the y variable is the radiosensitivity to 2 Gy of γ-rays (simplified to the 
variable RS2g). To simply discussion of each x variable in the following sections, we define 
each of the variables of interest below: 
• Age (in years) 
• SexMale (gender of the individual is denoted as either ‘male’ or ‘not male’ in the regression)  
• TL0: inherent telomere length (0 Gy), shown in Figure 27 to be correlated with age 
• TL2g: telomere length following 2 Gy γ-irradiation 
• ΔTLg, or the change in telomere length after 2 Gy γ-irradiation, was calculated from TL0 
and TL2g as follows: ΔTLg  =  TL2g  –  TL0 
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Results 
4.2.1 Age and gender significantly predict radiosensitivity 
To determine whether age and gender can be used to predict RS2g in this cohort of 
blood donors, we estimate Equation 2 with the ordinary least squares (OLS) method. The 
results of the regression in Equation 2 are reported in Table 4.  
 
𝑅𝑅𝑅𝑅2𝑔𝑔 = 𝛼𝛼 + 𝛽𝛽! 𝐴𝐴𝐴𝐴𝐴𝐴 + 𝛽𝛽! 𝑆𝑆𝑆𝑆𝑆𝑆!"#$  
Equation 2. Linear regression equation to determine effects of age and gender on the 
prediction of radiosensitivity to 2 Gy γ-irradiation. Results are reported in Table 4. 
 
Table 4. Results of the linear regression in Equation 2: effects of age and gender on the 
prediction of radiosensitivity to 2 Gy γ-irradiation‡‡‡‡. 
Explanatory Variable 
 
( 1 ) ( 2 ) ( 3 ) 
Age   β1 : -0.026** --- -0.029**** 
  (-2.184)  (-3.121) 
SexMale   β2 : --- -0.425*** -0.465**** 
   (-2.431) (-3.332) 
Constant α : 3.413 2.419 3.822  (5.921) (18.055) (8.270) 
Adjusted R2  0.191 0.235 0.516 
N  17 17 17 
β coefficients are given for each variable, and the t-statistics are reported in parentheses under each 
β coefficient. *, **, ***, **** correspond to p-values < 10%, 5%, 1%, 0.1%, respectively. Each column 
corresponds to a separate regression. 
 
                                                
 
‡‡‡‡ In these regression tables, each column corresponds to a separate regression. For example, 
Column (1) presents the prediction of RS2g in Equation 2 using age alone as the independent 
variable. Column (2), in turn, presents the prediction of RS2g using gender alone, while Column (3) 
takes into account both age and gender to predict RS2g. β coefficients are given for each variable, and 
the t-statistics are reported in parentheses under each β coefficient. The sign on the β coefficient 
(positive or negative) indicates the direction of the effect: a positive coefficient indicates how much the 
RS2g is expected to increase when that independent variable increases by one, holding all the other 
independent variables constant. Adjusted R2 values indicate R2 values adjusted to reflect the number 
of variables in the equation, and N is the number of donors analyzed.  
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Figure 30. Correlations between Age  and RS2g . The gender of each individual is also 
indicated.  
 
As shown in Column (1), age alone is a significant predictor of RS2g (p<0.05). The 
correlation between age and RS2g per donor is also illustrated in Figure 30; it is notable that 
the equation to predict RS2g in terms of age alone (both genders) in Figure 30, y   =   -­‐
0.026x+3.413, corresponds to the results of the regression in Column (1) of Table 4, with the 
constant (α variable) of 3.413 and a β coefficient (or slope) of -0.026. As shown in Figure 30, 
females in this cohort are slightly more radiosensitive compared to males of the same age. 
However, age-related decline in radiosensitivity in males and females each exhibit almost 
parallel slopes to the mean of this cohort, with β coefficients of -0.028 (in males) and -0.030 
(in females).  
As shown in Column (2) of Table 4, gender alone is also a significant predictor of 
RS2g (p<0.01). It is notable that though age is a significant predictor of RS2g, gender alone is 
a significantly stronger predictor of RS2g than age alone, as illustrated by the β coefficients of 
-0.425 for gender alone vs. -0.026 for age alone; thus, we can say that in comparison to the 
effect of gender on RS2g, the effect of age on RS2g is almost negligible. This is also 
illustrated the β coefficients in the regression of age and gender together (-0.029 and -0.465, 
respectively), as shown in Column (3) of Table 4, which was the strongest predictor of RS2g 
(p<0.001). Overall, age and gender are significant predictors of radiosensitivity to 2 Gy of γ-
irradiation.  
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4.2.2 Inherent telomere length in conjunction with change in telomere length 
following γ-irradiation significantly predicts radiosensitivity 
As discussed in Section 4.1.1 and presented in Figure 27 of this thesis, TL was 
measured following TC-FISH staining as total fluorescence intensity of telomeres (arbitrary 
units, A.U.) per metaphase, which was normalized to the number of chromosomes per 
metaphase. A wide range in TL was observed in this cohort of 12 healthy individuals (5 
females and 7 males), ranging from age 32 to 57 (mean age of 47), and inherent TL (TL0) in 
this cohort of blood donors decreased (by 16 A.U. per year) with increasing age, as 
expected (Figure 27).  
 
 
Figure 31. Mean TL after exposure to 2 Gy of γ-irradiation in PBL of 12 healthy individuals in 
correlation to each individual’s age. TL was measured as total fluorescence intensity of 
telomeres per metaphase following TC-FISH staining, normalized to the number of 
chromosomes per metaphase. Error bars represent standard error of measurements per 
donor. (A) TL measured after exposure to 2 Gy of γ-irradiation (TL2g) shows an age-dependent 
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decrease, decreasing at a rate of 14 A.U. per year. (B) Though there is no age-related trend in 
the change in TL following exposure to 2 Gy of γ-irradiation (ΔTLg), there is an overall 
shortening of TL post-irradiation. 
 
As shown in Figure 31A, TL measured after exposure to 2 Gy of γ-irradiation (TL2g) 
also shows an age-dependent decrease at a rate of 14 A.U. per year. Though there is no 
age-related trend in the change in TL following exposure to 2 Gy of γ-irradiation (ΔTLg) (as 
shown by the horizontal slope of 1 in Figure 31B), there is an overall shortening of TL post-
irradiation in this cohort.  
To determine whether inherent and post-irradiation TL (TL0  and  TL2g, respectively) 
and IR-induced changes in TL after 2 Gy γ-irradiation (ΔTLg) can be used to predict RS2g in 
this cohort of blood donors, we estimate Equation 3 with the ordinary least squares (OLS) 
method. The results of the regression in Equation 3 are reported in Table 5.  
 
𝑅𝑅𝑅𝑅2𝑔𝑔 = 𝛼𝛼 + 𝛽𝛽! 𝛥𝛥𝛥𝛥𝛥𝛥𝛥𝛥 + 𝛽𝛽! 𝑇𝑇𝑇𝑇0 + 𝛽𝛽! 𝑇𝑇𝑇𝑇2𝑔𝑔  
Equation 3. Linear regression equation to determine effects of telomere length on the 
prediction of radiosensitivity to 2 Gy γ-irradiation. Results are reported in Table 5. 
 
Table 5. Results of the linear regression in Equation 3: effects of telomere length on the 
prediction of radiosensitivity to 2 Gy γ-irradiation. 
Explanatory Variable 
 
( 1 ) ( 2 ) ( 3 ) ( 4 ) 
ΔTLg β1 : 0.284 --- 0.489** ---  (1.235)  (2.017)  
TL0 β2 : --- 0.181 0.439* ---   (0.707) (1.704)  
TL2g β3 : --- --- --- 0.467** 
     (2.276) 
Constant α : 2.315 2.024 1.751 1.710  (18.840) (5.502) (5.015) (6.421) 
Adjusted R2  0.046 -0.048 0.198 0.275 
N  12 12 12 12 
β coefficients are given for each variable, and the t-statistics are reported in parentheses under each 
β coefficient. *, **, ***, **** correspond to p-values < 10%, 5%, 1%, 0.1%, respectively. Each column 
corresponds to a separate regression. β coefficients for ΔTLg and TL0  were scaled by a factor of 1000 
to account for differences in magnitude within the data. Actual β coefficients are the above given 
number ×10-3.  
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Figure 32. (A) TL0  and (B) ΔTLg  alone do not predict RS2g . However, the regression (shown in 
Table 5 Column (3)) shows that ΔTLg  and TL0  together is a strong predictor of RS2g . (C) TL2g  
alone was shown to be a strong predictor of RS2g . 
 
As shown in Column (1) and (2) respectively, ΔTLg and TL0   alone do not predict 
RS2g; this is also illustrated in Figure 32A and B. However, as shown in Column (3), ΔTLg 
and TL0  together was shown to be a strong predictor of RS2g, with β coefficients of 0.489 
(p<0.05) and 0.439 (p<0.10), respectively. Additionally, TL2g alone was shown to be a 
strong predictor of RS2g (p<0.05) as shown in Column (4) in Table 5 and in Figure 32C. 
These preliminary results require further validation in a larger cohort of individuals 
characterized with extreme telomere lengths using other standard techniques of measuring 
TL (e.g. terminal restriction fragment [TRF] or Q-FISH). 
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4.2.3 Radiosensitivity differentially affects IR-induced changes in telomere 
lengths in cells with the shortest mean telomere lengths 
Interestingly, though ΔTLg, or the changes in mean TL following γ-irradiation, did not 
correlate with RS2g (Column (1) in Table 5 or Figure 32B), slight correlations between RS2g 
and changes in TL in cells with the shortest mean TL is suggested, as shown in Figure 33.  
 
 
Figure 33. Slight correlations between RS2g  and IR-induced changes in TL in cells with the 
shortest mean TL. Radioresistant donors (Donors A and C) show little changes in TL following 
irradiation, whereas radiosensitive donors (Donors O, P, Q, R) exhibit elongation in these 
cells. Donors of medium radiosensitivity exhibit telomere shortening in the cells with the 
shortest mean TL. 
 
Radioresistant donors (Donors A and C) show little changes in TL in cells with the 
shortest mean TL following irradiation, while radiosensitive donors (Donors O, P, Q, R) 
exhibit elongation in these cells. Donors of medium radiosensitivity, on the other hand, 
exhibit telomere shortening in cells with the shortest mean TL. Indeed, a recent clinical study 
found that while mean TL was not affected in peripheral leukocytes from patients after in 
vivo radiation treatment with a mean dose of 52 Gy, there was a significant decrease in the 
proportion of cells with short telomeres (Maeda et al., 2013). An in vitro study of changes in 
TL (assessed using the traditional TRF analyses) over the course of 4 days after X-ray 
irradiation (0.5 Gy) in normal human umbilical vein endothelial cells also found changes in 
TL distribution post-irradiation; in the irradiated cells, in the first 3 days post-irradiation, no 
significant telomere shortening of mean TRF length was found, but a decrease in the 
percentage of longer telomeres along with an increased percentage of the shortest 
H"
Q"
C"
A"
L"
J"
R"
P"
K"
O"
N"
F"
!700$
!600$
!500$
!400$
!300$
!200$
!100$
0$
100$
200$
300$
400$
500$
1.0$ 1.5$ 2.0$ 2.5$ 3.0$
Ch
an
ge
"in
"te
lo
m
er
e"l
en
gt
h"
in
"ce
lls
"w
ith
"
th
e"s
ho
rte
st
"m
ea
n"
te
lo
m
er
e"l
en
gt
h"
(g
am
m
a"2
Gy
)"
RS2g"
Telomere"elongaCon""
postEirradiaCon"
in"cells"with"the"
shortest"mean"
telomere"length""
Telomere"shortening""
postEirradiaCon"
in"cells"with"the"
shortest"mean"
telomere"length""
RadioresistantEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEERadiosensiCve"
  
 
 
128 
telomeres was demonstrated. These results suggest that the shortest telomeres are more 
sensitive to IR than longer telomeres (Guan et al., 2014).  
Though further studies are needed to verify our observations in this cohort, we 
speculate that our findings could be related to excessive IR-induced oxidative stress and the 
differential sensitivity of telomeres of different lengths to oxidative stress, as hypothesized by 
the authors of Guan et al (Guan et al., 2014). Less oxidative stress may be induced in 
radioresistant individuals compared to radiosensitive individuals, which may correlate with 
the decreased frequency of DNA damage (DSBs) found in radioresistant individuals (Figure 
17A). The increased levels of oxidative stress in radiosensitive individuals may cause 
excessive genomic damages that leads to senescence or apoptosis, which inflicts cells with 
the shortest mean telomeres first, and thereby leads to their loss from the cell population; we 
speculate that the apparent telomere elongation post-irradiation in radiosensitive individuals 
(Figure 33) could be due to the lack of the inclusion of these cells that underwent 
senescence or apoptosis. Another explanation for these findings could be related to varying 
levels of activation of telomerase activity in individuals of different radiosensitivity. Inherent 
telomerase activity in radioresistant donors (which may protect against IR-induced changes 
in TL) may in fact explain their radioresistance, as ectopic over-expression of telomerase in 
a human fibroblast cell line was previously shown to be associated with unusual 
spontaneous and IR-induced chromosome stability (Pirzio et al., 2004). Meanwhile, we 
hypothesize that activation of telomerase (thereby resulting in telomere elongation) infers 
increased radiosensitivity, whereas the lack thereof explains the telomere shortening 
observed in moderately radiosensitive individuals.  
  
 
  
  
 
 
129 
5 - ROLE OF TELOMERES IN LONG-TERM HUMAN HEALTH RISKS 
AFTER RADIATION EXPOSURE 
5.1 Telomere length as a predictor of cardiovascular disease  
Cardiovascular disease is well observed following IR exposure to the chest or heart 
(such as during radiotherapy for breast cancer, Hodgkin’s lymphoma, or head and neck 
cancer). Indeed, excess risk of cardiovascular and cerebrovascular diseases is proven 
following an acute dose of as low as 0.5 Gy (500 mSv) (Schultz-Hector and Trott, 
2007;Bhatti et al., 2008;Little et al., 2008;Baker et al., 2011). Most of the risk of developing 
cardiovascular disease could be accounted for by classical risk factors such as 
hypertension, smoking, dyslipidemia, age, and family history. However, wide variations are 
seen in both the occurrence of cardiovascular disease and the age of manifestation, even in 
individuals with the same classical risk factors. Though the reasons for this variability are 
unclear, it has been proposed that it is due to differences in the rate of biological aging. 
Aging is indeed a major risk factor of atherosclerosis, which is a common underlying cause 
of cardiovascular diseases, and aging-related endothelial dysfunction has been proposed to 
be the link between these variables. Endothelial dysfunction can arise due to constant 
bombardment of endothelial cells by atherogenic stimuli (e.g. elevated plasma cholesterol 
level, hypertension, diabetes, smoking). Endothelial dysfunction has been shown to be of 
central importance in the development and progression of atherosclerosis. Continuous 
mechanical, hemodynamic, and/or immunological damage (probably involving oxidative 
stress) to vascular endothelial cells during the progression of atherosclerosis may cause 
increased localized cellular turnover, leading to cellular senescence, myocardial cell death, 
or fibrosis (Schultz-Hector and Trott, 2007;Little et al., 2008;Sabatino et al., 2012;Shah and 
Mahmoudi, 2015).  
Telomere shortening has been shown to occur in human vascular tissue, which may 
be related to age-associated vascular disease. Telomeres have also been linked to several 
factors that influence cardiovascular risk (e.g. hypertension, diabetes, estrogens, oxidative 
stress, psychological stress), neovascularization, atherosclerosis, and heart disease. 
Furthermore, genomic instability may play a crucial role in the onset of atherosclerotic 
events (Balasubramanyam et al., 2007;Lin et al., 2012;Sabatino et al., 2012); a recent study 
showed that accelerated vascular aging and early atherosclerosis can be associated with 
telomere shortening, genomic instability, and deficient DNA repair capacity following chronic 
exposure to low doses of IR in catheterization laboratory personnel (Andreassi et al., 2015). 
However, additional studies are needed to clarify the link between IR-induced telomere 
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shortening and the development/progression of cardiovascular and other vascular effects 
(Sabatino et al., 2012).  
Hodgkin lymphoma is a malignant hematological disease that predominantly affects 
young patients. Despite the very high cure rate of this cancer using radiotherapy and 
chemotherapy (Specht et al., 2014), it is associated with low long-term survival rates due to 
non-cancer related secondary complications (such as cardiovascular diseases), as well as 
secondary cancers, long after being cured of their initial disease (Castellino et al., 2011). In 
this study, presented in our recent paper (M'Kacher et al., 2015b), we evaluate telomere 
length (TL) in PBL of 179 Hodgkin lymphoma patients that were treated with radiotherapy 
(and chemotherapy) and cured of their cancer, and investigate if TL can be correlated with 
the development of cardiovascular disease in this subset of patients long after their 
treatment. Other conventional prognostic factors investigated are described in detail in 
(Girinsky et al., 2014). Our study is the first to demonstrate the major role of telomeres in the 
occurrence of cardiovascular disease in a population exposed to IR for medical purposes. 
 
5.1.1 Summary of key results 
• This study included 179 Hodgkin lymphoma patients that were treated with radiotherapy 
(and chemotherapy in 173 of these patients) at a median age of 29 (range of 9 to 75) 
and cured of their cancer. Evidence of cardiovascular disease was evaluated with 
coronary computed tomography angiography (CCTA). CCTA was performed in these 
patients at a median age of 42 (range of 19 to 79), which is a median of 13 years after 
the treatment that cured their Hodgkin lymphoma.  
• TL was measured following quantitative fluorescent in situ hybridization (Q-FISH) of 
metaphases of PBL with a telomere-specific Cyanine3-labeled PNA probe, and 
quantitative image acquisition and analysis using MetaCyte software (MetaSystems); 
blood samples for TL analysis were obtained from patients before their CCTA procedure. 
I aided in the cell culture, sample processing and hybridization, and image acquisition of 
this analysis. 
• Comparisons of TL in Hodgkin lymphoma patients with cardiovascular disease 
(abnormal CCTA) vs. patients with no evident cardiovascular disease indicated that 
patients with cardiovascular disease have significant telomere shortening: mean TL of 
7.1 kb in patients with cardiovascular disease (mean age 48.5; 41 patients) vs. 7.9 kb in 
patients with no evident cardiovascular disease (mean age of 40.9; 125 patients). 
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• Patients with no evident cardiovascular disease had higher heterogeneity in mean TL 
(range of TL of 4.7 to 11.1 kb) compared to patients with cardiovascular disease (range 
of TL of 4.8 to 8.7 kb); this may be explained by short period of follow-up of some 
patients or possibly the occurrence of another complication (e.g. secondary cancer). 
• Univariate and multivariate analysis of conventional risk factors confirmed the 
significance of well-known prognostic factors of cardiovascular disease (e.g. 
hypertension, hypercholesterolemia, age at treatment, radiation dose to coronary artery 
origins).  
• Univariate analysis of less conventional risk factors, e.g. telomere length, showed that TL 
was a highly significant risk factor (p=0.006).  
• A multivariate analysis of all risk factors, including TL, found that only hypertension 
(p=0.007) and TL (p=0.03) were significant prognostic factors. 
• This study provides additional evidence that TL could be linked to inter-individual 
sensitivity to IR and other genotoxic agents. 
• These findings support the hypothesis that telomere shortening may represent an 
important mediator between IR exposure and vascular damage, and could be used to 
define new radiation protection strategies. As this study supports the quantification of 
telomeres as a prognostic factor of cardiovascular risk of population exposed to IR, this 
will require the development of a clinical method to measure telomere length.  
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5.2 Telomeres as a key player in the process of radiation-induced 
carcinogenesis 
As discussed in previous chapters, telomeres are involved in aging (Section 1.1.1), 
age-related human (non-cancer) pathologies (Section 1.1.3), and the development of 
cardiovascular diseases (Section 5.1). Telomeres can also be associated with the process of 
carcinogenesis, as telomere dysfunction (Section 1.1.2) via deregulation of telomere length, 
shelterin proteins, and DNA damage repair proteins (each of which have also been linked to 
cancer progression) induces genomic instability, which in turn is an important enabling factor 
that aids in the acquisition of the hallmark traits of cancer that allow cancer cells to survive, 
proliferate, and disseminate. In our review article (Shim et al., 2014), we present what is 
currently known on these related topics.  
 
5.2.1 Summary of key points 
• We review the current knowledge and understanding of telomeres, mechanisms of 
telomere maintenance, and mechanisms of telomere damage and repair.  
• We have compiled all the significant studies published in literature on telomeric shelterin 
proteins and DDR proteins and the consequences of their deficiency or dysfunction on 
telomere length and fusion in humans and mice. Upon combing through a plethora of 
conflicting data in literature, these novel tables (Tables 1 and 2 on page 4 of the article) 
highlight the complexity in studying these mechanisms in vitro and in vivo.  
• We discuss what is currently known about telomeric and chromosomal damage induced 
by direct and indirect IR exposure, and mechanisms by which these IR-induced 
damages may lead to genetic instability during proliferation.  
• Finally, we conclude the review paper with the proposal of a detailed model for how 
telomeres may be a key player in the process of IR-induced carcinogenesis. Briefly, 
telomeres and IR-induced dysfunction of telomere maintenance mechanisms play a 
central role in the emergence of delayed genetic instability and accelerated aging 
following irradiation (Figure 1 on page 10 of the article). As genomic instability can be 
induced by telomere dysfunction (due to deregulation of telomere length, shelterin 
proteins, and DDR proteins, factors that have all been linked to cancer progression), 
telomeres may facilitate the process of IR-induced carcinogenesis (Figures 2 and 3 on 
pages 11 and 12 of the article, respectively). These factors may have profound 
implications for long-term human health risks, and may be directly applicable to the 
efficacy and long-term consequences of cancer treatment with radiotherapy.  
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6 - DISCUSSION AND CONCLUSIONS 
 
As presented in this thesis, there are inter-individual variations in radiosensitivity, 
measured in terms of IR-induced DNA DSBs (Section 3), which may be linked to age, 
gender, and inherent and IR-induced changes in telomere length (Section 4). These 
differences in individual radiosensitivity have important implications in biological dosimetry 
(discussed in detail in Section 2 and in our recent paper (Viau et al., 2015)) and 
radiotherapy (discussed in detail in Section 1.4.2), as a given dose of IR can induce 
significantly different levels of cellular damage in individuals of different radiosensitivities. In 
the following chapters, we discuss how individual radiosensitivity can influence long-term 
health following IR exposure, specifically focusing on the development of cardiovascular 
disease and the process of carcinogenesis. As we have demonstrated a link between these 
pathologies and telomeres (in Sections 5.1 and 5.2, respectively), we elaborate on the 
detailed model for carcinogenesis originally presented at the conclusion of our original 
paper (Shim et al., 2014) (presented in Section 5.2) to tie in how telomeres also play a key 
role in the development of cardiovascular diseases and how individual radiosensitivity may 
influence these processes. We then conclude with an argument on how telomeres could be 
useful in the prediction of individual sensitivity to identify hyper-radiosensitive individuals that 
may be more vulnerable to the induction of these pathologies following IR exposure. 
 
6.1 Telomeres as key players in the process of radiation-induced 
carcinogenesis and cardiovascular disease, and the influence of 
individual radiosensitivity 
The propagation of genomic instability can have a wide variety of biological 
consequences for the cell and the organism/being. As discussed in Section 1.2, IR exposure 
also induces a variety of other DNA and cellular damage, perhaps most notably DNA DSBs 
(which can lead to the formation of chromosomal aberrations) and mitochondrial dysfunction. 
We showed in this thesis that the extent of IR-induced DSBs (calculated based on the 
frequency of IR-induced chromosomal aberrations) varies among individuals of different 
levels of radiosensitivity (Section 3). Meanwhile, IR-induced mitochondrial dysfunction 
results in the production of excess ROS that goes on to cause further damage to the 
genome. Stress signals can be transmitted from irradiated cells to the progeny of irradiated 
cells, as well as to neighboring bystander cells and their progeny, and can cause ongoing 
oxidative stress, prolonged cellular injury, and the propagation of genomic instability (Azzam 
et al., 2012;Morgan and Sowa, 2015); telomeres themselves may play a role in the long-
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term transmission of chromosomal instability (Shim et al., 2014). Depending on the level of 
genomic instability, cells may or may not be able to continue to proliferate. For the process 
of carcinogenesis, which requires accumulation and unmasking of recessive mutations at a 
combination of oncogenes and tumor suppressor genes, the mutations, chromosomal 
rearrangements, and other types of genetic alterations that are generated during the 
propagation of genomic instability may facilitate the unmasking of recessive mutations via 
loss of heterozygosity (LOH) and thereby fuel tumor progression (Hanahan and Weinberg, 
2011). Meanwhile, in the development of cardiovascular diseases, the continuous 
mechanical, hemodynamic, and/or immunological damage (probably involving oxidative 
stress) to vascular endothelial cells during the age-related progression of atherosclerosis (a 
common underlying cause of cardiovascular diseases) could cause increased localized 
cellular turnover, accumulating levels of DNA/cellular damage and genomic instability, 
leading to cellular senescence, myocardial cell death, or fibrosis (Schultz-Hector and Trott, 
2007;Little et al., 2008;Sabatino et al., 2012;Shah and Mahmoudi, 2015). Therefore, along 
the road to carcinogenesis, a careful level of genomic instability must be maintained, as ‘too 
much’ instability would be detrimental and would result in cell death or senescence, while 
‘too little’ instability would slow the progression to tumorigenesis. Thus, we propose that 
just the right amount of genomic instability would minimize the rate of cell 
death/senescence while maximizing the rate of progression to carcinogenesis 
(Komarova and Wodarz, 2004). Meanwhile, we propose that the cell death/senescence 
induced from ‘too much’ genomic instability leads to pathologies associated with 
these cellular states, including cardiovascular disease.  
As discussed in Section 1.1, genomic instability can be induced by deregulation of 
telomere length, shelterin proteins, and DNA damage repair proteins, factors that have all 
been linked to cancer progression. We have also reviewed how dysfunction of these factors 
can be induced following direct and indirect (via bystander effects) IR exposure. Telomere 
length (which varies between individuals (Gilson and Londono-Vallejo, 2007;Hernandez et 
al., 2015;Lapham et al., 2015), different cell types in a single individual, as well as on 
individual chromosome arms within a single cell (Pommier and Sabatier, 2002)) continuously 
decreases naturally with each cell replication cycle (Harley et al., 1990). This telomere 
shortening can be accelerated following IR exposure either via increased levels of cell 
proliferation in order to replenish cells killed by IR exposure, or via IR-induced damages to 
telomeres (either through a direct hit or indirectly-induced oxidative damage) that prevents 
adequate telomere maintenance. Accelerated telomere shortening will be further induced by 
continuous exposure to other endogenous and exogenous DNA damaging agents 
throughout the cell lifespan (d'Adda di Fagagna et al., 2003;Jackson and Bartek, 2009;Lin et 
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al., 2012;Price et al., 2013). Considering that the heterogeneity of telomere lengths on each 
arm of individual chromosomes is maintained as telomeres shorten with each cell cycle, the 
shortest telomeres will eventually become critically short and dysfunctional, and could result 
in chromosome fusion and lead to chromosomal instability (Murnane, 2012). As shown in 
Figure 34, we propose that the heterogeneity in telomere length, continuous telomere 
shortening, and the triggering of DNA damage repair pathways and senescence due 
to dysfunctional telomeres play an essential role in the process of carcinogenesis 
and the development of cardiovascular diseases.  
 
 
Figure 34. Our proposed model of the impact of telomere length heterogeneity on the 
processes of cellular aging, senescence, crisis, carcinogenesis, and the development of 
cardiovascular disease.  
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When the shortest telomeres become critically short and dysfunctional, these 
dysfunctional/uncapped telomeres are sensed as DNA damage and trigger DDR pathways, 
forming TIFs in normal cells with intact cell cycle checkpoints (Takai et al., 2003). An 
important study suggested that normal human cells are able to tolerate small numbers of 
dysfunctional telomeres, and cells can continue to proliferate until a threshold of five TIFs 
per cell is reached. In normal cells with intact cell cycle checkpoints, senescence or 
apoptosis is triggered when this threshold of 5 dysfunctional telomeres is reached. In cells 
that are unable to senesce due to the loss of cell cycle checkpoint proteins such as p53 or 
p16, senescence is temporarily bypassed, and cells continue to proliferate with further 
accumulation of chromosomal instability, TIFs, and telomere shortening, until “telomeric 
crisis” is reached. In virus-immortalized cells undergoing crisis, more than 5 dysfunctional 
telomeres were found (Kaul et al., 2012) along with massive chromosome fusion and cell 
death (Counter et al., 1992;Counter et al., 1994;Ducray et al., 1999), perhaps due to 
extreme telomere shortening and loss of shelterin proteins. We propose that this cell 
death due to ‘too much’ genomic instability halts the process of carcinogenesis, but 
is responsible for the increased risk of diseases related to cell death, such as 
cardiovascular diseases if cell death occurs in vascular tissues (Figure 34). 
On the other hand, as shown in Figure 34, in the case of carcinogenesis, we 
propose that careful accrual of genomic instability when there are 1 to 4 dysfunctional 
telomeres in the presence of dysfunctional cell cycle checkpoints and/or DNA 
damage response mechanisms is key to the fate of the cell/being. As mentioned above, 
the process of carcinogenesis requires just the right amount of genomic instability to 
minimize the rate of cell death/senescence while maximizing the rate of progression to 
carcinogenesis. At these low levels of telomere dysfunction (1 to 4 dysfunctional telomeres), 
low levels of chromosomal instability may be allowed to persist, including the accumulation 
of recessive mutations in the genome with each successive generation that would allow the 
emergence of cells with a proliferative advantage if unmasked via loss of heterozygosity 
(LOH). With continuous telomere shortening with each cell cycle, telomeric crisis can lead to 
the loss of whole chromosomes or partial chromosomal arms, thereby unmasking in a single 
step via telomere-induced chromosomal imbalances the recessive mutations of hundreds of 
genes that have accumulated in the genome; these recessive mutations would otherwise 
remain silent unless the other, normal allele becomes mutated, a highly unlikely event. This 
phenomenon that we have coined “TELOLOH” is triggered by the shortest telomere that will 
first reach the threshold of instability (Pommier et al., 1995), and could lead to the 
emergence of cells with a proliferative advantage, especially if coupled with loss of tumor 
suppressor function and activation of telomerase and/or ALT pathways, leading to cell 
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immortalization and eventually carcinogenesis (Pommier et al., 1995;Sabatier et al., 
1995;Raynaud et al., 2008b). Therefore, as telomere dysfunction (natural and/or IR-
induced) may cause and propagate genetic instability and LOH, telomeres may be 
considered as a key player in the process of radiation-induced carcinogenesis. The 
IR-induced acceleration of telomere shortening may lead to acceleration of this entire 
process to carcinogenesis or the development of cardiovascular diseases.  
As the rate at which these processes occur will vary depending on the inherent 
heterogeneity of telomere length of the given individual, this factor may be considered as the 
cornerstone of individual predisposition to carcinogenesis or cardiovascular diseases. In 
other words, the starting point (i.e. the inherent telomere length and telomere length 
heterogeneity both per individual and within the individual) on the road to senescence, crisis 
(premature or not), and/or carcinogenesis, and/or cardiovascular diseases can determine 
whether that road is taken, and how long the journey will be. Furthermore, accumulation of 
IR-induced genomic damage may be of particular concern in highly radiosensitive 
individuals, as these individuals harbor more IR-induced damage in the genome (as shown 
in this thesis) that may not be properly repaired than in more radioresistant individuals. 
Conversely, radiosensitive individuals may be radiosensitive due to inherent genetic 
mutations (e.g. defects/deficiencies in genes involved in the DNA damage repair pathways 
or in proteins involved in the activation of cell cycle checkpoints or DNA replication/repair) 
that may also predispose them to IR-associated cancers or cardiovascular diseases. These 
considerations highlight the importance of identifying these highly radiosensitive individuals 
and adapting diagnostic radiology and radiation protection protocols based on individual 
radiosensitivity, as they may not be adequately protected under current guidelines, which 
utilize population averages in radiosensitivity (Advisory Group on Ionising Radiation, 2013).  
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6.2 Telomeres and telomere maintenance as a predictor of individual 
radiosensitivity 
Several characteristics of telomeres and their maintenance mechanisms make this 
parameter a promising candidate as a predictive biomarker (see details and discussion in 
our original paper (Shim et al., 2014) presented in Section 5.2). In line with our paper 
(Shim et al., 2014), a recent paper (Mirjolet et al., 2015) highlights the potential of telomeres 
and telomere maintenance as key players in predicting individual radiosensitivity that can be 
applied to radiotherapy regimens to personalize treatment. The key points supporting 
telomeres as a predictive biomarker of individual radiosensitivity are summarized here: 
• Telomere length (TL) varies between individuals and on individual chromosome arms. TL 
in somatic proliferative tissues naturally declines with each cell replication cycle, and 
thus with increasing age. The natural shortening of telomeres can be accelerated by 
endogenous factors (e.g. metabolic stress leading to point mutations or deletions in 
genes encoding proteins involved in telomere protection, as well as recombination and 
epigenetic regulation) and by external environmental stress and lifestyle factors that 
cause DNA DSBs or mis-replication of telomeres (e.g. IR and other oxidizing agents, 
oxidative stress, inflammation, hyperoxia, oncogenes, toxins, chronic viral infections, 
smoking, alcohol consumption, obesity, stress, and even psychiatric conditions). TL can 
therefore be considered as a prognostic marker that takes into account a set of all 
past events. 
• Reduced TL reflects the accumulation of previous insults from various damaging 
conditions and has been associated with numerous chronic diseases that are generally 
considered to be diseases of aging, such as diabetes, cancer, and heart disease 
(M'Kacher et al., 2015b). Abnormal telomerase activity and TL regulation have also been 
linked to the pathology of several age-related human diseases, as described in Section 
1.1.3 (Armanios and Blackburn, 2012;Holohan et al., 2014). Telomerase is up-regulated 
in about 85% of human cancers (and is silent in most differentiated cells such as normal 
somatic cells), suggesting its important role in the process of cellular immortalization and 
tumorigenesis. This illustrates that telomeres and mechanisms of telomere 
maintenance play important roles at various stages in the initiation and 
development of cancer and other human pathologies. 
• Telomeric regions (and sub-telomeric regions) are particularly sensitive to IR-induced 
oxidative stress and are more prone to DSBs, perhaps due to their inappropriate 
processing: the presence of DNA damage within telomeric repeat sequences hinders 
telomere replication, leading to telomere shortening or loss, and the deficiency of DSB 
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repair near telomeres has been suggested to play a role in chromosomal instability 
associated with human cancers. This makes telomeres more sensitive to IR 
exposure than the rest of the genome, and thus to radiotherapy. 
• Telomeres and DDR mechanisms exhibit a co-dependent, bi-directional relationship, as 
dysfunctional telomeres are recognized as DSBs and trigger the DDR pathways, whose 
proteins are also involved in the normal maintenance and protection of telomeres 
(Section 1.1.2). As DDR processes are also closely linked to radiosensitivity, 
telomere maintenance is also likely to be closely linked to radiosensitivity.  
 
All of this evidence indicates that telomeres and telomere maintenance could be 
sensitive and reliable biomarkers of IR exposure, and could be a new parameter to predict 
individual radiosensitivity (Pernot et al., 2012;Shim et al., 2014;Mirjolet et al., 2015). As we 
have found that radiosensitivity could indeed be predicted by a combination of age and 
gender, as well as the combination of inherent and IR-induced changes in TL following TC-
FISH analysis (Section 4.2), we postulate that these factors can be adapted to establish a 
clinical method of identifying radiosensitive individuals. The ability to reliably predict 
individual radiosensitivity would have important implications in biological dosimetry 
(discussed in detail in Section 1.4.3) and radiotherapy (discussed in detail in Section 1.4.2), 
as it would allow for refinement of radiation protection protocols to identify and especially 
protect highly radiosensitive individuals. Though the analysis of telomeres and TL using TC-
FISH (or other methods) may be too complex (and time-consuming) to use as the actual 
biomarker to provide dose estimates based on its measurements for biodosimetry purposes 
(due to the intra- and inter-individual heterogeneity of TL), prior knowledge of an individual’s 
radiosensitivity (i.e. those individuals that have already been classified as highly 
radiosensitive) can perhaps aid in the proper medical triage of these individuals. TC-FISH 
analysis of telomeres and TL to predict individual radiosensitivity could, however, be useful 
in the context of radiotherapy. Nevertheless, there remains the issue of how to effectively 
measure and rank individuals based on their radiosensitivity, as discussed in Section 1.4.3. 
Since the method that we use to create triage categories in the case of an emergency 
situation using global fluorescence of γH2AX at the time point of 4 hours post-irradiation 
allows for creation of such triage categories independently of individual radiosensitivity 
(Section 2), it foregoes the issue of ranking individuals based on their radiosensitivity. 
Though this method is rapid and capable of high-throughput analysis (both crucial in the 
case of a mass accident), this analysis is hindered by the time-sensitive nature of the 
measurement of γH2AX. 
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In the context of radiotherapy, as also highlighted in (Mirjolet et al., 2015), the ability 
to reliably predict individual radiosensitivity could allow for personalization of treatment. 
Additionally, as radiosensitivity has been associated with TL and telomerase activity, the 
management of TL and telomerase could be useful during radiotherapy. Indeed, shorter TL 
has been linked with increased radiosensitivity in many in vivo and in vitro studies in 
telomerase-deficient mouse and human cells. Down-regulation or inhibition of telomerase 
was shown to compromise the viability of cancer cells while minimally affecting normal cells; 
thus, the use of telomerase inhibitors during cancer therapy may sensitize cancer cells to 
chemotherapy and radiotherapy. On the other hand, radioresistant carcinoma cells exhibited 
up-regulation of telomerase activity and longer telomeres (Genesca et al., 2006;Ayouaz et 
al., 2008;Shim et al., 2014). The authors of Mirjolet et al also propose that TL and telomeric 
shelterin protein analysis in both cancer cells (to assess tumor sensitivity) and normal cells 
(to assess radiotherapy tolerance) could be useful in the personalization of radiotherapy 
treatments based on individual radiosensitivity. TL could be used to adjust doses per 
fraction, and the effectiveness and safety of radiotherapy could be enhanced with the use of 
pharmacological interference of telomere biology (e.g. reduce TL) in tumor cells (Mirjolet et 
al., 2015).  
In the coming months, we aim to confirm the correlations between individual 
radiosensitivity and TL (presented in Section 4.2) in the PBL of a larger cohort of at least 30 
donors (in an ad hoc study with approved funding from DoReMi). This cohort will be selected 
from a previously established biobank for a separate project (EpiRadBio). As mean inherent 
TL was previously determined for the EpiRadBio project, donors representing the extremes 
in terms of TL will be selected and subjected to in vitro irradiation. TL will be determined 
following telomere-PNA FISH staining before and after irradiation, and will be analyzed by 
automated image capture and analysis. Metaphase spreads will also be stained with TC-
FISH, and radiosensitivity of the PBLs will be determined in terms of DSBs per cell following 
automated analysis with the software (TCScore) developed in our laboratory (previously 
discussed in Section 3, and presented in (M'Kacher et al., 2014)).  
Telomeres, long considered the guardians of the genome, can arguably represent 
the potential overall health of a being, as it can represent a lifetime of exposures to various 
DNA damaging agents including ionizing radiation (as they are deficient in repair and 
therefore leads to accumulation of damages). Telomeres and mechanisms of their 
maintenance could therefore have important implications in long-term human health. As 
humans are constantly exposed to IR via natural and man-made sources, determining if/how 
telomeres play a role in the mechanisms of direct and indirect IR-induced biological effects, 
as well as their role in the transmission of these IR-induced effects during cell proliferation 
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can be critical to the determination of the long-term effects of IR on human health, and can 
contribute to our understanding of how IR-associated cancers and other human pathologies 
arise.  
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APPENDIX 
A.1. Materials and Methods for lymphocyte radiosensitivity studies 
A.1.1. Cell culture and irradiation 
Peripheral blood lymphocytes (PBL) used in these studies were isolated from the 
whole blood of healthy blood donors (with negative viral status) from the Center of Blood 
Transfusions using the standard Ficoll isolation technique. After isolation, lymphocytes were 
frozen in liquid nitrogen (-196°C) until use. Lymphocytes were unfrozen 24 hours before 
irradiation and incubated at 37°C in an atmosphere of 5% CO2 in RPMI 1640 medium 
(Gibco) supplemented with 20% fetal bovine serum (FBS; Eurobio) and antibiotics 
(penicillin/streptomycin; Gibco). Lymphocytes were irradiated at various doses at room 
temperature (RT) with γ-rays from a Cesium-137 source at the CEA Fontenay aux Roses, 
France (dose-rate of 2 Gy/min).  
Carbon-13 irradiations were performed on the GANIL D1 high energy line with 
energy of 75 MeV/u. Lymphocytes were irradiated in small tubes with a glass wall of 2 mm 
thickness. Samples were irradiated at the plateau region of the Bragg peak curve; the mean 
LET at the sample was estimated to be approximately 36.5 keV/µm. The dosimetry was 
realized with the assistance of CIMAP-CIRIL physicists using a Faraday cup and an X-ray 
detector (5 µm stainless steel foil and photomultiplier). The photons emitted after traversal of 
the foil by the accelerated ions were counted, and a correlation at low fluences/doses was 
established with the real ion tracks measured on CR39 tracks detectors (C12H18O7)n. After 
exposure to the beam, the ion tracks in the CR39 were chemically etched for 8 to 12 min in 
12 N KOH at 80°C. Several microscope fields were photographed using an Olympus Vanox-
S, x100, equipped with a Cohn Pieper FK-7512-Q video camera. The tracks were then 
counted using a homemade image analysis application from the Aphelion® software. X-ray 
detector doses were also subsequently correlated to the doses measured with an ionizing 
chamber (Unidos 23332 or 23344, PTW Freiburg, Germany, depending on the ion atomic 
number and its track length) for further verification of the dose/fluence-ratio. The ionizing 
chamber was not used as reference dosimeter for the sample irradiations since it was 
designed for measuring photon fluxes (utilized in radiotherapy). 
 
A.1.2. Collection of metaphase spreads 
To obtain metaphases for cytogenetic analysis, isolated PBLs were stimulated 
immediately after irradiation using recombinant human interleukin 2 and phytohemagglutinin 
(PHA; Gibco), and bromodeoxyuridine (BrdU; Sigma-Aldrich) was added to the culture 
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medium. Lymphocytes were incubated with BrdU for 60 hours after irradiation at 37°C in an 
atmosphere of 5% CO2. At 60 hours post-irradiation, 60 ng/mL colchicine (Gibco) was added 
into culture media for 2 hours at 37°C and 5% CO2 to accumulate mitotic cells. Cells were 
harvested and centrifuged at RT at 1400 rpm for 7 min, almost all of the supernatant was 
aspirated, and cells were resuspended in 10 mL of 37°C 0.075 M KCl (hypotonic shock to 
swell the cells) and incubated for 20 min in a 37°C water bath. For prefixation, a few drops of 
fixative solution (3:1 v/v ethanol/acetic acid; both from VWR Chemicals) were added to each 
tube. Tubes were gently inverted several times to mix well, then centrifuged again at RT for 
1400 rpm for 7 min. The KCl solution was removed after the second centrifugation step, and 
cells were resuspended in 10 mL of fixative solution. These fixation and centrifugation steps 
were repeated twice more, and samples were incubated in fresh fixative solution overnight at 
4°C. Cells were washed once more with the fixative solution before metaphases were 
spread on ice cold, wet slides the next day. Slides with metaphase spreads were dried at RT 
overnight, and then stored in -20°C until use. 
 
A.1.3. Telomere/centromere-FISH (TC-FISH) 
Analysis of chromosomal aberrations was done as previously described (M'Kacher et 
al., 2014) on slides with metaphase spreads using telomere-specific Cyanine3-labeled 
protein nucleic acid (PNA) probe and centromere-specific FITC-labeled PNA probes (both 
from Panagene, Daejon, South Korea). Slides stored at -20°C were unfrozen and left at RT 
overnight before the experiment. Dry slides were soaked in PBS for at least 5 min, and then 
were fixed in 4% formaldehyde for 2 min followed by 3 successive washes in PBS for 5 min 
each. Pepsin (Gibco) was diluted in 1 N HCl pH 2 to a final concentration of 0.3 mg/mL, and 
40 µL were deposited on each slide, covered with a plastic coverslip, and incubated in a 
humid (H2O) chamber at 37°C for 7 min. Plastic coverslips were removed and slides were 
gently placed briefly (30 sec) in PBS. Slides were fixed again in 4% formaldehyde for 2 min, 
followed by 3 successive washes in PBS for 5 min each. Slides were dehydrated in 50%, 
70%, and 100% ice cold ethanol for 5 min each, and slides were left to dry at RT for ~20 
min. PNA telomere and centromere probes were diluted (1:100 dilution each) in home-made 
PNA hybridization buffer (70% formamide, 10 mM Tris pH 7.2), and 50 µL were deposited on 
each slide and covered with plastic coverslips. Slides were denatured for 3 min on a hot 
plate at 80°C, and then were left in dark humid chambers at RT for ~2 hours. Slides were 
washed twice for 15 min each in 70% formamide-10 mM Tris-HCl pH 7.2 solution, and then 
3 times for 5 min each in solution containing 50 mM Tris-HCl pH 7.2, 150 mM NaCl, and 
0.05% Tween-20. After counter-coloration of the DNA with 4´,6-diamidino-2-phenylindole 
(DAPI) for 5 min, slides were placed in PBS, and then mounted with coverslips with PPD (1 
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mg/mL p-phenylenediamine-90% glycerol-10% PBS). Slides were kept in a dark box at 
stored at -4°C until automated image capturing with MetaSystems, and images were 
analyzed using the MetaSystems ISIS software as previously described (M'Kacher et al., 
2014). 
 
A.1.4. Multicolor-FISH (M-FISH) 
Slides were hybridized with a 24XCyte mFISH kit (Metasystems Altlussheim, 
Germany) according to the protocol recommended by the manufacturer. If previous 
hybridization was done on the slides, slides were soaked in PBS for 15-30 min to remove 
the glass coverslip. To denature the chromosomes, slides were rinsed for 1 min in 0.1xSSC 
pH 6.3 (15 mM NaCl + 0.15 mM Tris sodium citrate) at RT, followed by 30 min in 2xSSC pH 
6.3 (300 mM NaCl + 30 mM Tris sodium citrate) at 70°C. The 2xSSC with the slides inside 
was cooled to 37°C, and slides were rinsed for 1 min each in 0.1xSSC pH 6.3 at RT, 0.07 N 
NaOH at RT, 0.1xSSC pH 6.3 at 4 °C, and 2xSSC pH 6.3 at 4°C. Slides were then 
dehydrated in 30%, 50%, 70%, and 100% ethanol for 1 min each at RT, and were dried at 
RT for at least 15 min. The probe was denatured for 5 min in 75°C, and pre-hybridized for 30 
min at 37°C. The probe was then centrifuged and vortexed, and ~10 µL was deposited onto 
each slide and covered with a plastic coverslip. Slides were incubated in a humid chamber 
of 50% formamide at 37°C for ~4 nights. Post-hybridization, slides were placed in pre-
warmed 0.4xSSC pH 7.0 at 72°C for 2 min, followed by 30 sec in 2xSSCT (2xSSC pH 7.0 
and 0.05% Tween-20) at RT. After counter-coloration of the DNA with DAPI for 5 min, slides 
were placed in PBS, and then mounted with coverslips with PPD. Slides were kept in a dark 
box at stored at -4°C until automated image capturing with MetaSystems, and images were 
analyzed using the MetaSystems ISIS software. 
 
A.1.5. γH2AX immunofluorescence  
At specified time points (0.5, 1, 2, and 24 hours) following γ-irradiation (0, 0.2, 2, and 
8 Gy), lymphocytes (approximately 100,000 cells) were fixed onto polylysine slides using 
Cytospin®. Cells were then fixed for 15 min in 0.4% paraformaldehyde (PFA), which stops 
cell metabolism. Slides were then placed in a permeabilization buffer (20 mM Hepes pH 7.9, 
50 mM sodium chloride, 3 mM magnesium chloride, 300 mM sucrose, and 0.5% Triton) for 
30 min, followed by 1 hour at 37°C in blocking buffer I (Boehringer Ingelheim 1% Blocking 
Reagent®, 5% FBS, and 0.5% Triton in PBS). Slides were incubated with primary antibody 
(Upstate anti-phosphorylated H2AX from mice, 2 µg/mL) diluted in blocking buffer I for 1 
hour at 37°C. Excess antibody was removed by three successive rinses in PBS-0.5% triton 
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for 5 min each, and slides were blocked once more in blocking buffer II (Boehringer 
Ingelheim 1% Blocking Reagent® and 0.1% Triton in PBS) for 10 min at RT. Slides were 
then hybridized with anti-mouse secondary antibody coupled to Cyanine-3 (Upstate) in 
blocking buffer II for 1 hour at 37°C, and excess secondary antibody was removed with three 
rinses in PBS-0.5% Triton for 5 min each. Slides were washed briefly in PBS, counterstained 
with DAPI, and then mounted with coverslips with PPD. Slides were kept in a dark box and 
stored at -4°C until capture with MetaSystems. 
 
A.1.6. Imaging using MetaSystems, and analysis using ISIS 
Images of hybridized slides were captured with a charge-coupled device camera 
(Zeiss, Thornwood, NY) coupled to a Zeiss Axioplan microscope. Two MetaSystems 
softwares allow automatic image scanning. “MetaCyte" photographs interphasic nuclei under 
10X objective and quantifies the cellular intensity of fluorescence markers of interest (e.g. 
telomeric PNA probes, γH2AX); this software rapidly photographs thousands of interphasic 
nuclei, and pooled data summaries or data of each individual nucleus could be directly 
exported for statistical analyses using Microsoft Excel or other statistical software. MetaCyte 
parameters used to capture γH2AX global fluorescence is described in our recently 
published paper (Viau et al., 2015). “AutoCapt" photographs metaphases hybridized with 
fluorescent probes (e.g. TC-FISH and M-FISH) under 63X objective; images were then 
exported for analysis using the MetaSystems ISIS software or other imaging software. 
Images of individual nuclei (e.g. for manual γH2AX foci scoring) can also be captured 
manually under 63X objective using the “Metafer4” software (MetaSystems). For the manual 
scoring of γH2AX foci, the integration time for DAPI was set to automatic, and the integration 
time for SpO to capture Cyanine-3 labeled foci was fixed to 0.003 sec. Additionally, to take 
into account the roundness of the interphasic nuclei of lymphocytes, images were captured 
in 8 stacks, 5 µm apart; the MetaSystems software automatically compiled these stacks into 
a single image per nucleus. Images were exported in JPEG format for analysis using Image 
J: upon opening the JPEG images in ImageJ, each nucleus was cropped, subjected to RGB 
split, and the number of foci was counted. 
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A.2. Supplemental figures 
 
Figure A-1. (A) Representative images of γH2AX foci for manual scoring in interphasic 
lymphocyte nuclei irradiated with γ-rays from a Cesium-137 source at the indicated doses (0 to 
8 Gy) at 2 and 24 hours post-irradiation. Images of nuclei for manual scoring of foci was 
captured under 63X magnification using Metafer® software (MetaSystems®). Foci were 
manually scored using ImageJ software. (B) Dispersion of manually scored γH2AX foci in 
lymphocytes from 5 blood donors (increasing radiosensitivity measured using cytogenetic 
analysis associated with labels from A to R, presented in Section 3.1.1 of this thesis). 
Lymphocytes were irradiated with γ-rays from a Cesium-137 source at the indicated doses (0 
to 8 Gy) and placed at 37°C for repair. Cells were harvested at the indicated times (0.5–24 
hours post-irradiation) for staining. Data points represent results obtained for one experiment 
with each donor. γH2AX foci following irradiation with 8 Gy at 0 to 2 hours post-irradiation was 
not quantifiable due to fluorescence saturation of nuclei; however, foci following 8 Gy 
irradiation were quantifiable at 24 hours post-irradiation. Large inter-individual variability can 
be observed; this variability increases with dose, with maximum variability at 1 hour after 2 Gy 
irradiation, and decreases with time post-irradiation. Basal levels of γH2AX (0 Gy) are not 
negligible (Complementary results of (Viau et al., 2015)).  
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Table A-1. Correlations between radiosensitivity (DSBs per cell) and induction of γH2AX (at 
several time points between 0.5 and 24 hours post-irradiation) to 2 Gy of γ-rays or carbon ions. 
γH2AX induction was measured in terms of global fluorescence in 8 donors (Donors A, B, G, H, 
K, M, Q, R) of the cohort discussed in Sections 3.1 and 3.2. Radiosensitivity to 2 Gy of γ-rays 
and γH2AX induction at 0.5 hours post-irradiation to 2 Gy of γ-rays show moderate correlation 
(R2 = 0.595, red text); however, these results remain to be confirmed in a larger cohort. This 
correlation is also plotted in Figure A-2 below. No other correlations were observed. 
 
Time post-
irradiation  
(hours) 
R2 values (8 donors) 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2Gy 
γH2AX - gamma 2Gy 0.5 0.595* 0.329 
 3 0.012* 0.082 
 6 0.002* 0.114 
 24 0.010 0.239 
    
γH2AX - carbon 2Gy 0.5 0.140 0.368 
 3 0.004 0.000** 
 24 0.001 0.076 
* Data for Donor H missing. ** Data for Donor G missing. 
 
 
Figure A-2. Moderate correlation (R2 = 0.595) between radiosensitivity to 2 Gy of γ-rays and 
γH2AX induction at 0.5 hours post-irradiation to 2 Gy of γ-rays. Induction of γH2AX was 
measured in terms of global fluorescence in 7 donors (Donors A, B, G, K, M, Q, R) of the 
cohort discussed in Sections 3.1 and 3.2. These results remain to be confirmed in a larger 
cohort. 
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Figure A-3. Sensitivity to IR-induced apoptosis after in vitro γ-irradiation (0 to 6 Gy) in 
lymphocyte subpopulations of 17 healthy blood donors (Donors A-H, J-R) of the cohort 
discussed in Section 3.1. Apoptosis (Annexin V) in quiescent lymphocytes was determined 
using 8-color flow cytometry [method details are given in (Schmitz et al., 2007)]. T and non-T 
lymphocytes were identified based on phycoerythrin-Texas-red fluorescence (CD3). A 
phycoerythrincyanin 7 (CD4) versus APC-cyanin 7 (CD8) histogram allowed for the 
identification of T4 and T8 lymphocytes. T4 and T8 subpopulations were discriminated using 
an APC (CD45RA) versus phycoerythrin (CD62L) histogram as follows: central memory (CM; 
CD62L+ CD45RA-), effector memory (EM; CD62L- CD45RA-), naive (N; CD62L+ CD45RA+), and 
terminal effector (TE; CD62L- CD45RA+). B cells were determined on a bivariate histogram of 
APC (CD45RA) vs. phycoerythrin-cyanin 5 (CD19) of non-T lymphocytes. Average surviving 
fractions (%) and standard deviation (error bars) are presented as a function of dose (Gy) of γ-
irradiation for (A) B-, T4-, and T8- lymphocyte subpopulations, and for (B) T8 and (C) T4 
subpopulations. Surviving fractions at 0 Gy were not normalized to 100% to illustrate basal 
(spontaneous) levels of apoptosis. As the susceptibility to IR-induced apoptosis in the T4-EM 
subpopulation was found to be correlated with radiosensitivity following γ-irradiation (Schmitz 
et al., 2007), we looked at whether the slope of IR-induced apoptosis in T4-EM lymphocytes 
between the doses of 0 and 6 Gy of γ-irradiation (blue data points in panel (C)) correlates to 
individual radiosensitivity to 2 Gy of γ-irradiation (Figure 17A); as shown in panel (D), no 
correlations were found (R2=0.045). 
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Table A-2. No correlations (R2 coefficients) between radiosensitivity (DSBs per cell) to 2 Gy of 
γ-rays or carbon ions and sensitivity to spontaneous (0 Gy) or IR-induced apoptosis (2 Gy of γ-
rays). Results of individual donors that were included in the analysis shown in Figure A-3 were 
correlated with radiosensitivity results discussed in Sections 3.1 and 3.2. Correlations with 
radiosensitivity to 2 Gy of γ-rays included 17 donors (Donors A-H, J-R), and correlations with 
radiosensitivity to 2 Gy of carbon ions included 13 donors (Donors A-C, E-H, J-M, Q, R). 
 
% Surviving fraction at  
0 Gy 
% Surviving fraction at  
2 Gy γ-irradiation 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
B 0.000 0.005 0.003 0.084 
T4 0.088 0.257 0.052 0.298 
T4-TE 0.015 0.466 0.013 0.304 
T4-N 0.023 0.322 0.045 0.121 
T4-CM 0.001 0.023 0.000 0.021 
T4-EM 0.080 0.227 0.048 0.262 
T8 0.025 0.299 0.037 0.231 
T8-TE 0.006 0.218 0.000 0.236 
T8-N 0.067 0.110 0.072 0.050 
T8-CM 0.051 0.000 0.057 0.020 
T8-EM 0.024 0.266 0.033 0.185 
 
 
Table A-3. No correlations (R2 coefficients) between radiosensitivity (DSBs per cell) to 2 Gy of 
γ-rays or carbon ions and sensitivity to IR-induced apoptosis at other doses of γ-irradiation 
(0.5, 1, 6 Gy). Results of individual donors that were included in the analysis shown in Figure 
A-3 were correlated with radiosensitivity results discussed in Sections 3.1 and 3.2. 
Correlations with radiosensitivity to 2 Gy of γ-rays included 17 donors (Donors A-H, J-R), and 
correlations with radiosensitivity to 2 Gy of carbon ions included 13 donors (Donors A-C, E-H, 
J-M, Q, R). 
 
% Surviving fraction at  
0.5 Gy γ-irradiation 
% Surviving fraction at  
1 Gy γ-irradiation 
% Surviving fraction at  
6 Gy γ-irradiation 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
B 0.010 0.004 0.006 0.081 0.012 0.092 
T4 0.071 0.277 0.084 0.266 0.071 0.230 
T4-TE 0.024 0.388 0.021 0.386 0.002 0.232 
T4-N 0.055 0.220 0.030 0.053 0.126 0.020 
T4-CM 0.004 0.000 0.002 0.047 0.027 0.103 
T4-EM 0.070 0.253 0.080 0.240 0.078 0.192 
T8 0.033 0.274 0.042 0.242 0.018 0.226 
T8-TE 0.003 0.242 0.001 0.236 0.008 0.200 
T8-N 0.030 0.150 0.014 0.014 0.005 0.029 
T8-CM 0.016 0.002 0.012 0.045 0.012 0.059 
T8-EM 0.027 0.247 0.034 0.184 0.010 0.150 
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Figure A-4. Sensitivity to IR-induced apoptosis after in vitro carbon irradiation (0 to 6 Gy) in 
lymphocyte subpopulations of 16 healthy blood donors (Donors A-H, J-O, Q, R) of the cohort 
discussed in Section 3.2. Apoptosis (Annexin V) in quiescent lymphocytes was determined 
using 8-color flow cytometry [method details are given in (Schmitz et al., 2007)]. T and non-T 
lymphocytes were identified based on phycoerythrin-Texas-red fluorescence (CD3). A 
phycoerythrincyanin 7 (CD4) versus APC-cyanin 7 (CD8) histogram allowed for the 
identification of T4 and T8 lymphocytes. T4 and T8 subpopulations were discriminated using 
an APC (CD45RA) versus phycoerythrin (CD62L) histogram as follows: central memory (CM; 
CD62L+ CD45RA-), effector memory (EM; CD62L- CD45RA-), naive (N; CD62L+ CD45RA+), and 
terminal effector (TE; CD62L- CD45RA+). B cells were determined on a bivariate histogram of 
APC (CD45RA) vs. phycoerythrin-cyanin 5 (CD19) of non-T lymphocytes. Average surviving 
fractions (%) and standard deviation (error bars) are presented as a function of dose (Gy) of 
carbon ions for (A) B-, T4-, and T8- lymphocyte subpopulations, and for (B) T8 and (C) T4 
subpopulations. Surviving fractions at 0 Gy were not normalized to 100% to illustrate basal 
(spontaneous) levels of apoptosis. (D) No correlations were found (R2=0.004) between the 
susceptibility to IR-induced apoptosis (i.e. slope of IR-induced apoptosis between the doses of 
0 and 6 Gy of carbon irradiation, the blue data points in panel (C)) in the T4-EM subpopulation 
and radiosensitivity following 2 Gy carbon irradiation (Figure 21A). 
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Table A-4. No correlations (R2 coefficients) between radiosensitivity (DSBs per cell) to 2 Gy of 
γ-rays or carbon ions and sensitivity to spontaneous (0 Gy) or IR-induced apoptosis (2 Gy of 
carbon ions). Results of individual donors that were included in the analysis shown in Figure 
A-4 were correlated with radiosensitivity results discussed in Sections 3.1 and 3.2. 
Correlations with radiosensitivity to 2 Gy of γ-rays included 16 donors (Donors A-H, J-O, Q, R), 
and correlations with radiosensitivity to 2 Gy of carbon ions included 13 donors (Donors A-C, 
E-H, J-M, Q, R). 
 
% Surviving fraction at  
0 Gy 
% Surviving fraction at  
2 Gy carbon irradiation 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
B 0.001 0.011 0.011 0.024 
T4 0.201 0.001 0.220 0.015 
T4-TE 0.033 0.053 0.044 0.117 
T4-N 0.000 0.040 0.027 0.047 
T4-CM 0.096 0.138 0.092 0.102 
T4-EM 0.177 0.002 0.199 0.000 
T8 0.025 0.124 0.055 0.150 
T8-TE 0.113 0.050 0.144 0.078 
T8-N 0.002 0.076 0.024 0.118 
T8-CM 0.066 0.016 0.093 0.065 
T8-EM 0.040 0.040 0.072 0.074 
 
 
Table A-5. No correlations (R2 coefficients) between radiosensitivity (DSBs per cell) to 2 Gy of 
γ-rays or carbon ions and sensitivity to IR-induced apoptosis at other doses of carbon 
irradiation (1, 6 Gy). Results of individual donors that were included in the analysis shown in 
Figure A-4 were correlated with radiosensitivity results discussed in Sections 3.1 and 3.2. 
Correlations with radiosensitivity to 2 Gy of γ-rays included 16 donors (Donors A-H, J-O, Q, R), 
and correlations with radiosensitivity to 2 Gy of carbon ions included 13 donors (Donors A-C, 
E-H, J-M, Q, R). 
 
% Surviving fraction at  
1 Gy carbon irradiation 
% Surviving fraction at  
6 Gy carbon irradiation 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
DSB/Cell 
Gamma 2Gy 
DSB/Cell 
Carbon 2 Gy 
B 0.011 0.040 0.000 0.039 
T4 0.253 0.001 0.200 0.009 
T4-TE 0.034 0.101 0.017 0.131 
T4-N 0.032 0.098 0.004 0.099 
T4-CM 0.170 0.215 0.368 0.143 
T4-EM 0.204 0.000 0.213 0.000 
T8 0.015 0.143 0.035 0.146 
T8-TE 0.121 0.068 0.118 0.070 
T8-N 0.023 0.058 0.013 0.001 
T8-CM 0.108 0.005 0.081 0.010 
T8-EM 0.028 0.046 0.036 0.052 
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A.3. Additional original bibliographies 
A.3.1. The impact of adaptive and non-targeted effects in the biological 
responses to low dose/low fluence ionizing radiation: The modulating 
effect of linear energy transfer 
 
In the following abstract (de Toledo et al., 2011), we discuss in detail evidence from 
mechanistic studies of the influence of radiation LET on the induction of the adaptive 
response and non-targeted effects following exposure to low doses of IR.  
 
 
Summary of the key points of this abstract: 
• Normal human or rodent cells exposed to low chronic doses of low-LET IR were better 
able to correctly repair DNA lesions resulting from endogenous metabolism or a 
subsequent challenge exposure to IR, and were less likely to transform to the neoplastic 
phenotype.  
• In contrast, cells exposed to low-doses of high-LET IR (including alpha and heavy ion 
particles) did not induce adaptive responses, but instead showed persistent stressful 
effects such as oxidative stress, mitochondrial dysfunction, and genomic DNA damage in 
both the directly targeted cell as well as their neighboring, bystander cells and their 
progeny. I aided in the development and optimization of the assays used to measure 
antioxidant enzyme activity in normal human cells and mice tissue; these assays were 
used in many of these studies in correlation to oxidative stress and levels of ROS. 
• The data strongly support a role for IR dose and quality (i.e. LET) in determining the 
nature of the induced IR effects at low doses. 
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A.3.2. Book Chapter – Bystander effects and adaptive responses modulate in 
vitro and in vivo biological responses to low dose ionizing radiation 
 
In this book chapter (Zhang et al., 2012), we provide a more detailed review of topics 
discussed in the preceding paper above (de Toledo et al., 2011). We characterize biological 
effects that are induced in normal mammalian cells and tissues exposed to low doses/low 
fluences of IR of various LET.  
 
 
Summary of the key points of this chapter: 
• There is strong evidence of bystander and adaptive responses. 
• The LET of the IR has been shown to play a critical role in triggering either protective 
or stressful effects at low doses of IR exposure.  
• The data strongly support a role for intercellular communication and oxidative 
metabolism in the mediation of IR-induced non-targeted effects. As above, I aided in 
the development and optimization of the assays used to measure antioxidant 
enzyme activity, which were used in many of these studies in correlation to oxidative 
stress and levels of ROS. 
• Our data suggest that biological responses to low doses of IR exposure alter the 
linearity of the dose-response relationship that is predicted by biophysical arguments.  
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A.3.3. Encyclopedia Entry – Telomere 
 
This encyclopedia entry, published in the Encyclopedia of Pathology, provides an 
overview of telomeres, mechanisms of telomere maintenance, and the roles of telomeres 
and telomerase in human pathology (Frenzel et al., 2014). I have contributed to the 
development of the manuscript and provided Figure 2 in the entry. 
 
 
Summary of the key points of this article: 
• Telomeres and their structure and functions are defined. 
• The role of telomeres in replicative senescence, the mechanisms of telomere 
maintenance, and consequences of telomere dysfunction and chromosomal 
instability are outlined. 
• Finally, the roles of telomeres and telomerase activity in carcinogenesis are 
discussed. 
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A.3.4. Lead exposure induces telomere instability in human cells 
 
In the following paper (Pottier et al., 2013), we present evidence that lead (Pb) 
neurotoxicity is due to Pb-induced “telomere-induced foci” (TIFs), which leads to telomere 
instability and loss of telomere maintenance. In this thesis, we expand upon the analysis of 
basal levels of telomere abnormalities (telomere loss or doublets) in 20 healthy individuals 
included in this paper (shown in Figure S2 in the paper) as we analyze a cohort of 35 
healthy individuals (age range of 23 to 58, mean age of 39.5); these results are described in 
Section 0 of this thesis.  
 
 
Summary of the key points of this paper: 
• While in vitro Pb exposure (in the form of lead nitrate) did not increase intra-
chromosomal γH2AX foci, it significantly increased the frequency of TIFs, which are 
formed when DNA repair machinery (e.g. γH2AX) recognize short or dysfunctional 
telomeres (uncapped or damaged telomeres) as DSBs, thus leading to γH2AX 
localization at these (intact) telomeres. 
• The formation of TIFs at these intact telomeres likely leads to their loss due to 
perturbations of telomere replication, particularly on the lagging DNA strand. 
• We propose a model for telomere instability following Pb exposure that could explain Pb-
induced neurotoxicity.  
• As numerous studies have demonstrated a role for telomere maintenance in brain 
development and tissue homeostasis, our results provide novel insight into the link 
between Pb exposure, telomere maintenance, and the biological responses that lead to 
the permanent neurotoxic effects. 
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Figure'S1.' Lead' induces' the'appearance'of' telomere'doublets.'Appearance'of'
telomere'doublets'observed'in'B3'cells'a=er'24'h'exposure'with'the'indicated'
Pb(NO3)2'concentraGons'and'normalized'to'the'corresponding'mitoGc'index.'''
Figure' S2.' Lead' induces' telomere' instability' in' primary' human' blood' lymphocytes.' To'
measure' inter:individual' variability,' the' spontaneous' level' of' telomere' loss' and' doublet'
forma>on'were'measured'in'the'blood'lymphocytes'of'20'healthy'donors'(Panels'A'and'B).'
The'values'represent'the'mean'of'the'independent'analyses'of'3'diﬀerent'evaluators.'The'
eﬀect' of' Pb' on' telomere' loss' and' doublet' forma>on' were' measured' in' human' blood'
lymphocytes'of'7'donors'aIer'24'h'exposure'with' the' indicated'Pb(NO3)2'concentra>ons'
(Panels'C'and'D).'*p<0.05,'**'p<0.01.'In'all'cases,'50'metaphase'spreads'were'analyzed.'
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